<?xml version="1.0" encoding="UTF-8"?>
<registryObjects xmlns="http://ands.org.au/standards/rif-cs/registryObjects"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xsi:schemaLocation="http://ands.org.au/standards/rif-cs/registryObjects https://researchdata.edu.au/documentation/rifcs/schema/registryObjects.xsd">
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043672</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043672</identifier>
            <identifier type="nhmrc">2043672</identifier>
            <name type="primary">
                <namePart>CELLOGRAMRx: Pan-Cancer Cellular composition and signalling relationship mapping to identify novel therapeutic targets</namePart>
            </name>
            <name type="alternative">
                <namePart>International Collaborations</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7043</identifier>
                <title>2024 NHMRC-AMED Adopting Sustainable Partnerships for an Innovative Research Ecosystem</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6862-136X</identifier>
                <title>Dr Ankur Sharma</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/057zh3y96</identifier>
                <title>University of Tokyo</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/030vbmf58</identifier>
                <title>RIKEN Advanced Science Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b3dvp57</identifier>
                <title>The Garvan Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Genomics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Tumour immunology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer diagnosis</subject>
            <subject type="local">genomics</subject>
            <subject type="local">cancer biology</subject>
            <subject type="local">tumour immunology</subject>
            <subject type="local">comparative genomics</subject>
            <subject type="local">immunotherapy</subject>
            <description type="Chief Investigator Team">Dr Ankur Sharma&lt;br/&gt;Prof Jacob George&lt;br/&gt;Prof Joseph Powell&lt;br/&gt;Prof Alexander Swarbrick&lt;br/&gt;Dr Ziyi Li&lt;br/&gt;Dr Archita Mishra&lt;br/&gt;Dr Shila Ghazanfar&lt;br/&gt;Assoc Prof Venessa Chin&lt;br/&gt;Dr Kylie James&lt;br/&gt;Dr Jia Liu&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;Japan&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-12T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">In collaboration between Australian and Japanese cancer researchers, clinicians and data scientists, we will build a comprehensive pan-cancer spatial map of cancer cells and their immune system from ~2000 patients representing top 10 cancers in our countries. This map will help in understanding why current therapies work only in some patients and some subtypes of cancers. This map will also allow us to identify new drug targets to develop novel therapies and rationalise treatment selection.</description>
            <description type="fundingAmount">$1,988,050.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2028-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043991</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043991</identifier>
            <identifier type="nhmrc">2043991</identifier>
            <name type="primary">
                <namePart>Mechanisms blocking the repair of mammalian hearts after injury: using AI-assisted directed evolution of novel biologics to empower regeneration.</namePart>
            </name>
            <name type="alternative">
                <namePart>International Collaborations</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7043</identifier>
                <title>2024 NHMRC-AMED Adopting Sustainable Partnerships for an Innovative Research Ecosystem</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1042-2587</identifier>
                <title>Prof Robert Graham</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03trvqr13</identifier>
                <title>Victor Chang Cardiac Research Institute Limited</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05gvja138</identifier>
                <title>Centenary Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01v55qb38</identifier>
                <title>National Cerebral and Cardiovascular Center</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/019wvm592</identifier>
                <title>Australian National University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Molecular evolution BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Synthetic biology</subject>
            <subject type="local">tissue repair</subject>
            <subject type="local">tissue regeneration</subject>
            <subject type="local">molecular evolution</subject>
            <subject type="local">cardiomyocytes</subject>
            <subject type="local">biological therapy</subject>
            <description type="Chief Investigator Team">Prof Robert Graham&lt;br/&gt;Assoc Prof Daniel Hesselson&lt;br/&gt;Prof Colin Jackson&lt;br/&gt;Dr Siiri Iismaa&lt;br/&gt;Dr Xenia Kaidonis&lt;br/&gt;Dr Alexander Cole&lt;br/&gt;Dr John Chen&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;Japan&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-12T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Heart attacks damage heart muscle cells and can lead to heart failure with a poor 5-year survival rate. This research will elucidate the mechanisms of this poor heart repair and develop promising therapeutics to stimulate the regrowth of heart muscle. The project will identify the best drug candidate and formulate it so that it can be easily delivered to heart attack patients. The overall goal of this research is to remove roadblocks that prevent the body from healing itself after an injury.</description>
            <description type="fundingAmount">$1,775,202.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044048</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044048</identifier>
            <identifier type="nhmrc">2044048</identifier>
            <name type="primary">
                <namePart>Control of endemic HTLV-1 to prevent silent global spread</namePart>
            </name>
            <name type="alternative">
                <namePart>International Collaborations</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7043</identifier>
                <title>2024 NHMRC-AMED Adopting Sustainable Partnerships for an Innovative Research Ecosystem</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-4485-1726</identifier>
                <title>Prof Damian Purcell</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/001ggbx22</identifier>
                <title>National Institute of Infectious Diseases</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Virology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Industrial biotechnology</subject>
            <subject type="anzsrc-for">Industrial molecular engineering of nucleic acids and proteins BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Clinical pharmacology and therapeutics</subject>
            <subject type="local">antiviral therapy</subject>
            <subject type="local">messenger rna (mrna)</subject>
            <subject type="local">chronic inflammation</subject>
            <subject type="local">viral disease</subject>
            <subject type="local">viral vaccines</subject>
            <description type="Chief Investigator Team">Prof Damian Purcell&lt;br/&gt;Dr Chantelle Ahlenstiel&lt;br/&gt;Dr Marcel Doerflinger&lt;br/&gt;Prof Anthony Kelleher&lt;br/&gt;Assoc Prof Lloyd Einsiedel&lt;br/&gt;Dr Natasha Jansz&lt;br/&gt;Assoc Prof David Jacques&lt;br/&gt;Prof Kevin Morris&lt;br/&gt;Dr Genoveffa Franchini&lt;br/&gt;Prof Pall Thordarson&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;Japan&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-12T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Australian and Japanese researchers will combine our respective strengths to develop RNA and small molecule medicines to prevent and treat the Human T-cell Leukaemia Virus (HTLV) that is a priority infectious agent in our respective communities. Australians bring expertise in RNA design, manufacture, formulation, delivery and regulatory affairs, and Japanese with clinical management, research materials and methods, and especially with HTLV infected primates needed for testing new medicines.</description>
            <description type="fundingAmount">$4,370,512.50</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2037072</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2037072</identifier>
            <identifier type="nhmrc">2037072</identifier>
            <name type="primary">
                <namePart>HIRAID Inpatient: Improving the safety and quality of nursing care for hospital patients</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 2</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3746-0348</identifier>
                <title>Prof Kate Curtis</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03pnv4752</identifier>
                <title>Queensland University of Technology</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04ttjf776</identifier>
                <title>RMIT University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01sf06y89</identifier>
                <title>Macquarie University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Nursing</subject>
            <subject type="anzsrc-for">Acute care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Patient safety</subject>
            <subject type="local">nursing practice</subject>
            <subject type="local">patient safety</subject>
            <subject type="local">adverse events</subject>
            <subject type="local">patient/professional communication</subject>
            <subject type="local">clinical patient management</subject>
            <description type="Chief Investigator Team">Prof Kate Curtis&lt;br/&gt;Prof Ramon Shaban&lt;br/&gt;Prof Julie Considine&lt;br/&gt;Dr Mary Lam&lt;br/&gt;Prof Steven McPhail&lt;br/&gt;Prof Richard Lindley&lt;br/&gt;Prof Rebecca Mitchell&lt;br/&gt;Prof Daryl Jones&lt;br/&gt;Dr Amith Shetty&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-21T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Australia’s hospitals are in crisis, because high rates of preventable adverse events (e.g infections, falls, medication errors), that cause patient harm, remain static. This codesigned HIRAID-Inpatient project will address this problem through the development of a new fit-for-purpose, “whole-of-patient" nursing assessment framework for any patient with any condition on any ward. It will support nurses to deliver consistent high quality and safe care, reduce patient deterioration and save lives.</description>
            <description type="fundingAmount">$1,499,999.99</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2039929</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2039929</identifier>
            <identifier type="nhmrc">2039929</identifier>
            <name type="primary">
                <namePart>Supporting shared decision making in practice: implementation and evaluation of the Finding Your Way model for Mob</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 2</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3350-1325</identifier>
                <title>Assoc Prof Heather Shepherd</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/89809648636</identifier>
                <title>Agency for Clinical Innovation</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">implementation</subject>
            <subject type="local">community participation</subject>
            <subject type="local">shared clinical decision making</subject>
            <subject type="local">patient/professional communication</subject>
            <description type="Chief Investigator Team">Assoc Prof Heather Shepherd&lt;br/&gt;Mr David Follent&lt;br/&gt;Dr Marguerite Tracy&lt;br/&gt;Tara Dimopoulos-Bick&lt;br/&gt;Prof Michelle Dickson&lt;br/&gt;Dr Emma Webster&lt;br/&gt;Mr Cory Paulson&lt;br/&gt;Ms Melissa Cawley&lt;br/&gt;Prof Gail Garvey&lt;br/&gt;Emer Prof Lyndal Trevena&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-21T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">In 2021 the Agency for Clinical Innovation (ACI) in New South Wales worked with NSW Aboriginal communities to create a tool 'Finding Your Way' to help health workers talk about COVID-19 vaccination. Now the ACI have described the skills health workers need to put this shared decision-making (SDM) tool into practice, for any conversation about health. With Aboriginal governance and leadership, this research will validate a culturally safe measure of SDM and develop a framework to implement SDM.</description>
            <description type="fundingAmount">$346,157.55</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2028-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040196</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040196</identifier>
            <identifier type="nhmrc">2040196</identifier>
            <name type="primary">
                <namePart>Investigating the health service pathways and outcomes of people seeking urgent care for mental illness, deliberate self-harm and suicidal behaviour</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 2</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_David_Preen</identifier>
                <title>Prof David Preen</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01nfmeh72</identifier>
                <title>University of Tasmania</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Mental health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiology not elsewhere classified</subject>
            <subject type="local">mental health</subject>
            <subject type="local">suicide prevention</subject>
            <subject type="local">hospital morbidity</subject>
            <subject type="local">data linkage</subject>
            <subject type="local">epidemiology</subject>
            <description type="Chief Investigator Team">Prof David Preen&lt;br/&gt;Dr Colleen O'Leary&lt;br/&gt;Dr Anna Waterreus&lt;br/&gt;Prof Matthew Spittal&lt;br/&gt;Assoc Prof Amanda Neil&lt;br/&gt;Assoc Prof Rebecca Glauert&lt;br/&gt;Dr Craig Cumming&lt;br/&gt;Prof Daniel Fatovich&lt;br/&gt;Prof Helen Leonard&lt;br/&gt;Dr Nathan Gibson&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-21T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Australia is in a mental health crisis. Each year, over 3000 people die by suicide, and half of these people had attend an emergency department (ED) in the year before death, but services failed to prevent suicide. We urgently need to understand what happens to people after they come to hospital so we can improve their MH outcomes. Working with key mental health agencies, results from this study will inform targeted, evidence based strategies to improve MH outcomes.</description>
            <description type="fundingAmount">$1,499,527.00</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040450</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040450</identifier>
            <identifier type="nhmrc">2040450</identifier>
            <name type="primary">
                <namePart>Midlines Across Paediatrics (MAP): An implementation project across regional and tertiary paediatrics</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 2</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8860-5319</identifier>
                <title>Prof Amanda Ullman</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/017ay4a94</identifier>
                <title>Sunshine Coast Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03pnv4752</identifier>
                <title>Queensland University of Technology</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04kd26r92</identifier>
                <title>Grampians Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00vyyx863</identifier>
                <title>Eastern Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/35655720546</identifier>
                <title>The Royal Children's Hospital Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00be8mn93</identifier>
                <title>Children's Health Queensland Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04c318s33</identifier>
                <title>Camden and Campbelltown Hospitals</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02sc3r913</identifier>
                <title>Griffith University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Infant and child health HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Nursing</subject>
            <subject type="anzsrc-for">Acute care</subject>
            <subject type="local">paediatric</subject>
            <subject type="local">antibiotic therapy</subject>
            <subject type="local">acute pain</subject>
            <subject type="local">bacterial infection</subject>
            <subject type="local">child</subject>
            <description type="Chief Investigator Team">Prof Amanda Ullman&lt;br/&gt;Dr Sarah McNab&lt;br/&gt;Assoc Prof Richard McGee&lt;br/&gt;Prof Samantha Keogh&lt;br/&gt;Ms Tricia Kleidon&lt;br/&gt;Assoc Prof David Tickell&lt;br/&gt;Dr Roni Cole&lt;br/&gt;Dr Jessica Costa-Pinto&lt;br/&gt;Prof Robert Ware&lt;br/&gt;Prof Joshua Byrnes&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-21T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Children in Australia are undergoing painful procedures in hospital, that could be prevented. Together, 10 hospitals from across Australia will work together with researchers and policy makers to put in to practice a new medical device that will reduce pain, and improve our ability to give therapies, such as antibiotics and hydration. We will then put together a tool-kit to allow other hospitals across Australia to do the same.</description>
            <description type="fundingAmount">$1,320,116.20</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040570</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040570</identifier>
            <identifier type="nhmrc">2040570</identifier>
            <name type="primary">
                <namePart>Direct access to publicly funded physiotherapy for musculoskeletal pain: effectiveness, cost effectiveness, and implementation (PhysioDirect-Aus)</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 2</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Paulo_Ferreira</identifier>
                <title>Prof Paulo Ferreira</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/023331s46</identifier>
                <title>The George Institute for Global Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Primary health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science</subject>
            <subject type="anzsrc-for">Physiotherapy HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">General practice</subject>
            <subject type="local">primary care</subject>
            <subject type="local">musculoskeletal disorders</subject>
            <subject type="local">physiotherapy management</subject>
            <subject type="local">access to health care</subject>
            <subject type="local">health service utilisation</subject>
            <description type="Chief Investigator Team">Prof Paulo Ferreira&lt;br/&gt;Prof Nadine Foster&lt;br/&gt;Prof Manuela Ferreira&lt;br/&gt;Prof Meredith Makeham&lt;br/&gt;Prof Kim Bennell&lt;br/&gt;Prof Michele Sterling&lt;br/&gt;Prof Haitham Tuffaha&lt;br/&gt;Assoc Prof Ingrid Hickman&lt;br/&gt;Prof Paul Hodges&lt;br/&gt;Emer Prof Adrian Bauman&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-21T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The aims of this project are to determine the benefit of adding a funded direct access physiotherapy pathway to usual GP-led primary care in Australia, for adults with musculoskeletal pain. We anticipate direct access to physiotherapy will lead to similar improvements in physical health but will reduce inappropriate healthcare utilisation (eg. fewer medication prescriptions, imaging requests, and specialist referrals) compared to usual GP-led care alone.</description>
            <description type="fundingAmount">$1,499,993.40</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040673</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040673</identifier>
            <identifier type="nhmrc">2040673</identifier>
            <name type="primary">
                <namePart>Promoting evidence-informed decisions about IVF add-ons through co-design, implementation, and evaluation of a new website</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 2</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1694-1142</identifier>
                <title>Dr Sarah Lensen</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Reproduction</subject>
            <subject type="local">in vitro fertilisation (ivf)</subject>
            <subject type="local">infertility</subject>
            <subject type="local">consumer information</subject>
            <subject type="local">evidence-based clinical practice</subject>
            <subject type="local">translation</subject>
            <description type="Chief Investigator Team">Dr Sarah Lensen&lt;br/&gt;Prof Cynthia Farquhar&lt;br/&gt;Prof Tammy Hoffmann&lt;br/&gt;Dr Karin Hammarberg&lt;br/&gt;Prof Luk Rombauts&lt;br/&gt;Prof Shanton Chang&lt;br/&gt;Assoc Prof Stephanie Best&lt;br/&gt;Assoc Prof Michelle Peate&lt;br/&gt;Assoc Prof Sabine Braat&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;New Zealand&lt;br/&gt;United Kingdom&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-21T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">IVF ‘add-ons’ are optional extras which can be added to standard IVF protocols. Most IVF add-ons are not proven to be beneficial or safe, but patients may not realise this as information on the internet is unreliable and exaggerates potential benefits. We will develop a new website that has accurate information about add-ons, based on scientific evidence, and is trusted by IVF patients and doctors. IVF patients and doctors will help us to design it and experts will review the evidence.</description>
            <description type="fundingAmount">$735,816.80</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040703</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040703</identifier>
            <identifier type="nhmrc">2040703</identifier>
            <name type="primary">
                <namePart>Stacking interventions for equitable child health and development: building evidence to support precision policy</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 2</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6520-7094</identifier>
                <title>Prof Sharon Goldfeld</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological methods HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Social determinants of health</subject>
            <subject type="local">equity</subject>
            <subject type="local">social determinants</subject>
            <subject type="local">early childhood</subject>
            <subject type="local">data analysis</subject>
            <subject type="local">population health</subject>
            <description type="Chief Investigator Team">Prof Sharon Goldfeld&lt;br/&gt;Dr Meredith O'Connor&lt;br/&gt;Prof Naomi Priest&lt;br/&gt;Prof Margarita Moreno-Betancur&lt;br/&gt;Dr Marnie Downes&lt;br/&gt;Prof Hannah Badland&lt;br/&gt;Prof Susan Woolfenden&lt;br/&gt;Dr Amanda Alderton&lt;br/&gt;Dr Sarah Gray&lt;br/&gt;Dr Andi Camden&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-21T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Children’s health and development are shaped by the environments in which they live. We aim to promote health and development for children, especially those experiencing socioeconomic disadvantage. Using existing Australian and international data, we will examine how best to create supportive environments in the early years. The insights gained will guide policymakers in prioritising opportunities to improve equity in children’s health and development.</description>
            <description type="fundingAmount">$492,908.96</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2028-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042295</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042295</identifier>
            <identifier type="nhmrc">2042295</identifier>
            <name type="primary">
                <namePart>A national research program guiding progress towards hepatitis C elimination in the prison</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 2</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2212-2028</identifier>
                <title>Assoc Prof Behzad Hajarizadeh</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Disease surveillance HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological modelling</subject>
            <subject type="local">hepatitis c infection</subject>
            <subject type="local">prison population</subject>
            <subject type="local">access to health care</subject>
            <subject type="local">economic evaluation</subject>
            <subject type="local">mathematical modelling</subject>
            <description type="Chief Investigator Team">Assoc Prof Behzad Hajarizadeh&lt;br/&gt;Prof Andrew Lloyd&lt;br/&gt;Dr Yumi Sheehan&lt;br/&gt;Prof Gregory Dore&lt;br/&gt;Prof Alexander Thompson&lt;br/&gt;Dr Marianne Martinello&lt;br/&gt;Prof Jason Grebely&lt;br/&gt;Assoc Prof Jane Davies&lt;br/&gt;Assoc Prof Richard Gray&lt;br/&gt;Dr Sophy Shih&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;Canada&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-21T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Hepatitis C infection causes progressive liver scarring, liver cancer and death. Hepatitis C is very common in the prisons, making this setting critical for hepatitis C control strategies, including delivery of testing and curative treatment. This project aims to develop a sustainable research framework to inform strategies to enhance hepatitis C testing, treatment and prevention efforts in each state and territory to underpin national elimination efforts.</description>
            <description type="fundingAmount">$1,499,541.20</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-04-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2028-03-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040834</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040834</identifier>
            <identifier type="nhmrc">2040834</identifier>
            <name type="primary">
                <namePart>Generating the evidence required to enable health equity for gender and sexuality diverse populations in Australia</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7952-7969</identifier>
                <title>Dr Mo Hammoud</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity</subject>
            <subject type="local">homosexuality</subject>
            <subject type="local">health promotion</subject>
            <subject type="local">public health</subject>
            <subject type="local">health inequalities</subject>
            <subject type="local">health services</subject>
            <description type="Chief Investigator Team">Dr Mo Hammoud&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Gender and sexuality diverse populations in Australia face higher morbidity rates than their heterosexual peers, with limited understanding due to small, non-probability samples. My goal is to reshape public health strategies by generating robust evidence to address these disparities, identify overlooked issues, and enhance healthcare access. By leveraging large-scale studies, I aim to strengthen the evidence base and develop strategies for improved chronic disease management.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040835</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040835</identifier>
            <identifier type="nhmrc">2040835</identifier>
            <name type="primary">
                <namePart>Precision Prevention, Targeted Treatment and Improved Survivorship to Decrease the Burden of Breast Cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0475-1771</identifier>
                <title>Prof Kelly-Anne Phillips</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Solid tumours</subject>
            <subject type="local">breast cancer</subject>
            <subject type="local">cancer treatment</subject>
            <subject type="local">breast cancer prevention</subject>
            <subject type="local">chemoprevention</subject>
            <subject type="local">ovarian function</subject>
            <description type="Chief Investigator Team">Prof Kelly-Anne Phillips&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Breast cancer affects 1 in 8 Australian women. Of all the cancers, breast cancer results in the largest number of years of healthy life lost from death and illness. My research will reduce this unacceptable burden of breast cancer for women and their families. Spanning prevention, through treatment to survivorship, it will facilitate reduced breast cancer incidence, better treatments and enhanced understanding of the effects of new treatments on ovarian function and fertility.</description>
            <description type="fundingAmount">$2,763,660.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040837</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040837</identifier>
            <identifier type="nhmrc">2040837</identifier>
            <name type="primary">
                <namePart>Exploiting the unique functions of MAIT cells to drive the rational design of new vaccines and immunotherapies</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-1618-4337</identifier>
                <title>Prof Alexandra Corbett</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology</subject>
            <subject type="local">adaptive immunity</subject>
            <subject type="local">t cell activation</subject>
            <subject type="local">antigen</subject>
            <subject type="local">bacterial infection</subject>
            <subject type="local">alternative vaccination strategies</subject>
            <description type="Chief Investigator Team">Prof Alexandra Corbett&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Mucosal-associated invariant T (MAIT) cells detect metabolites from microbes, and provide protective immunity against bacterial infection, but can also cause pathology. This study seeks to define the unique molecular signals driving the activation and function of MAIT cells over the course of their immune response, develop methods to modulate their functions, and test the therapeutic impact of MAIT cell modulation on immunity to infections and tumours using mouse models.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040839</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040839</identifier>
            <identifier type="nhmrc">2040839</identifier>
            <name type="primary">
                <namePart>Responsive, effective, efficient &amp; accountable action for adolescent health in the Asia Pacific.</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9280-6997</identifier>
                <title>Prof Peter Azzopardi</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/019wvm592</identifier>
                <title>Australian National University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01dbmzx78</identifier>
                <title>The Kids Research Institute Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Adolescent health HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Major global burdens of disease INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander public health and wellbeing</subject>
            <subject type="local">adolescent health</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">population health</subject>
            <subject type="local">health policy</subject>
            <subject type="local">regional health</subject>
            <description type="Chief Investigator Team">Prof Peter Azzopardi&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">More than half of the world's adolescents live in the Asia Pacific region, and my earlier work showing these young people to have substantial unmet health needs. MY VISION for the next five years is to define the best actions for adolescent health in our region. By ‘best actions’, I mean actions that are responsive to specific needs, effective because they are evidence based and implementable, efficient because they are cost-effective and synergistic, and monitored to ensure accountability.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040846</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040846</identifier>
            <identifier type="nhmrc">2040846</identifier>
            <name type="primary">
                <namePart>Development of Novel Anticoagulants with Improved Safety Profiles for Stroke Therapy</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3618-9226</identifier>
                <title>Prof Richard Payne</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">CHEMICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medicinal and biomolecular chemistry</subject>
            <subject type="anzsrc-for">Molecular medicine CHEMICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medicinal and biomolecular chemistry</subject>
            <subject type="anzsrc-for">Proteins and peptides</subject>
            <subject type="local">anticoagulants</subject>
            <subject type="local">thrombosis</subject>
            <subject type="local">coagulation protein</subject>
            <subject type="local">medicinal chemistry</subject>
            <subject type="local">ischaemic stroke</subject>
            <description type="Chief Investigator Team">Prof Richard Payne&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This project will use cutting-edge technologies to discover safe and effective new ‘clot busting’ therapies for stroke. Strokes are caused by blockages in blood flow to the brain, starving the tissues of oxygen and nutrients. One Australian suffers a stroke about every 19 mins, but the only therapy available does not work for many patients. Our novel anticoagulants are expected to dissolve clots without risky bleeding to save lives, prevent disability and reduce the enormous burden of stroke.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040856</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040856</identifier>
            <identifier type="nhmrc">2040856</identifier>
            <name type="primary">
                <namePart>Guiding Group A Streptococcus vaccines into clinical development.</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7423-2769</identifier>
                <title>Prof Mark Walker</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical microbiology</subject>
            <subject type="anzsrc-for">Medical bacteriology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Bacteriology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Infectious agents</subject>
            <subject type="local">streptococcus pyogenes</subject>
            <subject type="local">vaccine candidate molecules</subject>
            <subject type="local">vaccine</subject>
            <subject type="local">vaccine development</subject>
            <subject type="local">vaccine efficacy</subject>
            <description type="Chief Investigator Team">Prof Mark Walker&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Group A Streptococcus (StrepA) causes serious infections and autoimmune sequelae resulting in &gt;500,000 deaths/year. Alarmingly, invasive StrepA infections are increasing in Australia. StrepA induced rheumatic heart disease principally afflicts Australian Indigenous populations. A commercial vaccine to prevent StrepA infection is not available, but in partnership with vaccine manufacturers, my research team will progress StrepA vaccine formulations into clinical development.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040880</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040880</identifier>
            <identifier type="nhmrc">2040880</identifier>
            <name type="primary">
                <namePart>Integrating monogenic and polygenic epilepsy risk factors to advance molecular diagnoses and to understand disease risk</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-5188-6153</identifier>
                <title>Dr Karen Oliver</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Translational and applied bioinformatics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Central nervous system BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Neurogenetics</subject>
            <subject type="local">epilepsy</subject>
            <subject type="local">bioinformatics</subject>
            <subject type="local">neurodevelopmental disorders</subject>
            <subject type="local">complex genetic disease</subject>
            <subject type="local">genomics</subject>
            <description type="Chief Investigator Team">Dr Karen Oliver&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Epilepsy is a common neurological disease with many different types. Certain types of epilepsy are known to have a genetic basis; however, large gaps remain in our understanding. This project aims to fill in the gaps by studying patients and families with epilepsy to discover new epilepsy genes and risk factors. Knowing the genes and biological pathways involved in disease manifestation will inform future research, provide new therapeutic avenues, and lead to better patient outcomes.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040897</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040897</identifier>
            <identifier type="nhmrc">2040897</identifier>
            <name type="primary">
                <namePart>Climate change, bushfire smoke, and human health: multi-country and multi-omics approach</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-1906-8614</identifier>
                <title>Dr Rongbin Xu</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Environmental epidemiology EARTH SCIENCES</subject>
            <subject type="anzsrc-for">Atmospheric sciences</subject>
            <subject type="anzsrc-for">Air pollution processes and air quality measurement ENVIRONMENTAL SCIENCES</subject>
            <subject type="anzsrc-for">Climate change impacts and adaptation</subject>
            <subject type="anzsrc-for">Human impacts of climate change and human adaptation</subject>
            <subject type="local">bushfire</subject>
            <subject type="local">climate change adaption</subject>
            <subject type="local">air pollution</subject>
            <subject type="local">epigenetics</subject>
            <subject type="local">public health impact</subject>
            <description type="Chief Investigator Team">Dr Rongbin Xu&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Human-induced climate change (HICC) has already caused many problems including increasing health burden caused by bushfire smoke. This project will: 1) quantify global and country-specific bushfire smoke exposure caused by HICC and the related health burden during 2000-2025; 2) determine biomarkers and biological mechanisms that can detect and explain the health impacts of bushfire smoke. The outputs will inform targeted and effective preventions and interventions and promote climate actions.</description>
            <description type="fundingAmount">$656,215.26</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040902</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040902</identifier>
            <identifier type="nhmrc">2040902</identifier>
            <name type="primary">
                <namePart>Capturing high-resolution epigenomes to redirect cell destiny in neurological disease states</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5298-8730</identifier>
                <title>Assoc Prof Phillippa Taberlay</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01nfmeh72</identifier>
                <title>University of Tasmania</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01nfmeh72</identifier>
                <title>University of Tasmania</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Epigenetics (incl. genome methylation and epigenomics) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Genomics and transcriptomics</subject>
            <subject type="local">epigenetics</subject>
            <subject type="local">dna methylation</subject>
            <subject type="local">chromatin</subject>
            <subject type="local">chromatin structure</subject>
            <subject type="local">transcriptional regulation</subject>
            <description type="Chief Investigator Team">Assoc Prof Phillippa Taberlay&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The epigenome is the master regulator of cell fate and function, and subject to spectacular failure in disease. With frontier methodologies to capture epigenomes at unprecedented resolution, this project will focus on the aging brain to determine how brain cell-specific epigenetic changes drive neurological disease states in males and females, and importantly, how to reverse them. This work bridges the gap between technology and fundamental knowledge with the goal to improve future therapies.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">TAS</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040904</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040904</identifier>
            <identifier type="nhmrc">2040904</identifier>
            <name type="primary">
                <namePart>Better evidence and translation for healthcare associated infection prevention</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5406-9519</identifier>
                <title>Dr Jessica Schults</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/18496277942</identifier>
                <title>Metro North Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Nursing</subject>
            <subject type="anzsrc-for">Acute care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health surveillance</subject>
            <subject type="local">infection control</subject>
            <subject type="local">bacterial infection</subject>
            <subject type="local">surveillance</subject>
            <subject type="local">acute care</subject>
            <subject type="local">consumer participation</subject>
            <description type="Chief Investigator Team">Dr Jessica Schults&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">1 in 10 people admitted to hospital develop an infection as a complication of their healthcare. These infections lead to significant patient suffering and unnecessary deaths. Current methods for infection prevention and control are complex, inefficient and costly. In partnership with Queensland Health services and patients, I will develop state-of-the-art systems and knowledge translation solutions that inform infection control programs and combat rising infection-associated death rates.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040907</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040907</identifier>
            <identifier type="nhmrc">2040907</identifier>
            <name type="primary">
                <namePart>Harnessing incidental physical activity and other 24-hour physical behaviour to prevent CVD and cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7323-3225</identifier>
                <title>Prof Emmanuel Stamatakis</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiology not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological methods</subject>
            <subject type="local">cancer prevention</subject>
            <subject type="local">chronic diseases</subject>
            <subject type="local">cardiovascular disease prevention</subject>
            <subject type="local">lifestyle factors</subject>
            <subject type="local">behavioural epidemiology</subject>
            <description type="Chief Investigator Team">Prof Emmanuel Stamatakis&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Physical activity, sitting and sleep – termed “physical behaviours” – are major determinants of risk for cardiovascular disease and cancer, but we do not know what the optimal patterns of daily physical behaviour are. My program will harness the power of wearable devices to optimise guidelines and prevention practice by identifying the combined potential of more incidental physical activity, less sitting, and better sleep for CVD and cancer risk reduction.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040909</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040909</identifier>
            <identifier type="nhmrc">2040909</identifier>
            <name type="primary">
                <namePart>Guiding and delivering maternity healthcare that is free of weight stigma</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4993-3963</identifier>
                <title>Dr Briony Hill</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion HUMAN SOCIETY</subject>
            <subject type="anzsrc-for">Policy and administration</subject>
            <subject type="anzsrc-for">Health policy HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Midwifery</subject>
            <subject type="anzsrc-for">Psychosocial aspects of childbirth and perinatal mental health</subject>
            <subject type="local">women's health</subject>
            <subject type="local">implementation</subject>
            <subject type="local">public health policy</subject>
            <subject type="local">clinical practice guidelines</subject>
            <subject type="local">prospective cohort study</subject>
            <description type="Chief Investigator Team">Dr Briony Hill&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Two thirds of pregnant women experience frequent weight stigma, especially in healthcare. It has harmful effects on pregnancy and health outcomes. This research will address weight stigma in maternity healthcare and guidelines that inform care. It will generate new evidence on women’s experiences of weight stigma and its impacts, update guidelines to be non-stigmatising and implement better care into practice. Eliminating weight stigma from maternity care will improve women’s health outcomes.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040918</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040918</identifier>
            <identifier type="nhmrc">2040918</identifier>
            <name type="primary">
                <namePart>Thwarting Rare Blood Cancer in Kids with Single-cell Innovation (TRaCKIn)</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6735-6808</identifier>
                <title>Dr Zewen Kelvin Tuong</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Predictive and prognostic markers BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Paediatrics not elsewhere classified BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Tumour immunology</subject>
            <subject type="local">bioinformatics</subject>
            <subject type="local">t cell receptor</subject>
            <subject type="local">acute myeloid leukaemia (aml)</subject>
            <subject type="local">relapse prevention</subject>
            <subject type="local">expression profiling</subject>
            <description type="Chief Investigator Team">Dr Zewen Kelvin Tuong&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">My research will innovate new approaches to predict relapse and develop more effective cancer vaccines for children with a rare but deadly form of blood cancer. I will achieve this by tracking unique gene signatures, akin to "biometric fingerprints" unique to each child's individual cancer and immune cell, during the treatment and remission phases. This will improve cancer relapse monitoring and tailor cancer vaccine development towards each child, safeguarding and improving their lives.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040938</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040938</identifier>
            <identifier type="nhmrc">2040938</identifier>
            <name type="primary">
                <namePart>Uncovering the molecular mechanisms associated with exercise to develop therapies to treat obesity-related diseases</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9296-4418</identifier>
                <title>Prof Mark Febbraio</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04cxm4j25</identifier>
                <title>Australian Catholic University Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Cell metabolism BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Other biomedical and clinical sciences</subject>
            <subject type="anzsrc-for">Other biomedical and clinical sciences not elsewhere classified</subject>
            <subject type="local">obesity</subject>
            <subject type="local">metabolic disease</subject>
            <subject type="local">drug development</subject>
            <subject type="local">liver metabolism</subject>
            <subject type="local">exercise</subject>
            <description type="Chief Investigator Team">Prof Mark Febbraio&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Obesity can lead to many diseases such as diabetes, cardiovascular disease and cancer. In contrast, regular exercise can prevent or slow the progress of these diseases. To date, we do not know the precise ways obesity or exercise affects either the progression or prevention of these diseases. This research program will attempt to better understand what obesity and exercise do to the body, so that we can develop new and better drugs to treat diseases associated with obesity.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040939</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040939</identifier>
            <identifier type="nhmrc">2040939</identifier>
            <name type="primary">
                <namePart>Using sodium ascorbate to reduce neuroinflammation and delirium after cardiac surgery</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2044-5560</identifier>
                <title>Assoc Prof Lachlan Miles</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03a2tac74</identifier>
                <title>Florey Institute of Neuroscience and Mental Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Anaesthesiology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Central nervous system BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Surgery</subject>
            <subject type="local">cardiopulmonary bypass</subject>
            <subject type="local">delirium</subject>
            <subject type="local">cardiac surgery</subject>
            <subject type="local">anaesthesia and cognitive deficit</subject>
            <subject type="local">neuroinflammation</subject>
            <description type="Chief Investigator Team">Assoc Prof Lachlan Miles&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Patients who require cardiac surgery have a 40–50% risk of developing an acute brain injury after their operation. These complications increase the risk of dying after surgery, and can reduce long-term quality of life substantially. A specially formulated solution of mega-dose Vitamin C appears very effective to prevent, or to reduce the severity of this condition. My program of research will establish the best dose of this therapy, how it works, and its safety in large animals and humans</description>
            <description type="fundingAmount">$469,202.50</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040943</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040943</identifier>
            <identifier type="nhmrc">2040943</identifier>
            <name type="primary">
                <namePart>Advancing evidence synthesis methods to collaboratively improve child health outcomes</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2796-9220</identifier>
                <title>Dr Kylie Hunter</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological methods HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Neonatology</subject>
            <subject type="local">meta-analysis</subject>
            <subject type="local">premature birth</subject>
            <subject type="local">methodology</subject>
            <subject type="local">neonatology</subject>
            <subject type="local">epidemiological research methods</subject>
            <description type="Chief Investigator Team">Dr Kylie Hunter&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">To answer health research questions researchers traditionally bring together results from studies published in journals. But often, not all required information is available in these articles. New methods bring together full datasets of previous studies. My research program will advance these methods, looking at how to find and exclude fraudulent or low-quality studies and reduce bias or ‘spin’ in interpretation. I will apply these methods to answer crucial questions on care of premature babies.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040954</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040954</identifier>
            <identifier type="nhmrc">2040954</identifier>
            <name type="primary">
                <namePart>Establishing protective immunity against antigenically diverse viruses</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Marios_Koutsakos</identifier>
                <title>Dr Marios Koutsakos</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Virology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Humoural immunology and immunochemistry</subject>
            <subject type="local">influenza</subject>
            <subject type="local">adaptive immunity</subject>
            <subject type="local">vaccine</subject>
            <subject type="local">antibody</subject>
            <subject type="local">t cells</subject>
            <description type="Chief Investigator Team">Dr Marios Koutsakos&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Viruses like influenza and SARS-CoV-2 keep changing to avoid recognition by the immune system. This research program will study how the immune system responds to different variants, with the goal of informing vaccine design. This work will advance our understanding of viral immunology and significantly improve human health.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040955</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040955</identifier>
            <identifier type="nhmrc">2040955</identifier>
            <name type="primary">
                <namePart>Nutritional Psychiatry: Clarifying Mechanisms to Support Precision Interventions</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9825-0328</identifier>
                <title>Prof Felice Jacka</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Psychiatry (incl. psychotherapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Nutrition and dietetics not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified</subject>
            <subject type="local">depression</subject>
            <subject type="local">dietary factors</subject>
            <subject type="local">mental disorder</subject>
            <subject type="local">diet</subject>
            <subject type="local">treatment strategies</subject>
            <description type="Chief Investigator Team">Prof Felice Jacka&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Poor diet is a leading contributor to illness and death globally, and mental disorders are a major cause of disability. I have pioneered the field of Nutritional Psychiatry, establishing the link between diet and mental health. My research program will now generate critical new evidence on how diet influences mental health, supporting better interventions and outcomes for people with depression.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040965</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040965</identifier>
            <identifier type="nhmrc">2040965</identifier>
            <name type="primary">
                <namePart>Unlocking the therapeutic potential of anti-inflammatory mesenchymal stromal cells through a refined mode of action</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Andrew_Freeman</identifier>
                <title>Dr Andrew Freeman</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical biotechnology</subject>
            <subject type="anzsrc-for">Regenerative medicine (incl. stem cells)</subject>
            <subject type="local">cell therapy</subject>
            <subject type="local">immunomodulation</subject>
            <subject type="local">cell death</subject>
            <subject type="local">macrophages</subject>
            <subject type="local">mechanism of action</subject>
            <description type="Chief Investigator Team">Dr Andrew Freeman&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Cell therapy involves injecting specific types of cells into the bloodstream during disease for treatment. Mesenchymal stromal cells are a specialised type of cell that hold great potential in reducing inflammation in disease; however, they have shown mixed success in clinical trials to date. This project aims to uncover how these cells work in the body and discover innovative anti-inflammatory therapeutic targets that will improve patient outcomes.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040971</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040971</identifier>
            <identifier type="nhmrc">2040971</identifier>
            <name type="primary">
                <namePart>Transforming Epilepsy Management through Evidence-Driven Approaches</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8958-3844</identifier>
                <title>Dr Emma Foster</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Neurology and neuromuscular diseases</subject>
            <subject type="local">epilepsy</subject>
            <subject type="local">drug treatment</subject>
            <subject type="local">seizures</subject>
            <subject type="local">treatment outcomes</subject>
            <subject type="local">clinical research</subject>
            <description type="Chief Investigator Team">Dr Emma Foster&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Epilepsy is a major health issue, affecting over 250,000 Australians of all ages. Early diagnosis and treatment improve outcomes, but many Australians experiencing first seizures do not receive care that meets international standards. Additionally, half of those with epilepsy do not take their antiseizure medication as prescribed. My research program will use national healthcare data and interviews with people with epilepsy to find the best ways to improve epilepsy care and close knowledge gaps.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040972</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040972</identifier>
            <identifier type="nhmrc">2040972</identifier>
            <name type="primary">
                <namePart>Novel Neurobiological Treatment Mechanisms in Eating Disorders</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3116-8175</identifier>
                <title>Dr Trevor Steward</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Psychiatry (incl. psychotherapy) PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Clinical and health psychology</subject>
            <subject type="anzsrc-for">Clinical psychology</subject>
            <subject type="local">eating disorders</subject>
            <subject type="local">binge eating disorder</subject>
            <subject type="local">neuroimaging</subject>
            <subject type="local">psychiatric disorders</subject>
            <subject type="local">functional magnetic resonance imaging (fmri)</subject>
            <description type="Chief Investigator Team">Dr Trevor Steward&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Approximately 1.1 million Australians have eating disorders, but current treatments are ineffective, and developing new medications has stalled. My research will use advanced brain imaging technology to study how new drugs affect brain pathways in eating disorders. I will conduct studies on the impact of tirzepatide in binge eating disorder, ketamine for anorexia nervosa with depression, and orexin levels in bulimia. This work will aid in launching new treatment options for eating disorders.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040973</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040973</identifier>
            <identifier type="nhmrc">2040973</identifier>
            <name type="primary">
                <namePart>Generating a universal influenza vaccine</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Assoc_Prof_Linda_Wakim</identifier>
                <title>Assoc Prof Linda Wakim</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Immunology not elsewhere classified BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Infectious agents</subject>
            <subject type="local">cd8 t cells</subject>
            <subject type="local">influenza virus</subject>
            <subject type="local">vaccines</subject>
            <subject type="local">staphylococcus aureus</subject>
            <subject type="local">mucosal immunity</subject>
            <description type="Chief Investigator Team">Assoc Prof Linda Wakim&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Influenza is a highly contagious, rapidly spreading respiratory pathogen that causes profound morbidity and mortality. Current influenza vaccines are suboptimal, they need to be updated and administered annually, and provide no protection in the event of a pandemic influenza outbreak. This research program will see the development of a novel universal 'one-shot’ influenza vaccine that provides long term protection against both seasonal and newly emerging pandemic influenza strains.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040986</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040986</identifier>
            <identifier type="nhmrc">2040986</identifier>
            <name type="primary">
                <namePart>Transforming Lives: Transplant for All and One Transplant for Life</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8422-7269</identifier>
                <title>Prof Germaine Wong</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04gp5yv64</identifier>
                <title>Westmead Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Nephrology and urology HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity</subject>
            <subject type="local">kidney transplantation</subject>
            <subject type="local">public health impact</subject>
            <subject type="local">kidney disease</subject>
            <subject type="local">clinical epidemiology</subject>
            <subject type="local">equity</subject>
            <description type="Chief Investigator Team">Prof Germaine Wong&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Kidney transplantation is a life saving treatment for many patients with kidney failure. However, it is not available to all patients who need one due to limited organ availability. Once transplanted, there are also many challenges including increased cancer and infection risks, and early graft loss from rejection. This program of work will implement novel interventions and strategies to drive sustainable improvements in health outcomes and overall well-being of kidney transplant patients.</description>
            <description type="fundingAmount">$2,381,830.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041012</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041012</identifier>
            <identifier type="nhmrc">2041012</identifier>
            <name type="primary">
                <namePart>Unravelling immune responses to severe respiratory viral infection and vaccination in humans</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9294-7693</identifier>
                <title>Dr Thi Nguyen</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology</subject>
            <subject type="local">cellular immunology</subject>
            <subject type="local">covid-19</subject>
            <subject type="local">antiviral immunity</subject>
            <subject type="local">influenza virus</subject>
            <subject type="local">t cell activation</subject>
            <description type="Chief Investigator Team">Dr Thi Nguyen&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">We develop robust &amp; long-lasting immune responses to respiratory viral infections, yet some people still fall very ill despite being vaccinated. I will investigate immune responses that protect us from severe &amp; fatal infections; understand why some people fail to generate protective antibodies to the flu vaccine; &amp; identify key biomarkers aimed at reducing influenza disease impact in high-risk groups. This work will improve future vaccination regimens towards influenza &amp; newly-emerging viruses.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041019</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041019</identifier>
            <identifier type="nhmrc">2041019</identifier>
            <name type="primary">
                <namePart>Pathways to vision following lesions of the primary visual cortex</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6620-6285</identifier>
                <title>Prof Marcello Rosa</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Central nervous system BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Sensory systems</subject>
            <subject type="local">cerebral cortex</subject>
            <subject type="local">neuroanatomical connections</subject>
            <subject type="local">visual pathways</subject>
            <subject type="local">visual development</subject>
            <subject type="local">visual perception</subject>
            <description type="Chief Investigator Team">Prof Marcello Rosa&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Vision depends not only on the eyes, but also on many brain areas. Without the latter the visual information cannot be decoded, and the person becomes blind even if the eyes are spared. For example, when an area named the primary visual cortex (V1) is damaged by stroke or trauma, a type of profound blindness ensues, for which there is no treatment. I will explore how visual information can be channeled to non-damaged parts of the brain, in search of ways to restore vision following V1 damage.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041040</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041040</identifier>
            <identifier type="nhmrc">2041040</identifier>
            <name type="primary">
                <namePart>Improving cardiopulmonary outcomes in systemic sclerosis</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Mandana_Nikpour</identifier>
                <title>Prof Mandana Nikpour</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Rheumatology and arthritis BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Respiratory diseases</subject>
            <subject type="local">scleroderma</subject>
            <subject type="local">exercise</subject>
            <subject type="local">heart</subject>
            <subject type="local">pulmonary fibrosis</subject>
            <subject type="local">clinical trial</subject>
            <description type="Chief Investigator Team">Prof Mandana Nikpour&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Worldwide, Australia has the highest frequency of the autoimmune disease scleroderma, which affects people in the prime of life. Scleroderma can involve many organs within the body, particularly the heart and the lungs, and is associated with impaired physical function and markedly reduced life expectancy. This program of research aims to improve the outlook for those affected, through finding ways to determine who is at risk of poor outcomes and tailoring management to the individual.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041048</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041048</identifier>
            <identifier type="nhmrc">2041048</identifier>
            <name type="primary">
                <namePart>Creating A “Learning Health System” For Eating Disorder Treatment</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6736-7937</identifier>
                <title>Assoc Prof Deborah Mitchison</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03f0f6041</identifier>
                <title>University of Technology Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03f0f6041</identifier>
                <title>University of Technology Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health informatics and information systems HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Disease surveillance</subject>
            <subject type="local">eating disorders</subject>
            <subject type="local">implementation</subject>
            <subject type="local">clinical outcome</subject>
            <subject type="local">program evaluation</subject>
            <subject type="local">measurement</subject>
            <description type="Chief Investigator Team">Assoc Prof Deborah Mitchison&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Eating disorder (ED) treatment is currently not monitored for quality or safety, and yet we know that at least 50% of those who seek treatment have poor outcomes. This research program will embed a digital system to collect and collate clinical outcomes into ED clinics. The data will be used by consumers, clinicians, researchers and governments not only to tailor individual treatment, but to evaluate treatment at a national scale.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041052</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041052</identifier>
            <identifier type="nhmrc">2041052</identifier>
            <name type="primary">
                <namePart>Identifying molecular determinants of antiviral immunity conferred by effector T cells</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3490-4361</identifier>
                <title>Dr Curtis Cai</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b3dvp57</identifier>
                <title>The Garvan Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Immunogenetics (incl. genetic immunology)</subject>
            <subject type="local">cd8 t cells</subject>
            <subject type="local">t cell immunity</subject>
            <subject type="local">lymphocyte differentiation</subject>
            <subject type="local">covid-19</subject>
            <subject type="local">cellular immunity</subject>
            <description type="Chief Investigator Team">Dr Curtis Cai&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Primary immunodeficiencies arise from an error in a single gene in an individual from birth. As a result, many patients experience complications including increased susceptibility to life-threatening viral infections, severe allergies, and early-onset cancer. My research will uncover the immunological impact of such errors to support the identification of personalised treatments that alleviate symptoms and enhance patients’ quality of life.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041054</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041054</identifier>
            <identifier type="nhmrc">2041054</identifier>
            <name type="primary">
                <namePart>Targeting the bi-directional relationship between diet and microbes to optimise pouch health</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5301-2457</identifier>
                <title>Dr Chu (CK) Yao</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Clinical nutrition BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Gastroenterology and hepatology</subject>
            <subject type="local">inflammatory bowel disease (ibd)</subject>
            <subject type="local">gastrointestinal surgery</subject>
            <subject type="local">dietary intervention</subject>
            <subject type="local">diet</subject>
            <subject type="local">gastrointestinal symptoms</subject>
            <description type="Chief Investigator Team">Dr Chu (CK) Yao&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">After large bowel is removed in ulcerative colitis, inflammation of the pouch (pouchitis) commonly occurs. Diet is currently not part of the treatment plan for pouchitis. My research aims revolutionise its future management by understanding (1) what factors in diet and the pouch bacteria predict pouchitis, (2) how the pouch bacteria respond to diet in pouchitis, and (3) testing whether a specific diet strategy directed at the pouch bacteria is effective for these patients.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041062</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041062</identifier>
            <identifier type="nhmrc">2041062</identifier>
            <name type="primary">
                <namePart>Enhanced analysis of splice-altering variants to improve diagnostic rate in rare disease</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2135-0117</identifier>
                <title>Dr Ruebena Dawes</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b3dvp57</identifier>
                <title>The Garvan Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/052gg0110</identifier>
                <title>University of Oxford</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Genomics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Medical genetics (excl. cancer genetics)</subject>
            <subject type="local">clinical genetics</subject>
            <subject type="local">rare diseases</subject>
            <subject type="local">medical genetics</subject>
            <subject type="local">medical genomics</subject>
            <subject type="local">genomics</subject>
            <description type="Chief Investigator Team">Dr Ruebena Dawes&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United Kingdom&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">RNA is the ‘voice’ of our DNA, allowing fine-tuning of our genetic code. Changes in our DNA that alter RNA splicing can cause disease; however, RNA splicing variants are hard for clinicians to interpret. My research vision is to build tools to interpret RNA splicing variants. These tools will help diagnose more individuals with rare genetic disorders, providing families access to support groups, informed treatment options, knowledge of disease progression, and genetic therapies.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041063</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041063</identifier>
            <identifier type="nhmrc">2041063</identifier>
            <name type="primary">
                <namePart>Harnessing Precision Medicine to Combat Infections in Transplant Recipients</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-5609-3937</identifier>
                <title>Dr Bradley Gardiner</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04scfb908</identifier>
                <title>Alfred Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical microbiology</subject>
            <subject type="anzsrc-for">Medical microbiology not elsewhere classified BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Clinical sciences not elsewhere classified</subject>
            <subject type="local">organ transplantation</subject>
            <subject type="local">individualising management</subject>
            <subject type="local">infectious diseases</subject>
            <subject type="local">immunosuppression</subject>
            <subject type="local">biomarkers</subject>
            <description type="Chief Investigator Team">Dr Bradley Gardiner&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Organ transplants are life-saving but require long-term medications to block the immune system to prevent rejection. This means transplant recipients suffer enormously from serious, complex infections. My research program aims to improve the lives of transplant patients by using new tests of immune function to optimize the dosing of immunosuppressive medications, predicting and anticipating those at high risk and intervening before infections occur.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041068</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041068</identifier>
            <identifier type="nhmrc">2041068</identifier>
            <name type="primary">
                <namePart>Genetics of speech disorders: improving diagnosis, prognosis and management</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-1147-7405</identifier>
                <title>Prof Angela Morgan</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/35655720546</identifier>
                <title>The Royal Children's Hospital Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Community child health</subject>
            <subject type="local">developmental disorders</subject>
            <subject type="local">community paediatrics</subject>
            <subject type="local">speech</subject>
            <subject type="local">child development</subject>
            <subject type="local">clinical genetics</subject>
            <description type="Chief Investigator Team">Prof Angela Morgan&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Speech and language disorders are one of the most common disorders affecting our nation. Over 50% of children in the NDIS have a speech or language disorder, with an annual cost exceeding $5 billion. Current management focuses on symptoms, not the underlying cause, with limited effectiveness. My work is changing practice, showing the relevance of genetics to Speech Pathology. Research will advance detection, diagnosis, prognostic counselling and treatment of patients to optimise life outcomes.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041078</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041078</identifier>
            <identifier type="nhmrc">2041078</identifier>
            <name type="primary">
                <namePart>You are when you eat ! realising the importance of meal and macronutrient timing for health</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6393-3671</identifier>
                <title>Dr Amy Hutchison</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Nutritional science</subject>
            <subject type="local">type 2 diabetes mellitus (non-insulin dependent diabetes mellitus)</subject>
            <subject type="local">overweight/obesity</subject>
            <subject type="local">cardiovascular disease prevention</subject>
            <subject type="local">diabetes prevention</subject>
            <subject type="local">dietary protein</subject>
            <description type="Chief Investigator Team">Dr Amy Hutchison&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Dietary interventions for the prevention and treatment of type 2 diabetes tend to place considerable emphasis on what people eat, with little to no consideration of WHEN they eat. This work will extend current explorations of chrono-nutrition, using continuous glucose monitoring to explore the impacts of meal size, frequency, timing as well as macronutrient content, especially dietary protein, on blood glucose control and health, to develop personalized nutrition strategies to improve health.</description>
            <description type="fundingAmount">$600,724.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041099</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041099</identifier>
            <identifier type="nhmrc">2041099</identifier>
            <name type="primary">
                <namePart>Clinical trials addressing top priorities for stroke research</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6044-7328</identifier>
                <title>Prof Graeme Hankey</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04yn72m09</identifier>
                <title>Perron Institute for Neurological and Translational Science</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Central nervous system BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology not elsewhere classified</subject>
            <subject type="local">stroke</subject>
            <subject type="local">stroke prevention</subject>
            <subject type="local">acute stroke</subject>
            <subject type="local">stroke outcome</subject>
            <subject type="local">clinical trial</subject>
            <description type="Chief Investigator Team">Prof Graeme Hankey&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Stroke affects 29,000 Australians each year, of whom 7,600 die, and there are 387,000 stroke survivors who are at risk of another stroke. The program will address 4 of the top priorities for stroke research for stroke survivors by testing 4 new treatments which aim to protect the brain from damage during an acute stroke, reduce the likelihood of having another stroke, and help stroke survivors decide whether it is beneficial to take blood-thinning medicines to prevent another stroke.</description>
            <description type="fundingAmount">$2,000,000.00</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041107</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041107</identifier>
            <identifier type="nhmrc">2041107</identifier>
            <name type="primary">
                <namePart>Elimination of Mycobacterium ulcerans infection (Buruli ulcer)</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0150-123X</identifier>
                <title>Prof Tim Stinear</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Bacteriology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Infectious agents</subject>
            <subject type="local">mycobacterial infection</subject>
            <subject type="local">zoonotic infectious disease</subject>
            <subject type="local">mycobacteria</subject>
            <subject type="local">buruli or bairnsdale ulcer</subject>
            <subject type="local">bacterial infection</subject>
            <description type="Chief Investigator Team">Prof Tim Stinear&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Buruli ulcer is a neglected tropical skin infection caused by a bacterium. Through research led by my team over the past 20 years we now know the infection in Australia is spread by mosquitoes. In this project we will track the pathogen in the environment and eliminate Buruli ulcer by curing the infection in Australian native possums and by innovative mosquito control measures. We will also explore vaccines to prevent Buruli ulcer in humans.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041108</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041108</identifier>
            <identifier type="nhmrc">2041108</identifier>
            <name type="primary">
                <namePart>Targeting Novel Treatment Mechanisms in Mood and Anxiety Disorders</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2226-2074</identifier>
                <title>Prof Benjamin Harrison</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Psychiatry (incl. psychotherapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Central nervous system</subject>
            <subject type="local">depression</subject>
            <subject type="local">neuroimaging</subject>
            <subject type="local">anxiety disorders</subject>
            <subject type="local">posttraumatic stress disorder (ptsd)</subject>
            <subject type="local">functional magnetic resonance imaging (fmri)</subject>
            <description type="Chief Investigator Team">Prof Benjamin Harrison&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">To reduce the substantial burden of mood and anxiety-related disorders on individuals and society, more effective treatments are needed. I will use advanced brain imaging technology to better understand how current treatments work for people with depression and posttraumatic stress disorder, with the goal of delivering new insights that will inform the development of improved future treatments.</description>
            <description type="fundingAmount">$2,554,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041117</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041117</identifier>
            <identifier type="nhmrc">2041117</identifier>
            <name type="primary">
                <namePart>Long-lived remodelling of epigenetic state to treat disease</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Marnie_Blewitt</identifier>
                <title>Prof Marnie Blewitt</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Epigenetics (incl. genome methylation and epigenomics) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Gene expression (incl. microarray and other genome-wide approaches) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Neurology and neuromuscular diseases</subject>
            <subject type="local">epigenetics</subject>
            <subject type="local">neurodevelopmental disorders</subject>
            <subject type="local">control of gene expression</subject>
            <subject type="local">novel therapeutic agents</subject>
            <subject type="local">trinucleotide repeat disorder</subject>
            <description type="Chief Investigator Team">Prof Marnie Blewitt&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">In normal biology, genes can be switched on or off so that the same set of genes can result in many different cell types. If we can harness the power to switch genes on or off therapeutically then we could treat myriad incurable diseases. Here we will apply a new strategy to switch genes on and off. We will develop novel potential treatments for the neurodevelopmental disorder Prader Willi Syndrome and investigate in which other diseases our approach is suitable.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041123</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041123</identifier>
            <identifier type="nhmrc">2041123</identifier>
            <name type="primary">
                <namePart>Bridging the gap between evidence and practice to improve management of anterior cruciate ligament (ACL) injuries</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9624-0791</identifier>
                <title>Assoc Prof Stephanie Filbay</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science</subject>
            <subject type="anzsrc-for">Physiotherapy BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Orthopaedics</subject>
            <subject type="local">physiotherapy</subject>
            <subject type="local">sports medicine</subject>
            <subject type="local">knee</subject>
            <subject type="local">sports injury</subject>
            <subject type="local">musculoskeletal</subject>
            <description type="Chief Investigator Team">Assoc Prof Stephanie Filbay&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">An ACL (the main knee stabilising ligament) tear can have devastating outcomes. Patients are misinformed about treatments and physios lack skills to deliver quality care. We found that ACLs can heal, but we don’t know which ACLs will heal. To improve treatment of ACL tears, I will: 1) test a decision aid to inform patients about treatments 2) outline skills needed for physios to deliver quality care 3) develop and test an online course to train physios 4) discover which ACLs are most likely to heal</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041127</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041127</identifier>
            <identifier type="nhmrc">2041127</identifier>
            <name type="primary">
                <namePart>Unravelling epigenetic mechanisms to improve immunity</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6057-1855</identifier>
                <title>Dr Christine Keenan</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Epigenetics (incl. genome methylation and epigenomics) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Immunogenetics (incl. genetic immunology) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Respiratory diseases</subject>
            <subject type="local">epigenetics</subject>
            <subject type="local">genomics</subject>
            <subject type="local">immune dysfunction</subject>
            <subject type="local">humoral immunity</subject>
            <subject type="local">asthma</subject>
            <description type="Chief Investigator Team">Dr Christine Keenan&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Our immune systems protect us remarkably well from a constant barrage of germs. However, this protection must be finely balanced to not overreact (as in asthma) or leave us vulnerable to infection (as in immune deficiency). My research program aims to understand how DNA is read differently in different cells, termed 'epigenetics', despite all cells of the body having the same DNA code, with the ultimate goal to develop new epigenetic-targeting drugs to restore healthy immunity in disease.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041152</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041152</identifier>
            <identifier type="nhmrc">2041152</identifier>
            <name type="primary">
                <namePart>A new molecular era for dementia: Biomarker discovery through to implementation</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4877-1958</identifier>
                <title>Dr Pratishtha Chatterjee</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Neurology and neuromuscular diseases</subject>
            <subject type="local">dementia</subject>
            <subject type="local">neuropathology</subject>
            <subject type="local">clinical diagnosis</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">cognitive impairment</subject>
            <description type="Chief Investigator Team">Dr Pratishtha Chatterjee&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Dementia diagnosis is evolving from clinical to biologically informed methods, with biomarkers now crucial for diagnosis, treatment, and monitoring. My research has shown the immense potential of blood-biomarkers in Alzheimer's disease (AD) diagnostics. However, there are still gaps to address. Here, I will focus on developing novel biomarkers for non-AD dementias, assess how other health factors affect both AD and non-AD dementia biomarkers, and test how well these biomarkers work in clinics.</description>
            <description type="fundingAmount">$1,603,536.55</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041168</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041168</identifier>
            <identifier type="nhmrc">2041168</identifier>
            <name type="primary">
                <namePart>Periconception mechanisms impacting fertility and pregnancy health</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9967-0084</identifier>
                <title>Prof Sarah Robertson</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Obstetrics and gynaecology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Reproduction BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Foetal development and medicine</subject>
            <subject type="local">pregnancy complications</subject>
            <subject type="local">prematurity</subject>
            <subject type="local">female infertility</subject>
            <subject type="local">embryo implantation</subject>
            <subject type="local">reproductive immunology</subject>
            <description type="Chief Investigator Team">Prof Sarah Robertson&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Fertility and pregnancy disorders affect at least one in six intending parents and have long term impacts on women, men and children. This research will define how male and female factors interact before and during conception and develop tools to assist healthy embryo development and pregnancy progression. The goal is to reduce the incidence of infertility and pregnancy disorders, to deliver effective treatment options for these conditions, and maximise health outcomes for infants and families.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041176</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041176</identifier>
            <identifier type="nhmrc">2041176</identifier>
            <name type="primary">
                <namePart>Walk and live better: Non-surgical therapies for Australians with peripheral artery disease (PAD)</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Jonathan_Golledge</identifier>
                <title>Prof Jonathan Golledge</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04gsp2c11</identifier>
                <title>James Cook University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04gsp2c11</identifier>
                <title>James Cook University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/021zqhw10</identifier>
                <title>Townsville University Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Surgery</subject>
            <subject type="local">peripheral arterial disease</subject>
            <subject type="local">exercise therapy</subject>
            <subject type="local">abdominal aortic aneurysm</subject>
            <subject type="local">regional health</subject>
            <subject type="local">quality of life</subject>
            <description type="Chief Investigator Team">Prof Jonathan Golledge&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">One million Australians (250 million people worldwide) have blockage of the arteries in the abdomen or legs, causing walking impairment, poor quality of life, major amputation and death. Currently the only treatment for this disease is surgery, but this has durability and safety limitations. This research program will deliver unique clinical trials to test new ways to treat this problem non-surgically with drugs, counselling, medication optimisation and exercise suited to all Australians.</description>
            <description type="fundingAmount">$2,477,287.50</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041194</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041194</identifier>
            <identifier type="nhmrc">2041194</identifier>
            <name type="primary">
                <namePart>Unlocking the future of robotic imaging for surgical procedural navigation and verification</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0543-9170</identifier>
                <title>Dr Tess Reynolds</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">PHYSICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical and biological physics</subject>
            <subject type="anzsrc-for">Medical physics</subject>
            <subject type="local">medical imaging</subject>
            <subject type="local">radiology</subject>
            <subject type="local">imaging</subject>
            <subject type="local">orthopaedic surgery</subject>
            <subject type="local">cardiology</subject>
            <description type="Chief Investigator Team">Dr Tess Reynolds&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Robotic imaging systems have revolutionised surgical interventions. To deliver the future of 3D image guidance for challenging surgical interventions, where options remain limited, I will develop imaging technologies that promise to allow direct in-room surgical verification of orthopaedic hardware, adaptively sync to the patient to mitigate motion without mechanical intervention and facilitate long anatomical sites to be captured in a single image to assess anatomy alignment intraoperatively.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041202</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041202</identifier>
            <identifier type="nhmrc">2041202</identifier>
            <name type="primary">
                <namePart>Targeting whole genome duplication as a therapeutic vulnerability in high grade serous ovarian cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Nikki_Burdett</identifier>
                <title>Dr Nikki Burdett</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Solid tumours BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer genetics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer cell biology</subject>
            <subject type="local">oncology</subject>
            <subject type="local">translational research</subject>
            <subject type="local">ovarian cancer</subject>
            <subject type="local">genomics</subject>
            <subject type="local">aneuploidy</subject>
            <description type="Chief Investigator Team">Dr Nikki Burdett&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Ovarian cancer is an area of urgent need for new and effective treatments. I previously found that ovarian cancers which develop whole genome duplication (WGD) early have features that allow cancer cells to hide from the body’s immune system. These patients also have the worst prognosis. My research will explore the differences in ovarian cancer cells with WGD, assess changes linked with WGD even before the cancer is diagnosed, and look for therapeutic targets to treat cancers with WGD.</description>
            <description type="fundingAmount">$600,724.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041205</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041205</identifier>
            <identifier type="nhmrc">2041205</identifier>
            <name type="primary">
                <namePart>Understanding the role of an ancient fusogen in malaria parasite fertilisation and transmission</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9439-3487</identifier>
                <title>Dr Li-Jin Chan</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Infectious agents</subject>
            <subject type="local">malaria</subject>
            <subject type="local">fertilisation</subject>
            <subject type="local">antibody</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">mosquito transmission</subject>
            <description type="Chief Investigator Team">Dr Li-Jin Chan&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">The global effort toward malaria elimination requires an array of tools to prevent, treat and block transmission of the malaria parasite. Blocking transmission involves targeting proteins that are essential for malaria parasite fertilisation in mosquitos, thereby preventing mosquito to human transmission. Understanding how these proteins work and discovering new fertilisation proteins is essential for developing effective interventions, like antibody treatments, to prevent transmission.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041224</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041224</identifier>
            <identifier type="nhmrc">2041224</identifier>
            <name type="primary">
                <namePart>Patient-Centred Platforms for Preclinical Schizophrenia Research and Translation</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7100-651</identifier>
                <title>Dr Maria Di Biase</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Central nervous system BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Psychiatry (incl. psychotherapy)</subject>
            <subject type="local">schizophrenia and related disorders</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">neuroimaging</subject>
            <subject type="local">adult stem cells</subject>
            <subject type="local">neuroscience</subject>
            <description type="Chief Investigator Team">Dr Maria Di Biase&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Schizophrenia is a complex and severe brain disorder that can affect how someone thinks, feels, and behaves. The biological cause of schizophrenia likely differs from patient to patient, making it hard to develop optimal treatments that benefit all patients. This project is designed to develop personalised insights into schizophrenia by harnessing the power of stem cell science, genetics and neuroimaging. These insights could lead to improved diagnosis and tailored treatments for schizophrenia.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041226</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041226</identifier>
            <identifier type="nhmrc">2041226</identifier>
            <name type="primary">
                <namePart>Identification, Validation and Therapy of Autoinflammatory Diseases</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4763-576X</identifier>
                <title>Prof Seth Masters</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Innate immunity</subject>
            <subject type="local">innate immunity</subject>
            <subject type="local">interleukins (il)</subject>
            <subject type="local">immune-mediated inflammation</subject>
            <subject type="local">acute inflammation</subject>
            <subject type="local">cytokine signalling</subject>
            <description type="Chief Investigator Team">Prof Seth Masters&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Mutations of our genetic code can affect cells of our immune system, leading to a functional loss or gain that can cause recurrent infection, or in some cases, promote autoimmunity and autoinflammation. Our investigation of these inborn errors of immunity will advance the understanding of disease mechanisms, and fundamental workings of our immune system, in order to identify and improve therapies that will potentially treat a range of inflammatory diseases.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041249</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041249</identifier>
            <identifier type="nhmrc">2041249</identifier>
            <name type="primary">
                <namePart>Redefining Psychopathology: Empirical Phenotypes Offer a Path to Discovery</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6954-3818</identifier>
                <title>Dr Miriam Forbes</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01sf06y89</identifier>
                <title>Macquarie University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01sf06y89</identifier>
                <title>Macquarie University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Clinical and health psychology</subject>
            <subject type="anzsrc-for">Clinical psychology PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Applied and developmental psychology</subject>
            <subject type="anzsrc-for">Psychological methodology, design and analysis</subject>
            <subject type="local">psychopathology</subject>
            <subject type="local">mental illness</subject>
            <subject type="local">classification</subject>
            <subject type="local">diagnosis</subject>
            <subject type="local">mental disorder</subject>
            <description type="Chief Investigator Team">Dr Miriam Forbes&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">It is now clear that traditional approaches to diagnosing mental illness are hindering rather than helping progress in identifying underlying mechanisms, and improving treatment outcomes. My research takes a new approach, following the patterns in how symptoms naturally co-occur to define so-called ‘empirical phenotypes’. The proposed research will compare different diagnostic systems to determine which ones work best for different purposes, and will develop tools for using them in practice.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041250</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041250</identifier>
            <identifier type="nhmrc">2041250</identifier>
            <name type="primary">
                <namePart>Improving outcomes for patients with systemic lupus erythematosus</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9507-3338</identifier>
                <title>Prof Eric Morand</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Autoimmunity BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Rheumatology and arthritis</subject>
            <subject type="local">systemic lupus erythematosus (sle)</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">outcome measures</subject>
            <subject type="local">glucocorticoids</subject>
            <subject type="local">drug discovery</subject>
            <description type="Chief Investigator Team">Prof Eric Morand&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The autoimmune disease, systemic lupus erythematosus (SLE, or lupus) predominantly affects young women. SLE causes organ damage, poor quality of life, and early death. Many factors contribute to serial unsuccessful clinical trials and thus a lack of novel therapies, such that patients are still mostly treated with drugs from the 1950s. My research will address key issues in lupus, including measurement tools, biological insights, and developing both broad and specific novel therapies.</description>
            <description type="fundingAmount">$2,000,000.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041261</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041261</identifier>
            <identifier type="nhmrc">2041261</identifier>
            <name type="primary">
                <namePart>Stem cell model systems to reflect global diversity and unlock equitable cardiovascular disease research</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1783-6491</identifier>
                <title>Dr Drew Neavin</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b3dvp57</identifier>
                <title>The Garvan Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Genomics BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Statistical and quantitative genetics</subject>
            <subject type="local">genetics</subject>
            <subject type="local">adult stem cells</subject>
            <subject type="local">statistical genetics</subject>
            <subject type="local">bioinformatics</subject>
            <subject type="local">cardiovascular disease</subject>
            <description type="Chief Investigator Team">Dr Drew Neavin&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Cardiovascular diseases are a leading cause for disease burden and death in Australia. An individual’s genetic blueprint is an important contributor to risk of cardiovascular diseases. Evidence suggests that different ancestral groups have variable risk for developing cardiovascular diseases. My goal is to interrogate cardiovascular diseases across different ancestries to provide a more complete picture of the disease.</description>
            <description type="fundingAmount">$638,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041264</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041264</identifier>
            <identifier type="nhmrc">2041264</identifier>
            <name type="primary">
                <namePart>Implementation of genomics for infectious disease surveillance and response in the Northern Territory of Australia</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7993-820X</identifier>
                <title>Dr Ella Meumann</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Disease surveillance BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical microbiology</subject>
            <subject type="anzsrc-for">Medical bacteriology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases</subject>
            <subject type="local">infectious diseases</subject>
            <subject type="local">bacterial genetics</subject>
            <subject type="local">epidemiology</subject>
            <subject type="local">microbiology</subject>
            <subject type="local">rural and remote health</subject>
            <description type="Chief Investigator Team">Dr Ella Meumann&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Knowledge about communicable diseases is being transformed by sequencing the genetic material of microbes that cause infections. My program will use genomic sequencing to track and trace infectious diseases in Australia's Northern Territory. This will enhance understanding of disease patterns and support public health efforts while boosting genomics capabilities in northern Australia. The program will focus on three major infections: melioidosis, invasive Group A Streptococcus, and tuberculosis.</description>
            <description type="fundingAmount">$350,362.00</description>
            <coverage>
                <spatial type="text">NT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041273</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041273</identifier>
            <identifier type="nhmrc">2041273</identifier>
            <name type="primary">
                <namePart>Using modelling to guide the elimination of hepatitis B, hepatitis C and HIV</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9213-0798</identifier>
                <title>Assoc Prof Nick Scott</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05ktbsm52</identifier>
                <title>Burnet Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05ktbsm52</identifier>
                <title>Burnet Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological modelling ECONOMICS</subject>
            <subject type="anzsrc-for">Applied economics</subject>
            <subject type="anzsrc-for">Health economics</subject>
            <subject type="local">mathematical modelling</subject>
            <subject type="local">population health</subject>
            <subject type="local">infectious diseases</subject>
            <subject type="local">economic analysis</subject>
            <subject type="local">hepatitis</subject>
            <description type="Chief Investigator Team">Assoc Prof Nick Scott&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">I will use epidemic and economic modelling to guide responses to hepatitis B, hepatitis C and HIV in Australia and internationally. I will combine novel data from research studies, surveillance systems and international collaborations to identify affordable packages of effective interventions. My findings will inform resource allocation decisions by governments and global health organisations, saving lives by ensuring that funding is allocated to achieve maximum impact.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041275</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041275</identifier>
            <identifier type="nhmrc">2041275</identifier>
            <name type="primary">
                <namePart>Implementation research to eliminate HIV transmission in Australia: a community-based, digital and peer-enhanced approach</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2586-8274</identifier>
                <title>Prof Martin Holt</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation HUMAN SOCIETY</subject>
            <subject type="anzsrc-for">Sociology</subject>
            <subject type="anzsrc-for">Sociology of health</subject>
            <subject type="local">human immunodeficiency virus (hiv)</subject>
            <subject type="local">community intervention</subject>
            <subject type="local">behaviour</subject>
            <subject type="local">sexual health</subject>
            <subject type="local">chronic illness prevention</subject>
            <description type="Chief Investigator Team">Prof Martin Holt&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This research program will test community-based, digital and peer-enhanced ways of increasing engagement with HIV testing and HIV prevention among gay and bisexual men who are at risk of HIV. This will increase participants’ knowledge of their HIV status and use of effective prevention methods, while also identifying effective forms of engagement and promotion that can be adopted and scaled up by community organisations and governments to further reduce HIV transmission in Australia.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041278</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041278</identifier>
            <identifier type="nhmrc">2041278</identifier>
            <name type="primary">
                <namePart>Discovery and validation of drugs and diagnostics to propel a new era of dementia research</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8259-9069</identifier>
                <title>Prof Ashley Bush</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03a2tac74</identifier>
                <title>Florey Institute of Neuroscience and Mental Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Neurology and neuromuscular diseases</subject>
            <subject type="local">metal metabolism</subject>
            <subject type="local">iron metabolism</subject>
            <subject type="local">alzheimer disease</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">mitochondria</subject>
            <description type="Chief Investigator Team">Prof Ashley Bush&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Amyloid clearing drugs for Alzheimer’s disease (AD) are a step forward, but their benefits are limited, and we still need to understand much more about this incurable disorder. My program has studied the changes in brain iron in AD and recently linked these to energy failure. My program will illuminate the mechanisms involved, to identify new drug targets, imaging and blood tests, and test new drug candidates.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041301</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041301</identifier>
            <identifier type="nhmrc">2041301</identifier>
            <name type="primary">
                <namePart>Data and Artificial Intelligence for Advancing Cancer Care</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7652-4378</identifier>
                <title>Assoc Prof Ashley Hopkins</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Predictive and prognostic markers HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological modelling</subject>
            <subject type="local">artificial intelligence</subject>
            <subject type="local">clinical epidemiology</subject>
            <subject type="local">machine learning</subject>
            <subject type="local">oncology</subject>
            <subject type="local">health policy</subject>
            <description type="Chief Investigator Team">Assoc Prof Ashley Hopkins&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This project aims to advance cancer care using AI and data. It will develop benchmarks to ensure AI safety and reduce health disinformation, use AI to improve cancer patient monitoring and early treatment of adverse events, and build an international coalition to drive data transparency for understanding how cancer treatments affect different populations. These efforts will drive scientific discovery, improve clinical care, and set new standards for AI safety and data use in healthcare.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041304</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041304</identifier>
            <identifier type="nhmrc">2041304</identifier>
            <name type="primary">
                <namePart>Transforming pre-eclampsia risk screening and prevention in low- and middle-income countries</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3214-7096</identifier>
                <title>Prof Joshua Vogel</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05ktbsm52</identifier>
                <title>Burnet Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05ktbsm52</identifier>
                <title>Burnet Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Obstetrics and gynaecology HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified</subject>
            <subject type="local">maternal health</subject>
            <subject type="local">pre-eclampsia</subject>
            <subject type="local">randomised controlled trial (rct)</subject>
            <subject type="local">developing countries</subject>
            <subject type="local">premature birth</subject>
            <description type="Chief Investigator Team">Prof Joshua Vogel&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Pre-eclampsia is a pregnancy complication with high blood pressure and organ damage, affecting &gt;6 million women annually. In many low- and middle-income countries (LMICs) women at risk of pre-eclampsia are not identified. This means they do not receive aspirin which can prevent it. My research will determine how risk screening and preventing pre-eclampsia in LMICs can be improved. I will find out which dose of aspirin is best for women and babies and what new drugs can prevent pre-eclampsia.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041331</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041331</identifier>
            <identifier type="nhmrc">2041331</identifier>
            <name type="primary">
                <namePart>Improving Prostate Cancer Outcomes by Integrating Novel Imaging and Targeted Therapy (theranostics) for Personalised Medicine</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8622-159X</identifier>
                <title>Prof Michael Hofman</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Nuclear medicine BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Solid tumours</subject>
            <subject type="local">nuclear medicine</subject>
            <subject type="local">radiopharmaceuticals</subject>
            <subject type="local">radiology</subject>
            <subject type="local">prostate cancer</subject>
            <subject type="local">oncology</subject>
            <description type="Chief Investigator Team">Prof Michael Hofman&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This research aims to dramatically improve outcomes for patients with prostate cancer, which currently exceed 3500 in Australia annually, by using a technology called theranostics. Theranostics uses radioactive tumour seeking molecules to integrate whole body scanning and a targeted treatment. I will develop new radioactive molecules, perform clinical trials and use artificial intelligence, focussing on approaches with potential for global approval and adoption in less than 5-10 years.</description>
            <description type="fundingAmount">$2,763,660.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041334</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041334</identifier>
            <identifier type="nhmrc">2041334</identifier>
            <name type="primary">
                <namePart>Reducing inequities in injury across the life course</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3448-662X</identifier>
                <title>Prof Rebecca Ivers</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Injury prevention HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Aged health care</subject>
            <subject type="local">injury prevention</subject>
            <subject type="local">public health</subject>
            <subject type="local">equity</subject>
            <subject type="local">accidental falls</subject>
            <subject type="local">indigenous health</subject>
            <description type="Chief Investigator Team">Prof Rebecca Ivers&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">There remain significant global inequities in access to injury prevention and trauma care programs. My research will lead to better understanding of the injury burden and risk factors across the life-course in Australia and globally, and lead to development of and widespread access to culturally safe programs to prevent and treat injury, including for Indigenous people, those from culturally diverse communities in Australia, and for people in low- and middle-income countries.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041348</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041348</identifier>
            <identifier type="nhmrc">2041348</identifier>
            <name type="primary">
                <namePart>Drug and alcohol treatment in criminal justice system for Aboriginal and Torres Strait Islander people</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2083-8575</identifier>
                <title>Assoc Prof Michael Doyle</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander public health and wellbeing</subject>
            <subject type="local">indigenous australians</subject>
            <subject type="local">illicit drug use</subject>
            <subject type="local">prison population</subject>
            <subject type="local">alcohol and behaviour</subject>
            <subject type="local">behaviour change</subject>
            <description type="Chief Investigator Team">Assoc Prof Michael Doyle&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Indigenous people are imprisoned at 15.2 times the rate of other Australians. Over half the Indigenous people in prison have mental health or substance use issues. I aim to improve their health by making a culturally based wellbeing program available nationally, developing a model of care for men entering residential rehabilitation services from prison and enhancing access to pharmacotherapies. Additionally, I will develop a peer educator program for Indigenous people in and post-prison.</description>
            <description type="fundingAmount">$1,634,700.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041361</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041361</identifier>
            <identifier type="nhmrc">2041361</identifier>
            <name type="primary">
                <namePart>Age-related macular degeneration (AMD): causes and cures- intervening early, before vision is threatened</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9441-4356</identifier>
                <title>Prof Robyn Guymer</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01sqdef20</identifier>
                <title>Centre for Eye Research Australia Limited</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01sqdef20</identifier>
                <title>Centre for Eye Research Australia Limited</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Ophthalmology and optometry</subject>
            <subject type="anzsrc-for">Ophthalmology</subject>
            <subject type="local">retinal degeneration</subject>
            <subject type="local">randomised controlled trial (rct)</subject>
            <subject type="local">age-related</subject>
            <subject type="local">early intervention</subject>
            <subject type="local">vision loss</subject>
            <description type="Chief Investigator Team">Prof Robyn Guymer&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in our community. This research aims to identify new causative pathways leading to AMD as well as conduct two novel early interventions trials to prevent vision loss. This research will provide evidence for more feasible ways to conduct early intervention studies. With this new knowledge we will be closer to preventing vision loss from this prevalent and devastating disease.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041370</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041370</identifier>
            <identifier type="nhmrc">2041370</identifier>
            <name type="primary">
                <namePart>Transforming the prevention system to optimise population health</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6178-3868</identifier>
                <title>Prof Luke Wolfenden</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00eae9z71</identifier>
                <title>The University of Newcastle</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00eae9z71</identifier>
                <title>The University of Newcastle</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion</subject>
            <subject type="local">health promotion</subject>
            <subject type="local">implementation</subject>
            <subject type="local">population health</subject>
            <subject type="local">school health promotion</subject>
            <subject type="local">chronic diseases</subject>
            <description type="Chief Investigator Team">Prof Luke Wolfenden&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">If interventions we know are effective were implemented we could prevent half of all cancer occurring today. However, health agencies like government departments do not have the information they need to implement effective interventions. I will work with these agencies and undertake research to to identify what interventions need to be better implemented, how they currently do this, and how it could be improved. Agencies will use this to improve implementation of their initiatives.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041379</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041379</identifier>
            <identifier type="nhmrc">2041379</identifier>
            <name type="primary">
                <namePart>Improving Aboriginal cancer health outcomes in the precision medicine era</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9412-6808</identifier>
                <title>Dr Justine Clark</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/019wvm592</identifier>
                <title>Australian National University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01dbmzx78</identifier>
                <title>The Kids Research Institute Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Genomics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Haematological tumours INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander public health and wellbeing</subject>
            <subject type="local">oncology</subject>
            <subject type="local">genomics</subject>
            <subject type="local">haematological malignancy</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">cancer genetics</subject>
            <description type="Chief Investigator Team">Dr Justine Clark&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Cancer is one of the biggest diseases affecting Aboriginal people, who have limited access to culturally safe and effective cancer care. 'Precision' cancer care is a new way to use knowledge from our DNA to identify, prevent, diagnose and treat cancer to make sure each person gets the right treatment for them. This research will improve access to and benefit from precision cancer care for Aboriginal people according to an Aboriginal community-defined agenda, improving health outcomes.</description>
            <description type="fundingAmount">$685,231.91</description>
            <coverage>
                <spatial type="text">ACT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041400</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041400</identifier>
            <identifier type="nhmrc">2041400</identifier>
            <name type="primary">
                <namePart>DNA origami nanostructures for iPSC generation and cell reprogramming</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-8680-7766</identifier>
                <title>Dr Jessica Kretzmann</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical biotechnology</subject>
            <subject type="anzsrc-for">Gene and molecular therapy BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Synthetic biology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical biotechnology</subject>
            <subject type="anzsrc-for">Nanomedicine</subject>
            <subject type="local">nanotechnology</subject>
            <subject type="local">biomedical engineering</subject>
            <subject type="local">gene delivery</subject>
            <subject type="local">stem cell therapy</subject>
            <subject type="local">intracellular gene expression</subject>
            <description type="Chief Investigator Team">Dr Jessica Kretzmann&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Induced pluripotent stem cells (iPSCs) are critical for tissue replacement therapy, studying diseases, and trialling drugs. However, generating these cells and 'reprogramming' them, is expensive and time consuming, and produces cells of mixed quality. Making these cells requires the delivery of genes, which is not well understood. This research will develop new tools using 'DNA origami' to understand and improve how genes are delivered into cells, for safe and efficient generation of iPSCs.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041411</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041411</identifier>
            <identifier type="nhmrc">2041411</identifier>
            <name type="primary">
                <namePart>Improving knowledge and interventions to combat pathogenic arboviruses</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7248-0101</identifier>
                <title>Dr Daniel Rawle</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/31411813344</identifier>
                <title>The Council of the Queensland Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/31411813344</identifier>
                <title>The Council of the Queensland Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Virology</subject>
            <subject type="local">arbovirus diseases</subject>
            <subject type="local">japanese encephalitis virus</subject>
            <subject type="local">flavivirus</subject>
            <subject type="local">ross river virus</subject>
            <subject type="local">epidemic polyarthritis</subject>
            <description type="Chief Investigator Team">Dr Daniel Rawle&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Mosquito-borne flaviviruses and alphaviruses threaten ~4 billion people and cause ~5 million disability-adjusted life years lost annually. Treatment options for flaviviruses and alphaviruses are limited by a poor understanding of the mechanisms underpinning infection and disease. This research program will identify key mechanisms of JEV and CHIKV infection and disease, leading to new antiviral and anti-inflammatory strategies. The research program will also expedite development of new vaccines.</description>
            <description type="fundingAmount">$638,405.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041414</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041414</identifier>
            <identifier type="nhmrc">2041414</identifier>
            <name type="primary">
                <namePart>Improving access to postpartum contraception through a midwifery model of care</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6157-9739</identifier>
                <title>Dr Jessica Botfield</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health and community services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Midwifery</subject>
            <subject type="anzsrc-for">Midwifery not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion</subject>
            <subject type="local">contraception</subject>
            <subject type="local">access to health care</subject>
            <subject type="local">midwifery</subject>
            <subject type="local">reproductive health</subject>
            <subject type="local">maternal health</subject>
            <description type="Chief Investigator Team">Dr Jessica Botfield&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Women and their babies are healthier when pregnancies are spaced at least 18 months apart. However, lack of information and access to postpartum contraception means many women unintentionally fall pregnant again soon after birth. Midwives are well-placed to provide contraception information and care, yet this is not common practice in Australia. My research aims to develop, implement and evaluate a midwifery model of care to increase access to postpartum contraception.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041418</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041418</identifier>
            <identifier type="nhmrc">2041418</identifier>
            <name type="primary">
                <namePart>Non-protein ubiquitination in disease and inflammation</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Laura_Fielden</identifier>
                <title>Dr Laura Fielden</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Proteomics and intermolecular interactions (excl. medical proteomics) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Evolutionary biology</subject>
            <subject type="anzsrc-for">Host-parasite interactions BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Cell development, proliferation and death</subject>
            <subject type="local">ubiquitination</subject>
            <subject type="local">mitochondria</subject>
            <subject type="local">mass spectrometry</subject>
            <subject type="local">host/pathogen interaction</subject>
            <subject type="local">immune-mediated inflammation</subject>
            <description type="Chief Investigator Team">Dr Laura Fielden&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Regulation of different signals and processes is key to cellular health. A major way cells achieve this is attaching the small protein ‘ubiquitin’ to specific targets. This acts as a code, read by other proteins and results in changes to cell function. Recently, new players in this code have been identified but we have limited ways to ‘see’ them in cells. Our research will discover and understand the role of these new players in ubiquitin signalling during infection, cell death and inflammation.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041423</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041423</identifier>
            <identifier type="nhmrc">2041423</identifier>
            <name type="primary">
                <namePart>Activating AMPK to prevent Dnmt3a clonal haematopoiesis and atherosclerotic disease</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Dragana_Dragoljevic</identifier>
                <title>Dr Dragana Dragoljevic</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03rke0285</identifier>
                <title>Baker Heart and Diabetes Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03rke0285</identifier>
                <title>Baker Heart and Diabetes Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Other biological sciences</subject>
            <subject type="anzsrc-for">Other biological sciences not elsewhere classified</subject>
            <subject type="local">haematopoietic stem cells</subject>
            <subject type="local">experimental diabetes</subject>
            <subject type="local">haematopoiesis</subject>
            <subject type="local">atherosclerosis</subject>
            <subject type="local">dna methylation</subject>
            <description type="Chief Investigator Team">Dr Dragana Dragoljevic&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Recently, it was discovered that mutations in stem cells, termed CHIP, accelerate heart disease. Distressingly, there are no formal guidelines for clinicians in the management of CHIP as this is a new disease. This project aims to halt CHIP development, and prevent heart disease in this population. Our findings will have implications on how people with CHIP are managed in the clinic. Furthermore, we propose that these patients will benefit from an existing and safe diabetic therapeutic.</description>
            <description type="fundingAmount">$451,930.54</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041424</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041424</identifier>
            <identifier type="nhmrc">2041424</identifier>
            <name type="primary">
                <namePart>Accelerating rare disease diagnosis</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8640-1371</identifier>
                <title>Prof Zornitza Stark</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Genomics</subject>
            <subject type="local">medical genomics</subject>
            <subject type="local">health economics</subject>
            <subject type="local">bone marrow transplantation</subject>
            <subject type="local">cardiac transplantation</subject>
            <subject type="local">implementation</subject>
            <description type="Chief Investigator Team">Prof Zornitza Stark&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Rapid genomic diagnosis for rare disease in a matter of days is now a reality. How do we shorten this to hours and bring it closer to critically ill children, or better still, prevent critical illness? New technologies and new models of care, such as genomic newborn screening, are on the threshold of delivering this vision, and this program will drive innovation and provide comprehensive evaluation from a diagnostic, clinical and healthcare system perspective to inform policy and practice.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041434</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041434</identifier>
            <identifier type="nhmrc">2041434</identifier>
            <name type="primary">
                <namePart>Using sleep technologies to better define and manage insomnia</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0707-8068</identifier>
                <title>Dr Hannah Scott</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Digital health BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Clinical sciences not elsewhere classified</subject>
            <subject type="local">insomnia</subject>
            <subject type="local">cognitive behaviour therapy</subject>
            <subject type="local">sleep disturbance</subject>
            <subject type="local">biostatistics</subject>
            <subject type="local">diagnostic techniques</subject>
            <description type="Chief Investigator Team">Dr Hannah Scott&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Insomnia impacts 10-15% of the global population and impairs health, daytime function, and quality of life. Current diagnosis ignores the variable underlying causes of the disorder, and less than 1% of patients are referred for the recommended front-line treatment. My work will use sleep technologies to better identify the causes of insomnia so that tailored treatments can be delivered to better treat insomnia, using tools that can manage insomnia on a large scale for reduced cost.</description>
            <description type="fundingAmount">$663,405.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041439</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041439</identifier>
            <identifier type="nhmrc">2041439</identifier>
            <name type="primary">
                <namePart>Advancing Proteolysis Targeting Chimera Molecular Design with Geometric Deep Learning</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-5216-3213</identifier>
                <title>Dr Fuyi Li</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Bioinformatic methods development INFORMATION AND COMPUTING SCIENCES</subject>
            <subject type="anzsrc-for">Machine learning</subject>
            <subject type="anzsrc-for">Deep learning</subject>
            <subject type="local">bioinformatics</subject>
            <subject type="local">drug design</subject>
            <subject type="local">sequence analysis</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">applied statistics</subject>
            <description type="Chief Investigator Team">Dr Fuyi Li&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Imagine trying to fix a machine without knowing which part is broken. In diseases like cancer, some parts of our body’s machinery fail. I aim to develop special molecules called PROTACs to identify and remove these faulty parts. Using advanced artificial intelligent techniques, I will develop computational tools to guide the design of these molecules, making them more effective and faster to produce. This could lead to better treatments and help us combat diseases more effectively.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041446</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041446</identifier>
            <identifier type="nhmrc">2041446</identifier>
            <name type="primary">
                <namePart>Nutritional Psychiatry: Investigating the efficacy and mechanisms of dietary components in depression</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-8556-8230</identifier>
                <title>Dr Wolfgang Marx</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Nutrition and dietetics not elsewhere classified</subject>
            <subject type="local">mental health</subject>
            <subject type="local">depression</subject>
            <subject type="local">nutrition</subject>
            <subject type="local">diet</subject>
            <subject type="local">treatment strategies</subject>
            <description type="Chief Investigator Team">Dr Wolfgang Marx&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Depression is one of the leading causes of disability. Dietary interventions offer a new and effective way to reduce this burden. To advance our understanding of how diet may help prevent and manage depression, my research program aims to explore new dietary interventions for depression, understand how diet affects depression, and investigate which diet components might increase depression risk.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041474</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041474</identifier>
            <identifier type="nhmrc">2041474</identifier>
            <name type="primary">
                <namePart>Advancing the diagnosis and management of primary aldosteronism, a common but neglected cause of hypertension</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4620-4976</identifier>
                <title>Assoc Prof Jun Yang</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0083mf965</identifier>
                <title>Hudson Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Endocrinology</subject>
            <subject type="local">aldosterone</subject>
            <subject type="local">mineralocorticoid receptor</subject>
            <subject type="local">hypertension</subject>
            <subject type="local">endocrine disease</subject>
            <subject type="local">hyperaldosteronaemia</subject>
            <description type="Chief Investigator Team">Assoc Prof Jun Yang&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Primary aldosteronism (PA) is a hidden cause of high blood pressure that can lead to stroke, irregular heartbeat, and heart attack. It is caused by the adrenal glands producing too much aldosterone and is potentially curable. My goal is to identify over half a million patients with high blood pressure due to undiagnosed PA. We aim to revamp guidelines and develop better tests to ensure that every affected individual has the best chance for accurate diagnosis and effective treatment.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041481</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041481</identifier>
            <identifier type="nhmrc">2041481</identifier>
            <name type="primary">
                <namePart>Understanding determinants of memory T cell fate to enhance cellular immunity</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6000-2305</identifier>
                <title>Dr Pirooz Zareie</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology</subject>
            <subject type="local">cd8 t cells</subject>
            <subject type="local">cell-mediated immunity</subject>
            <subject type="local">t cell immunity</subject>
            <subject type="local">lymphocyte differentiation</subject>
            <subject type="local">antiviral immunity</subject>
            <description type="Chief Investigator Team">Dr Pirooz Zareie&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Memory T cells confer protection against infections and cancers, but to do so, they must be optimally localised and be armed with appropriate functionality. Generating memory T cells with optimal function and localisation is the ultimate goal of any vaccination and cancer therapy, yet we do not fully understand the mechanisms underlying their development. This study will investigate the factors driving development of immune cells in tissues, a critical step for advancing T cell-based medicines.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041484</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041484</identifier>
            <identifier type="nhmrc">2041484</identifier>
            <name type="primary">
                <namePart>Transforming care to achieve effective pathways to good health and quality of life for children with intellectual disability</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7358-9037</identifier>
                <title>Prof Jenny Downs</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">People with disability</subject>
            <subject type="local">intellectual disability</subject>
            <subject type="local">epidemiology</subject>
            <subject type="local">outcome measures</subject>
            <subject type="local">quality of life</subject>
            <subject type="local">health literacy</subject>
            <description type="Chief Investigator Team">Prof Jenny Downs&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Nearly 3% of children globally have intellectual disability. They have poorer health, functioning and quality of life than typically developing children. Their families want care to focus on better everyday health, functioning and quality of life, yet few evidence-based interventions are available. I will identify needed interventions and develop valid, reliable and sensitive ways of assessing their effectiveness. My research is discovering which treatments best improve these needed outcomes.</description>
            <description type="fundingAmount">$2,938,360.30</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041500</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041500</identifier>
            <identifier type="nhmrc">2041500</identifier>
            <name type="primary">
                <namePart>Generation Mental Wealth: A new paradigm for fostering youth mental health</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2380-1092</identifier>
                <title>Assoc Prof Jo-An Occhipinti (née Atkinson)</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Social determinants of health MATHEMATICAL SCIENCES</subject>
            <subject type="anzsrc-for">Applied mathematics</subject>
            <subject type="anzsrc-for">Dynamical systems in applications HUMAN SOCIETY</subject>
            <subject type="anzsrc-for">Sociology</subject>
            <subject type="anzsrc-for">Social change</subject>
            <subject type="local">social determinants</subject>
            <subject type="local">policy analysis</subject>
            <subject type="local">mental health</subject>
            <subject type="local">youth</subject>
            <subject type="local">modelling</subject>
            <description type="Chief Investigator Team">Assoc Prof Jo-An Occhipinti (née Atkinson)&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This innovative research will inform actions to address Australia’s youth mental health crisis. It will provide the evidence for shifting from traditional individual &amp; health systems perspectives to a broader Mental Wealth framework that aims to strengthen Australia’s socio-economic fabric, enabling young people to thrive. The program will generate new knowledge and tools to shape wellbeing-focused economies and enable civic engagement to foster youth mental health and wellbeing.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041519</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041519</identifier>
            <identifier type="nhmrc">2041519</identifier>
            <name type="primary">
                <namePart>Community-led Health Promotion in the Torres Strait</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6184-8249</identifier>
                <title>Dr Karla Canuto</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander peoples, society and community</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander community-based research</subject>
            <subject type="local">indigenous health</subject>
            <subject type="local">community development</subject>
            <subject type="local">health promotion</subject>
            <subject type="local">population health</subject>
            <subject type="local">capacity building</subject>
            <description type="Chief Investigator Team">Dr Karla Canuto&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">With rates of chronic diseases skyrocketing throughout the isolated communities of the Torres Straits, Maluilgal (the tribal people of Badu, Mabuiag and Moa Islands) are calling for urgent action to restore wellness. As a Torres Strait Islander researcher and recognised national leader in Indigenous health promotion, Associate Professor Karla Canuto has been endorsed by Tribal leads to lead a program of work to restore health through community-led evidence-based health promotion initiatives.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041556</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041556</identifier>
            <identifier type="nhmrc">2041556</identifier>
            <name type="primary">
                <namePart>Development of a novel cancer immunotherapy</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9402-274X</identifier>
                <title>Dr Nicole Campbell</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0083mf965</identifier>
                <title>Hudson Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Tumour immunology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy)</subject>
            <subject type="local">cancer metastasis</subject>
            <subject type="local">innate immunity</subject>
            <subject type="local">cancer immunotherapy</subject>
            <subject type="local">cancer immunology</subject>
            <subject type="local">type i interferon</subject>
            <description type="Chief Investigator Team">Dr Nicole Campbell&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">During metastasis, cancer cells spread from the primary tumour and form metastases at distant sites through dampening the body's anti-cancer immune response. I previously discovered that a unique immune molecule, interferon epsilon (IFNe), prevents metastasis of ovarian cancer. This project will investigate the mechanism of IFNe in ovarian cancer &amp; its effects in other cancers (pancreatic, gastric &amp; colorectal). It will also support the clinical development of IFNe as a new cancer immunotherapy.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041559</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041559</identifier>
            <identifier type="nhmrc">2041559</identifier>
            <name type="primary">
                <namePart>Development and Implementation of a Retinal Image-Based Deep Learning System for Precise Cardiovascular Risk Assessment and Personalised Care</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9897-1192</identifier>
                <title>Assoc Prof Zhuoting Zhu</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01sqdef20</identifier>
                <title>Centre for Eye Research Australia Limited</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01sqdef20</identifier>
                <title>Centre for Eye Research Australia Limited</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Ophthalmology and optometry</subject>
            <subject type="anzsrc-for">Ophthalmology</subject>
            <subject type="local">retina</subject>
            <subject type="local">artificial intelligence</subject>
            <subject type="local">cardiovascular disease</subject>
            <subject type="local">cardiovascular disease prevention</subject>
            <subject type="local">risk prediction</subject>
            <description type="Chief Investigator Team">Assoc Prof Zhuoting Zhu&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Cardiovascular disease (CVD), including heart disease and stroke, is responsible for one in four deaths. However, 80% of these deaths can be prevented through early detection and timely treatment. The eyes offer a unique window to visualise vascular health. My research aims to exploit an artificial intelligence model based on eye images to provide precise and personalised management of CVD, ultimately reducing the risk of death and disability from this life-threatening condition.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041618</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041618</identifier>
            <identifier type="nhmrc">2041618</identifier>
            <name type="primary">
                <namePart>Understanding systems abuse and Aboriginal resistance in child protection contexts</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Belinda_Newton</identifier>
                <title>Dr Belinda Newton</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HUMAN SOCIETY</subject>
            <subject type="anzsrc-for">Social work</subject>
            <subject type="anzsrc-for">Counselling, wellbeing and community services INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander peoples, society and community</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander perspectives INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander peoples, society and community</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander social work and social justice</subject>
            <subject type="local">aboriginal child</subject>
            <subject type="local">wellbeing</subject>
            <subject type="local">social and cultural issues</subject>
            <subject type="local">participatory action research</subject>
            <subject type="local">aboriginal mental health</subject>
            <description type="Chief Investigator Team">Dr Belinda Newton&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Self-determination is critical for Aboriginal health and wellbeing. My research aims to liberate Aboriginal people from the detrimental health and wellbeing impacts of systems abuse in child protection contexts by building evidence about the nature and impacts of systems abuse and the ways Aboriginal people have resisted these harms. Working with Aboriginal families, communities and organisations, I will spearhead tangible directions to achieve self-determination for Aboriginal people.</description>
            <description type="fundingAmount">$1,634,700.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041619</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041619</identifier>
            <identifier type="nhmrc">2041619</identifier>
            <name type="primary">
                <namePart>Optimising Risk Stratification for Sudden Cardiac Death in the Young</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3859-3716</identifier>
                <title>Prof Jamie Vandenberg</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03trvqr13</identifier>
                <title>Victor Chang Cardiac Research Institute Limited</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Genomics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Basic pharmacology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases)</subject>
            <subject type="local">functional genomics</subject>
            <subject type="local">drug discovery</subject>
            <subject type="local">cardiac electrophysiology</subject>
            <subject type="local">sudden cardiac death</subject>
            <subject type="local">ion channels</subject>
            <description type="Chief Investigator Team">Prof Jamie Vandenberg&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The ability of the heart to pump blood effectively is dependent on a robust electrical communication system. Mutations in the genes that control electrical activity of the heart increase the risk of abnormal heart rhythms and sudden death. The development of tests to accurately predict which mutations are high risk will enable implementation of therapy to reduce risk. The tools we develop will also enable us to screen for new drugs to treat patients at risk of cardiac arrhythmias.</description>
            <description type="fundingAmount">$2,814,025.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041625</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041625</identifier>
            <identifier type="nhmrc">2041625</identifier>
            <name type="primary">
                <namePart>Genomics-driven innovations to tackle drug-resistant bacterial infections</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0237-1473</identifier>
                <title>Prof Benjamin Howden</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical microbiology</subject>
            <subject type="anzsrc-for">Medical bacteriology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Bacteriology</subject>
            <subject type="local">bacterial infection</subject>
            <subject type="local">functional genomics</subject>
            <subject type="local">antibiotic resistance</subject>
            <subject type="local">comparative genomics</subject>
            <subject type="local">public health</subject>
            <description type="Chief Investigator Team">Prof Benjamin Howden&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">New approaches are needed to prevent and treat drug-resistant bacterial diseases. In this project I will use novel approaches to understand how bacterial pathogens are becoming resistant to antibiotics and how they are spreading, and identify new therapeutic options. I will leverage major advances in genomic technologies and cutting-edge techniques developed in my laboratory to deliver new strategies to address this global health threat.</description>
            <description type="fundingAmount">$2,668,202.50</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041635</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041635</identifier>
            <identifier type="nhmrc">2041635</identifier>
            <name type="primary">
                <namePart>Evidence to Impact: Solutions for Climate-Sensitive Health Challenges</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Karin_Leder</identifier>
                <title>Prof Karin Leder</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological methods ENVIRONMENTAL SCIENCES</subject>
            <subject type="anzsrc-for">Climate change impacts and adaptation</subject>
            <subject type="anzsrc-for">Human impacts of climate change and human adaptation</subject>
            <subject type="local">climate change</subject>
            <subject type="local">public health</subject>
            <subject type="local">epidemiological research methods</subject>
            <subject type="local">environmental health</subject>
            <subject type="local">enteric infections</subject>
            <description type="Chief Investigator Team">Prof Karin Leder&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">My research will address the complex challenges of poor sanitation causing gastrointestinal infections, and the health crisis from climate change. I will draw on my research experience to improve knowledge on interactions between contaminated environments, microbial risks, flooding and other climate variables, and I will determine research priorities for policy action. I will use evidence generated to inform climate adaptation solutions to improve health and resilience for people globally.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041653</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041653</identifier>
            <identifier type="nhmrc">2041653</identifier>
            <name type="primary">
                <namePart>Harnessing pathogen genomics to combat current and future threats of drug-resistant enteric bacteria</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0707-6537</identifier>
                <title>Dr Danielle Ingle</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Microbial genetics BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Infectious agents BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Computational ecology and phylogenetics</subject>
            <subject type="local">enteric bacteria</subject>
            <subject type="local">antimicrobial resistance</subject>
            <subject type="local">bacterial evolution</subject>
            <subject type="local">genomics</subject>
            <subject type="local">bioinformatics</subject>
            <description type="Chief Investigator Team">Dr Danielle Ingle&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Drug-resistant enteric bacteria represent a major global public health challenge. In this project I will provide critical insights on how these bacteria adapt and evolve for increased drug-resistance and/or pathogenicity, and develop novel approaches suitable for large scale datasets. This will facilitate enhanced public health surveillance through improved detection and prevention of outbreaks of these drug-resistant bacteria.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041670</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041670</identifier>
            <identifier type="nhmrc">2041670</identifier>
            <name type="primary">
                <namePart>Reframing narratives: Alcohol use among Aboriginal and Torres Strait Islander Peoples</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3224-5761</identifier>
                <title>Dr Teagan Weatherall</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01rxfrp27</identifier>
                <title>La Trobe University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01rxfrp27</identifier>
                <title>La Trobe University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander public health and wellbeing INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander peoples, society and community</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander peoples, society and community not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">access to health care</subject>
            <subject type="local">alcohol consumption</subject>
            <subject type="local">alcohol dependence</subject>
            <subject type="local">epidemiology</subject>
            <description type="Chief Investigator Team">Dr Teagan Weatherall&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Today, Indigenous Australians are still impacted by historical and social factors, and traumas. These may cause Indigenous Australians to turn to alcohol as a coping mechanism or to not access treatment services, as they may feel service providers may not be sensitive or understanding of them. The knowledge gained in this project will help reduce stigma associated with Indigenous Australians and alcohol, and inform the development of culturally-informed treatment and policy options.</description>
            <description type="fundingAmount">$424,043.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041673</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041673</identifier>
            <identifier type="nhmrc">2041673</identifier>
            <name type="primary">
                <namePart>Creating a cellular and microbial canvas of intestinal disease to guide patient stratification, response to treatment and precision therapy</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7107-0650</identifier>
                <title>Dr Kylie James</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b3dvp57</identifier>
                <title>The Garvan Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Genomics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Gastroenterology and hepatology</subject>
            <subject type="local">inflammatory bowel disease (ibd)</subject>
            <subject type="local">clinical microbiology</subject>
            <subject type="local">colon cancer</subject>
            <subject type="local">mast cells</subject>
            <subject type="local">mucosal immunology</subject>
            <description type="Chief Investigator Team">Dr Kylie James&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Response to treatment is difficult to predict for people with chronic intestinal diseases. This is largely due to complex disease mechanisms that are poorly understood. My research uses state-of-the-art genomics technologies to study intestinal cells and the microbiome in patients with inflammatory bowel disease, colitis linked to cancer immuno-therapy and colorectal cancer. The results from this work will facilitate drug discovery and personalised treatments.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041674</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041674</identifier>
            <identifier type="nhmrc">2041674</identifier>
            <name type="primary">
                <namePart>Quantitative Imaging At Nanoscale with SUper-resolution (QIAN SU) for Probing, Diagnosing and Monitoring Thrombotic Disease at the Molecular Level</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7364-3945</identifier>
                <title>Dr QIAN (Peter) SU</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03f0f6041</identifier>
                <title>University of Technology Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/046fa4y88</identifier>
                <title>Heart Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03f0f6041</identifier>
                <title>University of Technology Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05gpvde20</identifier>
                <title>Royal Prince Alfred Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical biotechnology</subject>
            <subject type="anzsrc-for">Medical biotechnology diagnostics (incl. biosensors) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology not elsewhere classified ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Biomedical instrumentation</subject>
            <subject type="local">biomedical engineering</subject>
            <subject type="local">nanotechnology</subject>
            <subject type="local">extracellular matrix</subject>
            <subject type="local">diagnostic imaging</subject>
            <subject type="local">molecular biology</subject>
            <description type="Chief Investigator Team">Dr QIAN (Peter) SU&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Thrombosis, causing heart attacks and strokes, affects millions of lives. An imaging chip that can visualise blood clotting will facilitate our knowledge and guide safer drug development. Building on my novel imaging profiling platform, I aim to integrate a molecular fingerprint database and translate it into a low-cost, portable, standardised point-of-care imaging chip to monitor blood clotting and test new drugs. It will be game-changing for our ability to diagnose and monitor thrombosis.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041692</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041692</identifier>
            <identifier type="nhmrc">2041692</identifier>
            <name type="primary">
                <namePart>Developing targeted therapies for gliomas by peptide-assisted fragment optimisation</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Yu_Heng_Lau</identifier>
                <title>Dr Yu Heng Lau</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">CHEMICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medicinal and biomolecular chemistry</subject>
            <subject type="anzsrc-for">Proteins and peptides CHEMICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medicinal and biomolecular chemistry</subject>
            <subject type="anzsrc-for">Molecular medicine</subject>
            <subject type="local">drug discovery</subject>
            <subject type="local">structure-activity relationships</subject>
            <subject type="local">medicinal chemistry</subject>
            <subject type="local">peptide synthesis</subject>
            <subject type="local">structure-based drug design</subject>
            <description type="Chief Investigator Team">Dr Yu Heng Lau&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Brain tumours are one of the most severe types of cancer, with ~2000 Australians diagnosed every year. High-grade gliomas are aggressive forms of brain cancer with extremely poor prognoses. While cancer researchers have identified proteins that are 'druggable' targets for glioma therapy, traditional methods for designing drugs against these targets have proven ineffective. I will establish a new design method - PaFO - to develop much needed drug candidates for treating this devastating disease.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041699</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041699</identifier>
            <identifier type="nhmrc">2041699</identifier>
            <name type="primary">
                <namePart>Transforming Living Kidney Donation in Australia: New Approaches to Increase Donor Rates, Improve Equity, and Save Lives</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9250-107X</identifier>
                <title>Dr Melanie Wyld</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Nephrology and urology HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health services and systems not elsewhere classified</subject>
            <subject type="local">kidney transplantation</subject>
            <subject type="local">access to health care</subject>
            <subject type="local">kidney failure</subject>
            <subject type="local">organ donation</subject>
            <subject type="local">clinical epidemiology</subject>
            <description type="Chief Investigator Team">Dr Melanie Wyld&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Living donor kidney transplants offer greater length and quality-of-life, and the kidneys last longer than those from deceased donor transplants. But fewer people than ever are receiving living donor transplants. Women, particularly women with other types of disadvantage, are less likely than men to receive a living donor transplant. This work aims to improve how potential donors are approached and assessed in order to increase access, and fairness, of living donor transplantation.</description>
            <description type="fundingAmount">$469,202.50</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041747</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041747</identifier>
            <identifier type="nhmrc">2041747</identifier>
            <name type="primary">
                <namePart>Enhancing Suicide Prevention and Mental Health Supports for Young People of Diverse Genders</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-4828-0983</identifier>
                <title>Dr Penelope Strauss</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HUMAN SOCIETY</subject>
            <subject type="anzsrc-for">Gender studies</subject>
            <subject type="anzsrc-for">Transgender studies HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified</subject>
            <subject type="local">gender</subject>
            <subject type="local">suicide prevention</subject>
            <subject type="local">mental health</subject>
            <subject type="local">mental health services</subject>
            <subject type="local">youth</subject>
            <description type="Chief Investigator Team">Dr Penelope Strauss&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Trans young people experience high rates of poor mental health, suicidality and experience barriers to support. The proposed research program will include 4 studies: 1) a survey to provide insight into the mental health of trans young people in Australia, 2) investigating how accessing gender-affirming surgery impacts the mental health of trans young adults, 3) mapping and analysing available crisis supports, 4) implementing suicide prevention guidelines into services to improve support.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041755</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041755</identifier>
            <identifier type="nhmrc">2041755</identifier>
            <name type="primary">
                <namePart>A Life Course Approach to Early Detection and Interventions to Stop Pre-COPD</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Shyamali_Dharmage</identifier>
                <title>Prof Shyamali Dharmage</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Respiratory diseases HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care</subject>
            <subject type="local">chronic obstructive pulmonary disease (copd)</subject>
            <subject type="local">biology</subject>
            <subject type="local">early intervention</subject>
            <subject type="local">prospective cohort study</subject>
            <subject type="local">clinical trial</subject>
            <description type="Chief Investigator Team">Prof Shyamali Dharmage&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Too many Australians struggle to breathe due to chronic obstructive lung disease (COPD) and many even die. In COPD, the lungs are gradually damaged but early progression is currently hard to detect. In fact, by the time someone is diagnosed with COPD they are on a deadly slippery slope. My program will find ways to identify early lung damage (so called pre-COPD) and new interventions (eg drugs, exercise) to stop pre-COPD, a globally health priority.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041762</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041762</identifier>
            <identifier type="nhmrc">2041762</identifier>
            <name type="primary">
                <namePart>Targeting DNA damage repair for new therapeutics in cancer and genetic disorders</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Sarah_Henrikus</identifier>
                <title>Dr Sarah Henrikus</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/52004705640</identifier>
                <title>St Vincent's Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/52004705640</identifier>
                <title>St Vincent's Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Enzymes BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Cell and nuclear division</subject>
            <subject type="local">dna repair</subject>
            <subject type="local">enzyme mechanism</subject>
            <subject type="local">protein biochemistry</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">molecular basis of disease</subject>
            <description type="Chief Investigator Team">Dr Sarah Henrikus&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">DNA repair is vital for maintaining cell health and preventing cancer. When DNA is damaged, the cell needs to repair it accurately to prevent harmful consequences. Fanconi anaemia (FA) proteins, together with BRCA1, are crucial components of this repair process. They help signal and coordinate the repair efforts, ensuring that the damage is repaired. My proposal aims to understand how these proteins facilitate DNA repair, to identify new targets to combat rare genetic disorders and cancer.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041792</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041792</identifier>
            <identifier type="nhmrc">2041792</identifier>
            <name type="primary">
                <namePart>Advancing image guided radiation therapy from discovery to clinical practice</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4803-6507</identifier>
                <title>Prof Paul Keall</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Medical devices</subject>
            <subject type="local">medical imaging</subject>
            <subject type="local">radiation oncology</subject>
            <subject type="local">machine learning</subject>
            <subject type="local">radiation therapy</subject>
            <subject type="local">targeted therapy</subject>
            <description type="Chief Investigator Team">Prof Paul Keall&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">In this Investigator Grant I will dramatically improve cancer treatment outcomes by advancing a pipeline of image guided radiation therapy innovations from discovery to clinical practice. As radiation therapy is recommended for half of the 20 million cases of cancer diagnosed annually around the world, advanced radiation therapy innovations from this grant will impact over 10 million cancer patients every year.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041798</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041798</identifier>
            <identifier type="nhmrc">2041798</identifier>
            <name type="primary">
                <namePart>And We Are: Determined as Indigenous Leaders to advance First Nation kidney health</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1867-4156</identifier>
                <title>Prof Jaquelyne Hughes</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander epidemiology INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander social determinants of health INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health policy</subject>
            <subject type="local">workforce policy</subject>
            <subject type="local">control of diabetes</subject>
            <subject type="local">end-stage kidney disease</subject>
            <subject type="local">data linkage</subject>
            <subject type="local">rural and remote health services</subject>
            <description type="Chief Investigator Team">Prof Jaquelyne Hughes&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The "And We Are" research program drives scalable and innovative practices to sustainable health improvements among Aboriginal and Torres Strait Islander people, family and community who live with kidney diseases as accelerated morbidity, disability, disadvantage, and health inequality, and is redress to systemised denial of human rights, and policy-poverty. "And We Are" honours Indigenous knowledge and capability, and actions health through Building, Learning and Advancing Pillars.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041810</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041810</identifier>
            <identifier type="nhmrc">2041810</identifier>
            <name type="primary">
                <namePart>Mapping and forecasting to counter biological threats to malaria control in Africa</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8916-5570</identifier>
                <title>Prof Nicholas Golding</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n415q13</identifier>
                <title>Curtin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n415q13</identifier>
                <title>Curtin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01dbmzx78</identifier>
                <title>The Kids Research Institute Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">MATHEMATICAL SCIENCES</subject>
            <subject type="anzsrc-for">Statistics</subject>
            <subject type="anzsrc-for">Applied statistics HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological modelling</subject>
            <subject type="local">malaria control</subject>
            <subject type="local">decision making</subject>
            <subject type="local">applied statistics</subject>
            <subject type="local">dynamic process modelling</subject>
            <subject type="local">mathematical modelling</subject>
            <description type="Chief Investigator Team">Prof Nicholas Golding&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Since 2000, more than 11 million lives have been saved in Africa by using tests, treatments, and mosquito control to fight malaria. But progress has stalled, and our gains are threatened by the evolution of resistance to these interventions, and by a new invasive mosquito that could bring malaria into Africa's cities. My research program will deliver new approaches to map and forecast these threats so we can better target new interventions and get malaria control back on track.</description>
            <description type="fundingAmount">$2,618,905.00</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041812</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041812</identifier>
            <identifier type="nhmrc">2041812</identifier>
            <name type="primary">
                <namePart>Prevention of cardiometabolic-related disease in women of reproductive age and beyond – risk prediction, screening and precision lifestyle approaches</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Assoc_Prof_Lisa_Moran</identifier>
                <title>Assoc Prof Lisa Moran</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Nutrition and dietetics not elsewhere classified BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Reproductive medicine not elsewhere classified BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology not elsewhere classified</subject>
            <subject type="local">obesity</subject>
            <subject type="local">pregnancy</subject>
            <subject type="local">polycystic ovarian syndrome (pcos)</subject>
            <subject type="local">infertility</subject>
            <subject type="local">cardiovascular disease prevention</subject>
            <description type="Chief Investigator Team">Assoc Prof Lisa Moran&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Reproductive aged women, including women with polycystic ovary syndrome, infertility, diabetes in pregnancy and pregnancy-related high blood pressure, are at a higher risk for future diabetes and heart disease. This offers opportunities for prevention early in life. Here I extend my work with high-risk women and health professionals to improve identification, awareness, screening, lifestyle and weight management during the reproductive years to optimise long term heart disease prevention.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041819</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041819</identifier>
            <identifier type="nhmrc">2041819</identifier>
            <name type="primary">
                <namePart>Harnessing genetics to unlock endometrial cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5436-3232</identifier>
                <title>Assoc Prof Tracy O'Mara</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/31411813344</identifier>
                <title>The Council of the Queensland Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/31411813344</identifier>
                <title>The Council of the Queensland Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer genetics</subject>
            <subject type="local">cancer genetics</subject>
            <subject type="local">genetic epidemiology</subject>
            <subject type="local">endometrial cancer</subject>
            <subject type="local">statistical genetics</subject>
            <subject type="local">functional genomics</subject>
            <description type="Chief Investigator Team">Assoc Prof Tracy O'Mara&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Studies investigating thousands of genetic markers have revolutionised our understanding of genes involved in cancer. This project will discover new genes involved in endometrial cancer by detailed genetic analysis, and investigate how genetics can be used to identify which women are at greatest risk of developing this type of cancer. Results will improve the understanding of endometrial cancer and provide opportunity to discover future cancer treatments.</description>
            <description type="fundingAmount">$2,418,905.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041822</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041822</identifier>
            <identifier type="nhmrc">2041822</identifier>
            <name type="primary">
                <namePart>ROIDCheck: Reducing illicit steROID harms through drug Checking services</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6177-0266</identifier>
                <title>Dr Timothy Piatkowski</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02sc3r913</identifier>
                <title>Griffith University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02sc3r913</identifier>
                <title>Griffith University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health and community services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation</subject>
            <subject type="local">substance use</subject>
            <subject type="local">health promotion</subject>
            <subject type="local">community health</subject>
            <subject type="local">health services</subject>
            <subject type="local">community care</subject>
            <description type="Chief Investigator Team">Dr Timothy Piatkowski&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Anabolic steroid use poses serious health risks from unknown substances in illicit products. Unlike other drugs, Australia lacks a steroid-specific drug checking service. This project aims to bridge this gap with ROIDCheck, testing illicit steroids for safety and providing a health intervention. It seeks to reduce harm, improve health outcomes, and inform public health strategies by understanding usage patterns, motivations, and health impacts in collaboration with consumers and workforce.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041824</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041824</identifier>
            <identifier type="nhmrc">2041824</identifier>
            <name type="primary">
                <namePart>Targeting Muscle Loss to Improve Outcomes from Critical Illness</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3340-1965</identifier>
                <title>Dr Yasmine Ali Abdelhamid</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04z4kmw33</identifier>
                <title>Melbourne Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Intensive care BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Clinical nutrition</subject>
            <subject type="local">intensive care medicine</subject>
            <subject type="local">clinical trial</subject>
            <subject type="local">intensive care</subject>
            <subject type="local">critical care</subject>
            <subject type="local">enteral nutrition</subject>
            <description type="Chief Investigator Team">Dr Yasmine Ali Abdelhamid&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Patients admitted to the Intensive Care Unit (ICU) are some of the sickest in hospital and require many days of 'life support' therapies. ICU survivors are often affected by severe muscle loss, weakness and disability. To improve health outcomes, we need to increase our understanding of how muscle loss occurs and we need new treatments. I will evaluate novel, practical and inexpensive treatment strategies, in order to improve outcomes for thousands of vulnerable critically ill people each year.</description>
            <description type="fundingAmount">$556,883.50</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041888</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041888</identifier>
            <identifier type="nhmrc">2041888</identifier>
            <name type="primary">
                <namePart>Using protein structure to combat antimicrobial resistance</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2948-2413</identifier>
                <title>Prof David Ascher</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03rke0285</identifier>
                <title>Baker Heart and Diabetes Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Receptors and membrane biology</subject>
            <subject type="local">protein structure</subject>
            <subject type="local">drug development</subject>
            <subject type="local">antimicrobial resistance</subject>
            <subject type="local">molecular modelling</subject>
            <subject type="local">bioinformatics</subject>
            <description type="Chief Investigator Team">Prof David Ascher&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This project aims to address the global threat of antimicrobial resistance by utilizing protein structural information and large-scale genomic sequencing. The misuse and overuse of antimicrobial drugs have led to the emergence and spread of resistant pathogens, posing a severe risk to public health. The project will develop novel tools that combines molecular insights from protein coding variants with genomic data to predict the development of therapeutic resistance before it becomes widespread.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041910</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041910</identifier>
            <identifier type="nhmrc">2041910</identifier>
            <name type="primary">
                <namePart>Kidney health for all – Improving kidney failure care accessibility, affordability, quality and outcomes</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-5491-3460</identifier>
                <title>Prof David Johnson</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Nephrology and urology</subject>
            <subject type="local">nephrology</subject>
            <subject type="local">patient safety</subject>
            <subject type="local">kidney failure</subject>
            <subject type="local">consumers</subject>
            <subject type="local">collaboration</subject>
            <description type="Chief Investigator Team">Prof David Johnson&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Kidney failure is common, harmful and treatable, yet treatment is costly, difficult to access and often varies in quality. This grant will support my ongoing world-leading research program on transforming home-based dialysis to make it cheaper, less burdensome, safer and more effective by standardising quality indicators, conducting real-world, patient-centric trials, implementing these findings globally, and confirming better patient outcomes with the program’s global monitoring structures.</description>
            <description type="fundingAmount">$2,304,207.50</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041943</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041943</identifier>
            <identifier type="nhmrc">2041943</identifier>
            <name type="primary">
                <namePart>Advancing Cartilage Regeneration via Oxygen-driven Stem Cell Therapies</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9662-0049</identifier>
                <title>Dr Lilith Caballero Aguilar</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Tissue engineering BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical biotechnology</subject>
            <subject type="anzsrc-for">Regenerative medicine (incl. stem cells) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences not elsewhere classified</subject>
            <subject type="local">knee cartilage</subject>
            <subject type="local">drug delivery</subject>
            <subject type="local">tissue repair</subject>
            <subject type="local">tissue engineering</subject>
            <subject type="local">peptides</subject>
            <description type="Chief Investigator Team">Dr Lilith Caballero Aguilar&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Osteoarthritis (OA) is caused by the degeneration of cartilage, a tissue essential for normal joint function. The damage is not repaired naturally, and clinical strategies to generate healthy cartilage have failed. To address this vital gap in the treatment of OA, this project focuses on the key challenge of oxygen regulation in engineered tissues. It will create biomaterials with novel oxygen delivery capabilities, which will enable successful cartilage repair.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041946</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041946</identifier>
            <identifier type="nhmrc">2041946</identifier>
            <name type="primary">
                <namePart>Unlocking the protective nature of Human Leukocyte Antigens in the fight against viruses</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Dimitra_Chatzileontiadou</identifier>
                <title>Dr Dimitra Chatzileontiadou</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01rxfrp27</identifier>
                <title>La Trobe University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01rxfrp27</identifier>
                <title>La Trobe University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Receptors and membrane biology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology</subject>
            <subject type="local">human leukocyte antigen (hla)</subject>
            <subject type="local">infectious diseases</subject>
            <subject type="local">t cell epitope</subject>
            <subject type="local">t cell receptor</subject>
            <subject type="local">x-ray crystallography</subject>
            <description type="Chief Investigator Team">Dr Dimitra Chatzileontiadou&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Viruses are a constant threat to global health, as exemplified by the COVID pandemic. My research program aims to understand the molecular mechanisms of protective immunity against viruses. This can inform the design and development of new vaccines and therapies against viruses to provide better protection to the population. In addition, my work has the potential to reveal common mechanisms of the immune system against a board range of viruses that could limit the next viral pandemic.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041952</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041952</identifier>
            <identifier type="nhmrc">2041952</identifier>
            <name type="primary">
                <namePart>Advancing ocular genomics to propel breakthrough treatments for blindness</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1101-2870</identifier>
                <title>Dr Alexis Britten-Jones</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Ophthalmology and optometry</subject>
            <subject type="anzsrc-for">Ophthalmology and optometry not elsewhere classified BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Ophthalmology and optometry</subject>
            <subject type="anzsrc-for">Optometry BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Genomics</subject>
            <subject type="local">retinal dystrophy</subject>
            <subject type="local">retinal disease</subject>
            <subject type="local">genetic disorders</subject>
            <subject type="local">genetic testing</subject>
            <subject type="local">clinical genetics</subject>
            <description type="Chief Investigator Team">Dr Alexis Britten-Jones&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Inherited retinal diseases (IRD) cause gradual blindness from a young age. An accurate genetic diagnosis is vital for accessing and developing new IRD treatments. My program uses new genetic technologies to improve the diagnosis of IRDs and understand what factors affect disease presentation. I will also evaluate the value of genetics in managing IRDs. Together, my program will advance the diagnosis and treatment of early-onset blindness and pave the way for genetic medicine in eye care.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041965</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041965</identifier>
            <identifier type="nhmrc">2041965</identifier>
            <name type="primary">
                <namePart>New insights into the management of arrhythmia mediated cardiomyopathy</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2694-2245</identifier>
                <title>Assoc Prof Sandeep Prabhu</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03rke0285</identifier>
                <title>Baker Heart and Diabetes Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03rke0285</identifier>
                <title>Baker Heart and Diabetes Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04scfb908</identifier>
                <title>Alfred Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases)</subject>
            <subject type="local">chronic heart failure (chf)</subject>
            <subject type="local">cardiac arrhythmia</subject>
            <subject type="local">atrial fibrillation</subject>
            <subject type="local">cardiomyopathy</subject>
            <subject type="local">cardiovascular pharmacology</subject>
            <description type="Chief Investigator Team">Assoc Prof Sandeep Prabhu&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Heart rhythm problems such as atrial fibrillation (AF) (an irregular heart rhythm, or frequent 'extra beats' can be the cause of a weakened heart muscle. Eliminating the abnormal rhythm can restore heart function often completely, however the usual medications used in a weakened heart are currently continued indefinitely. Similarly, when treated early, such usual medications may not be needed at all. This study explores this type of weakened heart treatment through several clinical trials.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041967</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041967</identifier>
            <identifier type="nhmrc">2041967</identifier>
            <name type="primary">
                <namePart>Fetal growth restriction and cardiovascular-related death in adulthood: a world first in transforming detection and intervention</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-8602-8519</identifier>
                <title>Prof Janna Morrison</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01p93h210</identifier>
                <title>University of South Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01p93h210</identifier>
                <title>University of South Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Paediatrics not elsewhere classified</subject>
            <subject type="local">fetal growth restriction</subject>
            <subject type="local">blood pressure regulation</subject>
            <subject type="local">cardiac</subject>
            <subject type="local">fetal hypoxia</subject>
            <subject type="local">biomarkers</subject>
            <description type="Chief Investigator Team">Prof Janna Morrison&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Every day, 80 Australian babies are born too small, increasing their risk of heart and other diseases later in life. My first aim is to improve our ability to detect these small babies before they are born. My second aim is to discover how to intervene to improve their growth. If we can find small babies earlier and intervene to improve their growth, we can set them up with healthy hearts for life.</description>
            <description type="fundingAmount">$2,354,575.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042003</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042003</identifier>
            <identifier type="nhmrc">2042003</identifier>
            <name type="primary">
                <namePart>Addressing the critical questions in chronic pain</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1206-9107</identifier>
                <title>Prof Paul Hodges</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science</subject>
            <subject type="anzsrc-for">Physiotherapy BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Neurosciences not elsewhere classified</subject>
            <subject type="local">chronic pain</subject>
            <subject type="local">pain measurement</subject>
            <subject type="local">back pain</subject>
            <subject type="local">experimental pain</subject>
            <subject type="local">pain management</subject>
            <description type="Chief Investigator Team">Prof Paul Hodges&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Many Australians suffer from chronic pain, but we don't know how to match patients with the right treatments. This program of research will address the major barriers that impede progress. Across three integrated streams this program will develop methods to improve how we understand and measure pain; develop technologies to assess, guide and support treatment; and design and deploy a game-changing clinical trial to simultaneously test and refine how treatments are matched to patients.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042008</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042008</identifier>
            <identifier type="nhmrc">2042008</identifier>
            <name type="primary">
                <namePart>The antimicrobial strikes back – using pharmacometrics and international collaboration in the war against sepsis and antimicrobial resistant superbugs</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Mohd_Hafiz_Abdul-Aziz</identifier>
                <title>Dr Mohd Hafiz Abdul-Aziz</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Clinical pharmacology and therapeutics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Intensive care</subject>
            <subject type="local">clinical pharmacology</subject>
            <subject type="local">pharmacodynamics</subject>
            <subject type="local">pharmacokinetics</subject>
            <subject type="local">antibiotics</subject>
            <subject type="local">intensive care medicine</subject>
            <description type="Chief Investigator Team">Dr Mohd Hafiz Abdul-Aziz&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">My research program will demonstrate how tailored and personalised antimicrobial therapy can both help patients to fully recover from infections and reduce the risk of developing antimicrobial resistant bacteria. My research will set new standards for treating severe infections in the intensive care unit. It will change how we treat the "sickest-of-the-sickest" patients in the hospital, and improve patient survival and quality of life.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042010</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042010</identifier>
            <identifier type="nhmrc">2042010</identifier>
            <name type="primary">
                <namePart>Structural approaches to assist the development of selective antagonists of adrenomedullin receptors</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Jianjun_Cao</identifier>
                <title>Dr Jianjun Cao</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Basic pharmacology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Receptors and membrane biology</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">molecular pharmacology</subject>
            <subject type="local">g protein-coupled receptors</subject>
            <subject type="local">electron microscopy</subject>
            <subject type="local">drug discovery</subject>
            <description type="Chief Investigator Team">Dr Jianjun Cao&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Blocking adrenomedullin (AM) signaling has emerged as a promising strategy to suppress solid tumor growth and prevent their spread. However, AM acts through two receptors, AM1R and AM2R, which differently affect tumor development and cardiovascular function. My research focuses on developing molecules that can distinguish between these two AM receptors, advancing our understanding of AM physiology and offering insights for developing cancer treatments.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042013</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042013</identifier>
            <identifier type="nhmrc">2042013</identifier>
            <name type="primary">
                <namePart>Extracellular vesicles as a new paradigm of cardiovascular therapeutics</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0579-9897</identifier>
                <title>Assoc Prof Joy Wolfram</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Biofabrication</subject>
            <subject type="local">secretion</subject>
            <subject type="local">cardiovascular</subject>
            <subject type="local">therapeutic effects</subject>
            <subject type="local">therapeutic agents</subject>
            <subject type="local">biological therapy</subject>
            <description type="Chief Investigator Team">Assoc Prof Joy Wolfram&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Cardiovascular disease is the leading cause of death worldwide. There is an urgent need for new therapies that can target multiple disease-causing pathways, while reducing side effects. My research program aims to develop a pipeline for novel biotherapeutics (extracellular vesicles) to treat cardiovascular disease. This work is expected to alter the trajectory of cardiovascular disease, improve patient outcomes, and prolong healthy life.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042035</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042035</identifier>
            <identifier type="nhmrc">2042035</identifier>
            <name type="primary">
                <namePart>Developing a novel nanotechnology platform to bridge the discovery and translation of circulating small extracellular vesicles as biomarkers for improved triple-negative breast cancer management</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3627-7397</identifier>
                <title>Prof Yuling Wang</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01sf06y89</identifier>
                <title>Macquarie University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01sf06y89</identifier>
                <title>Macquarie University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Medical devices BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Industrial biotechnology</subject>
            <subject type="anzsrc-for">Nanobiotechnology ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Biomaterials</subject>
            <subject type="local">nanotechnology</subject>
            <subject type="local">biomaterials</subject>
            <subject type="local">breast cancer diagnosis</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">biotechnology</subject>
            <description type="Chief Investigator Team">Prof Yuling Wang&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Triple-negative breast cancer (TNBC) is the most aggressive breast cancer with poor clinical outcomes. Currently there are no specific blood biomarkers/tools for TNBC diagnosis, prognosis and monitoring. Circulating small extracellular vesicles (sEVs) offer exciting prospects as cancer biomarkers, however, their application in clinic has been limited. This program aims to develop a novel nanotechnology platform to translate sEVs as cancer biomarkers for personalized TNBC management.</description>
            <description type="fundingAmount">$2,778,520.64</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042036</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042036</identifier>
            <identifier type="nhmrc">2042036</identifier>
            <name type="primary">
                <namePart>Towards evidence-supported precision surgery for gynaecological cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2199-1117</identifier>
                <title>Prof Andreas Obermair</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Obstetrics and gynaecology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Surgery</subject>
            <subject type="local">gynaecological cancers</subject>
            <subject type="local">uterine cancer</subject>
            <subject type="local">clinical trial</subject>
            <subject type="local">endometrial cancer</subject>
            <subject type="local">rare cancer</subject>
            <description type="Chief Investigator Team">Prof Andreas Obermair&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Gynaecological cancers are the fourth most common cancer type in Australian women but current treatment guiding surgical practice lacks quality evidence for patient benefit. My work will address this gap through my leadership of 4 international clinical trials. My aim is to improve surgical outcomes in gynaecological cancer through evidence-based, personalised and patient-centred care. My decision-making tools are expected to lead to fewer complications and better quality of life for patients.</description>
            <description type="fundingAmount">$2,068,202.50</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042061</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042061</identifier>
            <identifier type="nhmrc">2042061</identifier>
            <name type="primary">
                <namePart>‘Nothing about us without us’– boosting diversity in the health and medical research workforce to progress action on health equity</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4340-9132</identifier>
                <title>Prof Anna Peeters</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Social determinants of health HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity</subject>
            <subject type="local">equity</subject>
            <subject type="local">participatory action research</subject>
            <subject type="local">databases</subject>
            <subject type="local">policy development</subject>
            <subject type="local">implementation</subject>
            <description type="Chief Investigator Team">Prof Anna Peeters&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Inequalities in health remain stark within high income countries such as Australia. To reverse this trajectory, greater involvement in health and medical research from those who experience these inequalities is required. In this Investigator Grant I will focus on a neglected aspect of diversity within health and medical research activity – the research workforce itself. The outcomes will improve equity, within the health and medical research workforce and, over time, in health outcomes.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042072</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042072</identifier>
            <identifier type="nhmrc">2042072</identifier>
            <name type="primary">
                <namePart>Unravelling cellular plasticity to find novel therapeutic targets for breast cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Katie_Fennell</identifier>
                <title>Dr Katie Fennell</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer cell biology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Epigenetics (incl. genome methylation and epigenomics) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Gene expression (incl. microarray and other genome-wide approaches)</subject>
            <subject type="local">cancer cell biology</subject>
            <subject type="local">chromatin</subject>
            <subject type="local">epigenetics</subject>
            <subject type="local">cancer metastasis</subject>
            <subject type="local">breast cancer</subject>
            <description type="Chief Investigator Team">Dr Katie Fennell&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Cancer cells can change their behaviour in response to therapy, a process called "cellular plasticity." This adaptability results in metastatic disease and treatment resistance. Targeting these plastic cells could be a new way to treat cancer. My aim is to understand how “plasticity” occurs by using advanced molecular techniques to discover new pathways and targets associated with these particular cancer cells. The end goal of my research is to improve outcomes for breast cancer patients.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042089</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042089</identifier>
            <identifier type="nhmrc">2042089</identifier>
            <name type="primary">
                <namePart>Proteins and nucleotides in programmed axon death: molecular characterisation and therapeutic targeting</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0113-1905</identifier>
                <title>Assoc Prof Thomas Ve</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02sc3r913</identifier>
                <title>Griffith University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02sc3r913</identifier>
                <title>Griffith University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling) CHEMICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medicinal and biomolecular chemistry</subject>
            <subject type="anzsrc-for">Biologically active molecules BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Enzymes</subject>
            <subject type="local">protein structure</subject>
            <subject type="local">axonal degeneration</subject>
            <subject type="local">structure-based drug design</subject>
            <subject type="local">nicotinamide adenine dinucleotide (nad)</subject>
            <subject type="local">protein-protein interaction</subject>
            <description type="Chief Investigator Team">Assoc Prof Thomas Ve&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Axons connect neurons to their targets and are responsible for carrying information throughout the human body. In many neurodegenerative disorders including Alzheimer’s disease and ALS, axon loss is an early event contributing to dysfunction of the nervous system. My research will provide mechanistic insight into the axon degeneration program and deliver new strategies for developing neuroprotective therapies.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042090</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042090</identifier>
            <identifier type="nhmrc">2042090</identifier>
            <name type="primary">
                <namePart>Exploring Cell Death Signaling for Drug Target Discovery</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2594-496X</identifier>
                <title>Prof Peter Czabotar</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Cell development, proliferation and death BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling)</subject>
            <subject type="local">cell death</subject>
            <subject type="local">drug discovery</subject>
            <subject type="local">apoptosis</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">death signalling</subject>
            <description type="Chief Investigator Team">Prof Peter Czabotar&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Our bodies use programmed cell death to kill cells that are dangerous or superfluous. The pathways that control cell death are exciting targets for drug discovery, for example to kill cells that cause cancer, or to keep cells alive in heart attack or stroke. Our studies of the molecular components of the cell death machinery will reveal new strategies for developing novel therapeutics to manipulate dysfunctional cell death in disease settings.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042095</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042095</identifier>
            <identifier type="nhmrc">2042095</identifier>
            <name type="primary">
                <namePart>Accelerating Global Vaccine Policy: Leveraging Regional Networks to Address Vaccine Research Gaps</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3077-9639</identifier>
                <title>Prof Fiona Russell</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care</subject>
            <subject type="local">immunisation</subject>
            <subject type="local">vaccination policy</subject>
            <subject type="local">vaccine strategy</subject>
            <subject type="local">infectious diseases</subject>
            <subject type="local">epidemiology</subject>
            <description type="Chief Investigator Team">Prof Fiona Russell&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">My research focuses on informing immunisation policy locally and globally. I will fill evidence gaps through clinical trials and observational studies, in collaboration with regional leaders: 1. Assessing if two doses of pneumococcal vaccine are as effective as three. 2. Studying long-term protection from a single HPV vaccine dose. 3. Evaluating meningococcal vaccine's effect on gonorrhoea. 4. Identifying COVID-19 vaccine needs in children. 5. Preparing for a maternal Group B Strep vaccine.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042103</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042103</identifier>
            <identifier type="nhmrc">2042103</identifier>
            <name type="primary">
                <namePart>Targeting metastasis to trigger immunogenic cell death</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9850-9803</identifier>
                <title>Dr Robert Ju</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Molecular targets BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Predictive and prognostic markers BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Tumour immunology</subject>
            <subject type="local">metastatic cancer</subject>
            <subject type="local">metastasis suppressor</subject>
            <subject type="local">cancer immunotherapy</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">enhanced immunogenicity</subject>
            <description type="Chief Investigator Team">Dr Robert Ju&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">There is currently no cure for cancer metastasis, where cancer spreads throughout the body, which is responsible for &gt;80% of all cancer deaths. My research program aims to build new knowledge to identify those cancers prone to spreading and a new drug to target metastasis. This work is expected to inform development of an anti-metastatic drug which would improve prognostic and diagnostic knowledge, patient survival and health outcomes.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042139</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042139</identifier>
            <identifier type="nhmrc">2042139</identifier>
            <name type="primary">
                <namePart>Cancer control through applied epidemiology</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Rachel_Neale</identifier>
                <title>Prof Rachel Neale</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/31411813344</identifier>
                <title>The Council of the Queensland Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/31411813344</identifier>
                <title>The Council of the Queensland Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health services and systems not elsewhere classified</subject>
            <subject type="local">skin cancer</subject>
            <subject type="local">diagnosis</subject>
            <subject type="local">sun protection</subject>
            <subject type="local">pancreatic cancer</subject>
            <subject type="local">health services</subject>
            <description type="Chief Investigator Team">Prof Rachel Neale&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">This grant will fund research across two programs: (1) Balancing the harms and benefits of sun exposure; and (2) Reducing pancreatic cancer mortality. Program 1 focuses on enhancing evidence-based advice that will enable Australians to make informed decisions about how to avoid the harms of sun exposure while gaining the benefits. Program 2 will use a large-scale data platform to inform strategies to diagnose pancreatic cancer earlier and ensure equitable access to high-quality care.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042144</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042144</identifier>
            <identifier type="nhmrc">2042144</identifier>
            <name type="primary">
                <namePart>Enhancing tissue-resident memory T cell immunity through the microbiota</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2105-1160</identifier>
                <title>Dr Maximilien Evrard</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology</subject>
            <subject type="local">cd8 t cells</subject>
            <subject type="local">mucosal immunology</subject>
            <subject type="local">t cell memory</subject>
            <subject type="local">t cell development</subject>
            <subject type="local">tumour immunology</subject>
            <description type="Chief Investigator Team">Dr Maximilien Evrard&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The microbiome, a group of microorganisms in our bodies, helps train immune cells and influences how we fight cancer. This research uses a mouse model that mirrors human exposure to microbes to study how the microbiome affects tissue-resident memory T cells (TRM), an immune population that protects organs like the gut from infections and cancer, with the goal of finding new ways to boost the immune system and improve cancer treatment.</description>
            <description type="fundingAmount">$613,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042161</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042161</identifier>
            <identifier type="nhmrc">2042161</identifier>
            <name type="primary">
                <namePart>Going the last mile to end HIV transmission in Australia: ensuring no one is left behind</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-5784-7403</identifier>
                <title>Prof Jason Ong</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care</subject>
            <subject type="local">human immunodeficiency virus (hiv)</subject>
            <subject type="local">public health</subject>
            <subject type="local">sexual health</subject>
            <subject type="local">health economics</subject>
            <subject type="local">disease modelling</subject>
            <description type="Chief Investigator Team">Prof Jason Ong&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Eliminating HIV transmission is possible with effective methods like treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP). However, disparities remain, with new infections decreasing among Australian-born men who have sex with men, but not among overseas-born men. My research uses community input to create and evaluate HIV prevention solutions, helping to shape policy and ensure no one is left behind as Australia aims to be the first in the world to eliminate HIV transmission.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042204</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042204</identifier>
            <identifier type="nhmrc">2042204</identifier>
            <name type="primary">
                <namePart>The neonatal microbiome and antibiotic resistance: Utilising metagenomics to reduce infant morbidity and mortality across Australia and Southeast Asia</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2250-0594</identifier>
                <title>Assoc Prof Phoebe Williams</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Infectious agents BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Infant and child health HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion</subject>
            <subject type="local">neonatal survival</subject>
            <subject type="local">maternal and child health</subject>
            <subject type="local">antimicrobial resistance</subject>
            <subject type="local">clinical microbiology</subject>
            <subject type="local">antibiotic use</subject>
            <description type="Chief Investigator Team">Assoc Prof Phoebe Williams&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Babies are vulnerable to infections, particularly with multidrug-resistant bacteria that have emerged with increasing antibiotic resistance worldwide. We will conduct an international multicentre study across Australia, Vietnam, Indonesia &amp; the Philippines to identify how, and when, babies become colonised &amp; infected with multidrug-resistant bacteria. We will find ways to interrupt this transmission, and provide world-first data to understand the impact antibiotics have on the infant microbiome.</description>
            <description type="fundingAmount">$1,498,960.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042249</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042249</identifier>
            <identifier type="nhmrc">2042249</identifier>
            <name type="primary">
                <namePart>Exploiting therapy-induced senescence to prevent recurrence and bone metastasis in ERa+ breast cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1831-4601</identifier>
                <title>Dr Lena Batoon</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02qp3tb03</identifier>
                <title>Mayo Clinic, Rochester</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer cell biology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Tumour immunology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Orthopaedics</subject>
            <subject type="local">breast cancer metastases</subject>
            <subject type="local">bone metastasis</subject>
            <subject type="local">breast cancer</subject>
            <subject type="local">senescence</subject>
            <subject type="local">macrophages</subject>
            <description type="Chief Investigator Team">Dr Lena Batoon&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United States of America&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Breast cancers with ERα protein (~80% of breast cancers) are treated with therapies that inhibit cancer growth but do not kill them. Thus, these cells persist and can cause recurrence or incurable metastasis. I aim to characterize these persistent cancer cells and explore strategies for their elimination to prevent recurrence/spread. If successful, I will identify a strategy that can be integrated into standard-of-care therapies to permanently eradicate these persistent cells and achieve a cure.</description>
            <description type="fundingAmount">$652,131.49</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042250</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042250</identifier>
            <identifier type="nhmrc">2042250</identifier>
            <name type="primary">
                <namePart>Future-proofing population breast cancer screening: Generating and translating evidence to guide screening practice and improve health outcomes.</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3641-952X</identifier>
                <title>Prof Nehmat Houssami</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Clinical sciences not elsewhere classified</subject>
            <subject type="local">breast cancer</subject>
            <subject type="local">digital imaging</subject>
            <subject type="local">mammography</subject>
            <subject type="local">population screening</subject>
            <subject type="local">artificial intelligence</subject>
            <description type="Chief Investigator Team">Prof Nehmat Houssami&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Breast cancer (BC) screening reduces risk of BC death. There is uncertainty about how BC screening programs could be improved to increase benefit. This research plan will fill key knowledge gaps to inform changes to BC screening by investigating new technologies (tomosynthesis, AI), assessing impact on women of being informed they have dense breasts, and examining risk-adapted screening. Findings will prepare BC screening programs including BreastScreen for future practice to improve outcomes.</description>
            <description type="fundingAmount">$2,811,220.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042281</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042281</identifier>
            <identifier type="nhmrc">2042281</identifier>
            <name type="primary">
                <namePart>New strategies for managing gonorrhoea and emerging antimicrobial resistance</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Assoc_Prof_David_Whiley</identifier>
                <title>Assoc Prof David Whiley</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical microbiology</subject>
            <subject type="anzsrc-for">Medical bacteriology</subject>
            <subject type="local">neisseria gonorrhoeae</subject>
            <subject type="local">diagnostic</subject>
            <subject type="local">antibiotic resistance</subject>
            <subject type="local">molecular biology</subject>
            <subject type="local">genomics</subject>
            <description type="Chief Investigator Team">Assoc Prof David Whiley&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Millions of people worldwide are infected by gonorrhoea each year. Infection can be severe, and can lead to infertility. Unfortunately, infection rates are increasing and we are fast losing effective treatments due to the development of antimicrobial resistance. This project will develop new ways to manage gonorrhoea, including developing new rapid detection methods and validating Covid-19 style tracking via genomic methods to improve detection and treatment of cases and sexual contacts.</description>
            <description type="fundingAmount">$2,409,452.50</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042290</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042290</identifier>
            <identifier type="nhmrc">2042290</identifier>
            <name type="primary">
                <namePart>Achieving global health gains from potassium-enriched salt</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0490-7465</identifier>
                <title>Prof Bruce Neal</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/023331s46</identifier>
                <title>The George Institute for Global Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Public health nutrition</subject>
            <subject type="local">dietary salt</subject>
            <subject type="local">blood pressure</subject>
            <subject type="local">clinical trial</subject>
            <subject type="local">cardiovascular disease</subject>
            <subject type="local">gastric cancer</subject>
            <description type="Chief Investigator Team">Prof Bruce Neal&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The results from randomised trials are a cornerstone of health research. Getting trials done is difficult and so is getting the findings of trials used by patients, doctors, industry, and policy makers. I will do new trials focused on making discoveries about how to prevent strokes and heart attack. I will also test ways of doing the studies more efficiently and work out how to get research findings taken up more quickly by community, patients, industry and government.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042298</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042298</identifier>
            <identifier type="nhmrc">2042298</identifier>
            <name type="primary">
                <namePart>A biosensor for the detection of Merkel cell carcinoma</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6119-4417</identifier>
                <title>Dr Saimon Moraes Silva</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01rxfrp27</identifier>
                <title>La Trobe University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01rxfrp27</identifier>
                <title>La Trobe University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">CHEMICAL SCIENCES</subject>
            <subject type="anzsrc-for">Analytical chemistry</subject>
            <subject type="anzsrc-for">Sensor technology (incl. chemical aspects) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Industrial biotechnology</subject>
            <subject type="anzsrc-for">Industrial biotechnology diagnostics (incl. biosensors) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical biotechnology</subject>
            <subject type="anzsrc-for">Medical biotechnology diagnostics (incl. biosensors)</subject>
            <subject type="local">biosensor</subject>
            <subject type="local">biotechnology</subject>
            <subject type="local">diagnostic assay</subject>
            <subject type="local">diagnostic techniques</subject>
            <subject type="local">cancer screening</subject>
            <description type="Chief Investigator Team">Dr Saimon Moraes Silva&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This research program will address the unmet need in the biosensing field: to develop technologies that can quantify cancer biomarkers directly in human bodily fluids. This is vital for early disease diagnosis and clinical monitoring. It will focus on detecting small RNA sequences called microRNA using a handheld analyser. The resulting sensing platforms will be integrated into technologies comprising the next generation of precision sensors for cancer detection and treatment monitoring.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042312</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042312</identifier>
            <identifier type="nhmrc">2042312</identifier>
            <name type="primary">
                <namePart>Addressing childhood trauma to prevent substance use and mental disorders: Improving precision psychiatry and developing innovative interventions</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Lucinda_Grummitt</identifier>
                <title>Dr Lucinda Grummitt</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Mental health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological modelling</subject>
            <subject type="local">traumatic stress</subject>
            <subject type="local">addiction prevention</subject>
            <subject type="local">mental health</subject>
            <subject type="local">substance use</subject>
            <subject type="local">adolescence</subject>
            <description type="Chief Investigator Team">Dr Lucinda Grummitt&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Mental and substance use disorders cause significant harm to individuals, their families, societies, and the economy. This research aims to improve efforts to prevent mental and substance use disorders, by addressing a common and strong risk factor: childhood trauma. This research will use large-scale, longitudinal data to understand which children are most in need of preventive interventions, and will develop and test a trauma-informed program to prevent mental and substance use disorders.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042321</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042321</identifier>
            <identifier type="nhmrc">2042321</identifier>
            <name type="primary">
                <namePart>Use Of Artificial Intelligence and Robotics To Improve Detection and Management of Heart Failure</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9065-0899</identifier>
                <title>Prof Thomas Marwick</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03rke0285</identifier>
                <title>Baker Heart and Diabetes Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03rke0285</identifier>
                <title>Baker Heart and Diabetes Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases)</subject>
            <subject type="local">congestive heart failure</subject>
            <subject type="local">artificial intelligence</subject>
            <subject type="local">echocardiography</subject>
            <subject type="local">electrocardiogram (ecg)</subject>
            <subject type="local">cardiovascular risk</subject>
            <description type="Chief Investigator Team">Prof Thomas Marwick&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Heart failure is a major cause of disability, frequent hospital admissions and fatalities. Prevention is feasible but needs to be guided by the recognition of risk and detection of early-stage disease. This proposal seeks to develop efficient screening using Artificial Intelligence approaches to provide the cornerstone diagnostic techniques – advanced electrocardiography and echocardiography - to the hands of non-cardiologists who care for at-risk patients, especially in rural and remote areas.</description>
            <description type="fundingAmount">$2,608,415.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042324</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042324</identifier>
            <identifier type="nhmrc">2042324</identifier>
            <name type="primary">
                <namePart>The freedom to live a flourishing life: Co-creating autistic wellbeing</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6669-9385</identifier>
                <title>Dr Rachel Grove</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Applied and developmental psychology</subject>
            <subject type="anzsrc-for">Psychological methodology, design and analysis HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">People with disability</subject>
            <subject type="local">autism</subject>
            <subject type="local">measurement</subject>
            <subject type="local">wellbeing</subject>
            <subject type="local">quality of life</subject>
            <subject type="local">mental health</subject>
            <description type="Chief Investigator Team">Dr Rachel Grove&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Autistic people often face unequal opportunities in society, which negatively affects their mental health and wellbeing. This project will be led by autistic people. It aims to define what a good life means for autistic people, develop a new measure of wellbeing and recommend ways to better support autistic people in society. This will lead to better health outcomes for autistic people, promote inclusion and acceptance and ensure everyone in Australia has an equal right to a fulfilling life.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042329</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042329</identifier>
            <identifier type="nhmrc">2042329</identifier>
            <name type="primary">
                <namePart>Pregnancy: Window to Health Futures</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9250-2192</identifier>
                <title>Prof Claire Roberts</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Obstetrics and gynaecology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Infant and child health</subject>
            <subject type="local">pregnancy</subject>
            <subject type="local">metabolic syndrome</subject>
            <subject type="local">placenta</subject>
            <subject type="local">gestational diabetes</subject>
            <subject type="local">hypertension</subject>
            <description type="Chief Investigator Team">Prof Claire Roberts&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Pregnancy complications occur in 25-30% of the 310,000 Australian births each year and foreshadow future health for mother and child. This research will study maternal and child health from conception, focusing on genetic and modifiable risk factors common to pregnancy complications and later cardiometabolic diseases. It will create new knowledge, identify molecular targets and generate novel interventions, co-designed with consumers, to improve intergenerational health across the life course.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042341</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042341</identifier>
            <identifier type="nhmrc">2042341</identifier>
            <name type="primary">
                <namePart>Next-generation techniques to identify and model brain dysfunction in dementia</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3638-1605</identifier>
                <title>Dr Brandon Munn</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Biological psychology</subject>
            <subject type="anzsrc-for">Cognitive neuroscience PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Cognitive and computational psychology</subject>
            <subject type="anzsrc-for">Cognition</subject>
            <subject type="local">neuroimaging</subject>
            <subject type="local">dementia</subject>
            <subject type="local">noradrenaline</subject>
            <subject type="local">mathematical modelling</subject>
            <subject type="local">brain mapping</subject>
            <description type="Chief Investigator Team">Dr Brandon Munn&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">I will use advanced brain imaging analyses to identify and model brain changes in people with dementia. The project will improve our ability to identify affected individuals earlier in the disease course and advance our understanding of the causes of the brain changes, to inform strategies for future clinical interventions.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042354</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042354</identifier>
            <identifier type="nhmrc">2042354</identifier>
            <name type="primary">
                <namePart>Improving treatments for severe and treatment resistant depression</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3267-0554</identifier>
                <title>Prof Colleen Loo</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/023331s46</identifier>
                <title>The George Institute for Global Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04rfr1008</identifier>
                <title>Black Dog Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b05bn14</identifier>
                <title>Ramsay Health Care</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Psychiatry (incl. psychotherapy)</subject>
            <subject type="local">major depression</subject>
            <subject type="local">clinical</subject>
            <subject type="local">antidepressant therapy</subject>
            <subject type="local">electroconvulsive therapy (ect)</subject>
            <subject type="local">clinical trial</subject>
            <description type="Chief Investigator Team">Prof Colleen Loo&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Some people with depression do not respond to treatment with standard medications and psychological therapy. This research program will focus on the development of new treatment approaches for these people: assessing new treatment approaches for ketamine, psilocybin -assisted therapy and electroconvulsive therapy, better understanding how they work, who will most benefit and when these treatments should be used in the treatment pathway.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042383</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042383</identifier>
            <identifier type="nhmrc">2042383</identifier>
            <name type="primary">
                <namePart>Advancing the analysis of 24-hour time-use data</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3057-0963</identifier>
                <title>Prof Dorothea Dumuid</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01p93h210</identifier>
                <title>University of South Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01p93h210</identifier>
                <title>University of South Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Behavioural epidemiology</subject>
            <subject type="local">physical activity</subject>
            <subject type="local">applied statistics</subject>
            <subject type="local">sedentary behaviour</subject>
            <subject type="local">sleep</subject>
            <subject type="local">lifestyle factors</subject>
            <description type="Chief Investigator Team">Prof Dorothea Dumuid&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This project will create new methods to help researchers analyse how daily time spent in behaviours like physical activity, sedentary time, and sleep affects health and wellbeing. It will address key gaps for informing the design and analysis of time-use interventions, for example: how many participants should be included in a study, how to determine feasible behaviour-change goals for individuals, and how to assess the impact of different behaviour-change options on health and wellbeing.</description>
            <description type="fundingAmount">$1,323,700.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042407</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042407</identifier>
            <identifier type="nhmrc">2042407</identifier>
            <name type="primary">
                <namePart>Autocatalytic CRISPR sensor for ultrasensitive detection of cell free DNA in precision oncology</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5606-0278</identifier>
                <title>Dr Fei Deng</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Biomedical engineering not elsewhere classified</subject>
            <subject type="local">biosensor</subject>
            <subject type="local">genetic testing</subject>
            <subject type="local">molecular diagnosis</subject>
            <subject type="local">cancer detection</subject>
            <subject type="local">mutation detection</subject>
            <description type="Chief Investigator Team">Dr Fei Deng&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This project aims to develop advanced, affordable biosensors for non-invasive cancer monitoring by detecting cell-free DNA in blood. The sensors will quickly identify specific cancer mutations, delivering results in under 15 minutes for less than $1 per test, with accuracy comparable to lab tests. They aim to improve cancer monitoring by detecting therapy resistance and recurrence, potentially replacing traditional biopsies and making cancer care more accessible and efficient.</description>
            <description type="fundingAmount">$663,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042414</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042414</identifier>
            <identifier type="nhmrc">2042414</identifier>
            <name type="primary">
                <namePart>Improving the Functional Integration of Human Pluripotent Stem Cell-Derived Neural Grafts</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Niamh_Moriarty</identifier>
                <title>Dr Niamh Moriarty</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03a2tac74</identifier>
                <title>Florey Institute of Neuroscience and Mental Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Other biomedical and clinical sciences</subject>
            <subject type="anzsrc-for">Other biomedical and clinical sciences not elsewhere classified</subject>
            <subject type="local">neuroscience</subject>
            <subject type="local">cell transplantation</subject>
            <subject type="local">regenerative medicine</subject>
            <subject type="local">neural stem cell</subject>
            <subject type="local">parkinson disease</subject>
            <description type="Chief Investigator Team">Dr Niamh Moriarty&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Parkinson’s Disease (PD) is a debilitating neurological disorder affecting ~10 million people. With no disease modifying treatment, human stem cell-derived neural grafts present a new therapeutic option, with trials currently underway. However, preclinical studies highlight poor graft survival and plasticity. My research will focus on enhancing these neural transplants through combined neurotrophic support and environmental enrichment strategies, to treat cognitive and motor symptoms of PD.</description>
            <description type="fundingAmount">$613,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042421</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042421</identifier>
            <identifier type="nhmrc">2042421</identifier>
            <name type="primary">
                <namePart>Innovating in breast cancer immunology treatment and prevention</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6137-9171</identifier>
                <title>Prof Sherene Loi</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Molecular targets</subject>
            <subject type="local">breast cancer</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">oncology</subject>
            <subject type="local">immunotherapy</subject>
            <subject type="local">genetics</subject>
            <description type="Chief Investigator Team">Prof Sherene Loi&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Breast cancer is a major health and economic issue globally, leading to significant mortality in women. My five-year research plans to understand how the immune system works to combat breast cancers. I will study how specific immune cells can detect and control the disease, and factors influencing their presence in the breast. My goal is to enhance the effectiveness of current immunotherapy regimens, with the goal of reducing breast cancer incidence, and improving patient outcomes.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042423</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042423</identifier>
            <identifier type="nhmrc">2042423</identifier>
            <name type="primary">
                <namePart>Targeting the Alternative RNA Splicing Dichotomy of Brain Cancer as a Novel Anticancer Strategy</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1376-4515</identifier>
                <title>Prof Simon Conn</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Molecular targets BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Gene expression (incl. microarray and other genome-wide approaches)</subject>
            <subject type="local">alternative splicing</subject>
            <subject type="local">gene regulation</subject>
            <subject type="local">glioma</subject>
            <subject type="local">molecular biology</subject>
            <subject type="local">clustered regularly interspaced short palindromic repeats (crispr)</subject>
            <description type="Chief Investigator Team">Prof Simon Conn&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Loss of one or more genes is an essential hallmark of cancer. My laboratory has identified three genes which affect our genetic makeup are lost in the two deadliest children's brain cancers. We show that replenishing these lost genes or destroying their genetic products can be achieved inside intact brains and stops the cancer. My laboratory is uniquely positioned to investigate these pivotal processes in these incurable kids' cancers to provide much-needed and novel therapeutic options.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042446</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042446</identifier>
            <identifier type="nhmrc">2042446</identifier>
            <name type="primary">
                <namePart>Transforming exercise care for metabolic dysfunction-associated steatotic liver disease</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-5357-2721</identifier>
                <title>Dr Shelley Keating</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Sports science and exercise</subject>
            <subject type="anzsrc-for">Exercise physiology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Gastroenterology and hepatology</subject>
            <subject type="local">exercise</subject>
            <subject type="local">central obesity</subject>
            <subject type="local">hepatic steatosis</subject>
            <subject type="local">exercise physiology</subject>
            <subject type="local">physical activity</subject>
            <description type="Chief Investigator Team">Dr Shelley Keating&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Metabolic dysfunction-associated steatotic liver disease (MASLD, previously called 'fatty liver' disease) affects 1 in 3 adults and can lead to heart and advanced liver disease. Exercise is beneficial but not regularly undertaken by most people with MASLD. My research program will establish: an exercise care pathway to support people with MASLD; the benefit of exercise on important features of severe liver disease; and sustainable exercise options that maintain health benefits long-term.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042450</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042450</identifier>
            <identifier type="nhmrc">2042450</identifier>
            <name type="primary">
                <namePart>Strengths-based approaches: Responding to older Aboriginal and Torres Strait Islander adults’ needs for aged care services</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3463-6827</identifier>
                <title>Dr Jesse Zanker</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Aged health care INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health services</subject>
            <subject type="local">frailty</subject>
            <subject type="local">indigenous health</subject>
            <subject type="local">strength</subject>
            <subject type="local">aged care</subject>
            <subject type="local">culturally appropriate methodology</subject>
            <description type="Chief Investigator Team">Dr Jesse Zanker&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The number of older Aboriginal and Torres Strait Islander (First Nations) peoples is growing, and home-based aged care services may not meet their needs because they focus on problems and not a person’s strengths. First Nations researchers and Elders have shown we must work with people’s strengths to solve health and ageing challenges. This project will show how older First Nations people’s strengths can be built on to ensure that aged care services meet their needs and support healthy ageing.</description>
            <description type="fundingAmount">$469,202.50</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042468</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042468</identifier>
            <identifier type="nhmrc">2042468</identifier>
            <name type="primary">
                <namePart>Using the 3D genome to predict and treat leukaemia</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4605-6416</identifier>
                <title>Dr Timothy Johanson</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Epigenetics (incl. genome methylation and epigenomics)</subject>
            <subject type="local">acute leukaemia</subject>
            <subject type="local">b cells</subject>
            <subject type="local">molecular biology</subject>
            <subject type="local">molecular basis of disease</subject>
            <subject type="local">epigenetics</subject>
            <description type="Chief Investigator Team">Dr Timothy Johanson&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Leukaemia is the most common cancer in children and, despite high cure rates, is a leading cause of childhood mortality in Australia. The disease is caused by mutations in DNA, however the factors that influence when and where within the genome these mutations occur are poorly understood. In this project, I aim to reveal how the genome is organized in three dimensions and explore how disorganization of this intricate DNA network may influence DNA mutations and thus the development of leukaemia.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042481</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042481</identifier>
            <identifier type="nhmrc">2042481</identifier>
            <name type="primary">
                <namePart>Developing muscle-strengthening activity competency in youth: Supporting community health through enhancing knowledge, skills, and behaviour</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9804-616X</identifier>
                <title>Dr Sarah Kennedy</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03t52dk35</identifier>
                <title>Western Sydney University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03t52dk35</identifier>
                <title>Western Sydney University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Sports science and exercise</subject>
            <subject type="anzsrc-for">Sports science and exercise not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Community child health</subject>
            <subject type="local">muscle strength</subject>
            <subject type="local">youth</subject>
            <subject type="local">physical activity</subject>
            <subject type="local">child behaviour</subject>
            <subject type="local">community health</subject>
            <description type="Chief Investigator Team">Dr Sarah Kennedy&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Muscle strengthening activity (MSA) positively impacts physical and psychological health, yet youth participation is limited. Sport offers a unique setting to target youth activity behaviour, as well as influence knowledge and understanding of MSA. However, few sports provide evidence-based MSA information to end-users. My program of research aims to support healthy communities through the generation of new evidence to inform MSA knowledge, skills and competency within grassroots sport.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042482</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042482</identifier>
            <identifier type="nhmrc">2042482</identifier>
            <name type="primary">
                <namePart>Improving care for chronic pain: implementing effective treatments and reducing medicine-related harms</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4190-7912</identifier>
                <title>Dr Aidan Cashin</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01g7s6g79</identifier>
                <title>Neuroscience Research Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Pain HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science</subject>
            <subject type="anzsrc-for">Physiotherapy HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Primary health care</subject>
            <subject type="local">chronic pain</subject>
            <subject type="local">evidence-based health care</subject>
            <subject type="local">low back pain</subject>
            <subject type="local">clinical research</subject>
            <subject type="local">implementation</subject>
            <description type="Chief Investigator Team">Dr Aidan Cashin&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The program will generate transformative knowledge on how to better manage chronic pain, a condition affecting 20% of all Australians. The program aims to improve access to effective and safe treatments, and to reduce medicine-related harms. The work will involve an intersectoral team of clinicians, patients, industry and consumer partners. It will lead to highly significant findings that will influence policy and practice globally.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042486</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042486</identifier>
            <identifier type="nhmrc">2042486</identifier>
            <name type="primary">
                <namePart>Understanding the clinical presentation of Aboriginal and Torres Strait Islanders with Parkinson’s disease in Australia</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3168-3388</identifier>
                <title>Dr Paulo Pelicioni</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01g7s6g79</identifier>
                <title>Neuroscience Research Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander public health and wellbeing BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Neurology and neuromuscular diseases HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity</subject>
            <subject type="local">parkinson disease</subject>
            <subject type="local">physical activity</subject>
            <subject type="local">equity</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">disease progression</subject>
            <description type="Chief Investigator Team">Dr Paulo Pelicioni&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">It is not known how Parkinson’s disease (PD) affect Aboriginal people. Thus, in this program, I will 1) explore the best ways to engage with Aboriginal people with PD and enhance their experience through research; 2) investigate the progression of motor and non-motor PD symptoms among Aboriginal people; 3) test the effectiveness of a physical activity program on mobility and to reduce the PD burden among Aboriginal people.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042524</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042524</identifier>
            <identifier type="nhmrc">2042524</identifier>
            <name type="primary">
                <namePart>Gene engineering approaches to enhance the efficacy of adoptive cellular therapy of cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2116-013</identifier>
                <title>Assoc Prof Paul Beavis</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Tumour immunology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)</subject>
            <subject type="local">t cell immunotherapy</subject>
            <subject type="local">cancer immunotherapy</subject>
            <subject type="local">tumour immunotherapy</subject>
            <subject type="local">tumour immunology</subject>
            <subject type="local">cd8 t cells</subject>
            <description type="Chief Investigator Team">Assoc Prof Paul Beavis&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This project will enhance the effectiveness of a type of immune based therapy where a patient’s own immune cells are genetically engineered to recognise and kill cancer cells. One key advance will be the application of advanced cellular engineering methodologies to improve existing gene therapies. If successful, the developed technologies could be rapidly applied to patients afflicted by a range of cancers including multiple myeloma, sarcoma and lung cancer.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042554</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042554</identifier>
            <identifier type="nhmrc">2042554</identifier>
            <name type="primary">
                <namePart>Innovative Approaches to Optimising Existing and New Antimalarial Therapies</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2660-2013</identifier>
                <title>Prof Julie Simpson</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">MATHEMATICAL SCIENCES</subject>
            <subject type="anzsrc-for">Statistics</subject>
            <subject type="anzsrc-for">Biostatistics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases</subject>
            <subject type="local">biostatistics</subject>
            <subject type="local">malaria drug resistance</subject>
            <subject type="local">malaria therapy</subject>
            <subject type="local">malaria control</subject>
            <subject type="local">mathematical modelling</subject>
            <description type="Chief Investigator Team">Prof Julie Simpson&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Malaria is a major global health problem, causing over 240 million cases and 600,000 deaths annually. The global malaria burden is rising, exacerbated by drug resistance and inadequate treatments. My research program will investigate safe and effective antimalarial treatments for falciparum and vivax malaria, inform the dosing regimens of new antimalarials, build research capacity and foster new leaders in the cross-disciplinary field of biostatistics and applied mathematics.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042563</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042563</identifier>
            <identifier type="nhmrc">2042563</identifier>
            <name type="primary">
                <namePart>Tunapri Ngini, Tunapri Rrala (Old Knowledge, Strong Knowledge) – a research program to Protect and Respect First Peoples’ Cultural Medicine knowledges</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2503-2696</identifier>
                <title>Dr Alana Gall</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/001xkv632</identifier>
                <title>Southern Cross University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/001xkv632</identifier>
                <title>Southern Cross University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander medicine and treatments INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander social, emotional, cultural and spiritual wellbeing INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health policy</subject>
            <subject type="local">indigenous australians</subject>
            <subject type="local">decolonization</subject>
            <subject type="local">indigenous health</subject>
            <subject type="local">health policy</subject>
            <subject type="local">social and cultural issues</subject>
            <description type="Chief Investigator Team">Dr Alana Gall&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This First Peoples led research program is focused on First Peoples' Cultural Medicines (also called bush medicine) across two key areas: 1) embedding Cultural Medicines into Australian health policies to improve cultural safety, health and wellbeing, and 2) protect Cultural Medicine knowledge through research that informs the regulation of Cultural Medicines and intellectual property legislation, to realise the economic self-determination of First Peoples and their communities.</description>
            <description type="fundingAmount">$649,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042569</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042569</identifier>
            <identifier type="nhmrc">2042569</identifier>
            <name type="primary">
                <namePart>Addressing the gaps in knowledge, policy, and guidelines on menstrual and gynaecological conditions and their consequences across life</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9610-5904</identifier>
                <title>Prof Gita Mishra</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiology not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health and community services</subject>
            <subject type="local">women's health</subject>
            <subject type="local">endometriosis</subject>
            <subject type="local">chronic diseases</subject>
            <subject type="local">reproductive disorders</subject>
            <subject type="local">female menopause</subject>
            <description type="Chief Investigator Team">Prof Gita Mishra&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Disruptive menstrual symptoms, such as heavy menstrual bleeding and severe menstrual pain, are common conditions that place a heavy social, physical, and mental toll on many Australians. Lack of knowledge on menstrual and gynaecological conditions and their consequences is a barrier in current healthcare. My research will reveal the evidence needed to improve health policy and guidelines for better diagnosis and management of these conditions and improve health and wellbeing across life.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042570</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042570</identifier>
            <identifier type="nhmrc">2042570</identifier>
            <name type="primary">
                <namePart>Advancing Precision Medicine for Colorectal Cancer through Liquid Biopsy</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9244-2057</identifier>
                <title>Prof Jeanne Tie</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Liquid biopsies BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Predictive and prognostic markers BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Solid tumours</subject>
            <subject type="local">colorectal cancer</subject>
            <subject type="local">adjuvant therapy</subject>
            <subject type="local">prognostic markers</subject>
            <subject type="local">translational research</subject>
            <subject type="local">clinical trial</subject>
            <description type="Chief Investigator Team">Prof Jeanne Tie&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">I am leveraging my world leading studies of liquid biopsy testing in bowel cancer as a marker to predict cancer relapse, to further improve patient selection for treatment, both in terms of who to treat and what treatment to use. Using state-of-the-art technology, I will also improve the understanding of how cancer cells become resistant to chemotherapy and targeted therapy, which will facilitate the development of new treatment.</description>
            <description type="fundingAmount">$2,655,124.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042605</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042605</identifier>
            <identifier type="nhmrc">2042605</identifier>
            <name type="primary">
                <namePart>Strengthening Australia's response to our increasingly toxic unregulated drug supply</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1015-9379</identifier>
                <title>Dr Monica Barratt</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04ttjf776</identifier>
                <title>RMIT University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04ttjf776</identifier>
                <title>RMIT University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified</subject>
            <subject type="local">substance use</subject>
            <subject type="local">substance misuse</subject>
            <subject type="local">overdose</subject>
            <subject type="local">harm reduction</subject>
            <subject type="local">drug information</subject>
            <description type="Chief Investigator Team">Dr Monica Barratt&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">In response to increasingly toxic drug markets, Australian jurisdictions have initiated drug checking services which analyse illicit drugs and give results back to consumers within a health intervention. Through mixed-methods participatory research, I will address knowledge gaps regarding longer term health outcomes, leveraging community experiences and reaching diverse groups. This work will prevent drug overdoses, reducing morbidity, mortality, and economic costs to our healthcare system.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042634</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042634</identifier>
            <identifier type="nhmrc">2042634</identifier>
            <name type="primary">
                <namePart>Antiviral drug discovery using an interdisciplinary approach</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6302-7524</identifier>
                <title>Prof Mark von Itzstein</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02sc3r913</identifier>
                <title>Griffith University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02sc3r913</identifier>
                <title>Griffith University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Virology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Glycobiology CHEMICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medicinal and biomolecular chemistry</subject>
            <subject type="anzsrc-for">Glycoconjugates</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">carbohydrates</subject>
            <subject type="local">antiviral agents</subject>
            <subject type="local">drug discovery</subject>
            <subject type="local">glycobiology</subject>
            <description type="Chief Investigator Team">Prof Mark von Itzstein&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The most recent pandemic, COVID-19, highlighted how under prepared we are against emerging and reemerging viruses. The control of such viruses demands both novel drug discovery and vaccine development programs. This investigator award tackles clinically-significant viruses that have major health burden, in the context of morbidity, mortality and economic impact. The major outcome of this award will be the delivery of novel antiviral drug candidates that will reduce this health burden.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042647</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042647</identifier>
            <identifier type="nhmrc">2042647</identifier>
            <name type="primary">
                <namePart>The elimination of cervical cancer: Effective implementation and scale-up of the World Health Organisation strategy in Australia, the Indo-Pacific and globally</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6443-6618</identifier>
                <title>Prof Karen Canfell</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care</subject>
            <subject type="local">cancer control</subject>
            <subject type="local">gynaecological cancers</subject>
            <subject type="local">cancer detection</subject>
            <subject type="local">cancer epidemiology</subject>
            <subject type="local">cancer screening</subject>
            <description type="Chief Investigator Team">Prof Karen Canfell&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Cervical cancer can be eliminated via HPV vaccination, screening with HPV testing, and providing access to cancer and precancer treatment services. This Investigator Grant will build on prior global leadership of the cervical cancer elimination agenda. Critical new policy-focused and implementation research will build further evidence towards an Australian and global understanding of optimal approaches to the sustainable and equitable realisation of cervical cancer elimination.</description>
            <description type="fundingAmount">$2,000,000.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042655</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042655</identifier>
            <identifier type="nhmrc">2042655</identifier>
            <name type="primary">
                <namePart>Epidemiology of complications of diabetes: from causes to population burden</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6187-2203</identifier>
                <title>Prof Jonathan Shaw</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03rke0285</identifier>
                <title>Baker Heart and Diabetes Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03rke0285</identifier>
                <title>Baker Heart and Diabetes Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Endocrinology</subject>
            <subject type="local">diabetic complications</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">diabetic nephropathy</subject>
            <subject type="local">data linkage</subject>
            <subject type="local">biological risk factors</subject>
            <description type="Chief Investigator Team">Prof Jonathan Shaw&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">This project will advance our understanding of the complications of diabetes. Using the PREDICT study, it will identify better ways to find those people who are at high risk of developing complications of diabetes. A second study will examine the national and global impact of diabetes, by determining patterns of hospital admissions, death and use of medications and services.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042660</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042660</identifier>
            <identifier type="nhmrc">2042660</identifier>
            <name type="primary">
                <namePart>Transforming transfusion research to deliver better outcomes for patients and the community</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7527-2340</identifier>
                <title>Prof Erica Wood</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Haematology</subject>
            <subject type="local">blood transfusion</subject>
            <subject type="local">health services research</subject>
            <subject type="local">haematological malignancy</subject>
            <subject type="local">blood diseases</subject>
            <subject type="local">patient outcomes</subject>
            <description type="Chief Investigator Team">Prof Erica Wood&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Blood transfusions save lives, but carry risks and costs. Donated by volunteers, we have a responsibility to use blood wisely. Australia spends $1.6+ billion/year on blood products, but lacks data on how blood is used, hospital costs of providing transfusion services, and patient outcomes. My research will transform how and why we use blood products, and deliver more personalised, evidence-based transfusion support and safer, more cost-effective use of blood for better patient outcomes.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042668</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042668</identifier>
            <identifier type="nhmrc">2042668</identifier>
            <name type="primary">
                <namePart>Dissecting divergent pathway activation at Frizzled receptors</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Wessel_Burger</identifier>
                <title>Dr Wessel Burger</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Basic pharmacology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Receptors and membrane biology</subject>
            <subject type="local">biochemistry</subject>
            <subject type="local">g protein-coupled receptors</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">molecular pharmacology</subject>
            <subject type="local">electron microscopy</subject>
            <description type="Chief Investigator Team">Dr Wessel Burger&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">This project aims to provide increased understanding of proteins found on the outside of cells that are heavily implicated in many cancer disorders. By uncovering new potential cancer therapeutics, this research has the potential to benefit the millions of people suffering from cancer disorders.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042675</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042675</identifier>
            <identifier type="nhmrc">2042675</identifier>
            <name type="primary">
                <namePart>Improving women’s health before conception: an evidence based strategy to break the intergenerational obesity cycle</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6363-4874</identifier>
                <title>Prof Jodie Dodd</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Obstetrics and gynaecology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Infant and child health</subject>
            <subject type="local">reproductive health</subject>
            <subject type="local">child health</subject>
            <subject type="local">pregnancy outcome</subject>
            <subject type="local">overweight/obesity</subject>
            <subject type="local">lifestyle factors</subject>
            <description type="Chief Investigator Team">Prof Jodie Dodd&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">In Australia, 1:2 women who enter pregnancy live with overweight or obesity. To reduce pregnancy and birth complications current care has focused on dietary changes to limit the amount of weight gained during pregnancy. Direct evidence from my research program has shown this approach is ineffective. A better approach is to improve women’s health before pregnancy. I will generate reliable, evidence-based information to change care and improve health outcomes for all women and their babies.</description>
            <description type="fundingAmount">$2,477,287.50</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042685</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042685</identifier>
            <identifier type="nhmrc">2042685</identifier>
            <name type="primary">
                <namePart>Innovative approaches to repair soft-tissue damage in critical organs</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-8106-4836</identifier>
                <title>Prof Anthony Weiss</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Biomaterials</subject>
            <subject type="local">tropoelastin</subject>
            <subject type="local">biomaterials</subject>
            <subject type="local">elastin</subject>
            <subject type="local">tissue engineering</subject>
            <subject type="local">extracellular matrix</subject>
            <description type="Chief Investigator Team">Prof Anthony Weiss&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This research program will develop and test new ways to repair damaged pancreas and heart by harnessing the restorative capabilities of the key elastic protein tropoelastin. By restoring elasticity, we expect to significantly improve organ function after disease. We will also spatially map elastin’s distribution in the normal and diseased lung. This research will pave the way for new treatments to improve outcomes from common conditions such as cancer, heart attack, and damaged lung.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042721</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042721</identifier>
            <identifier type="nhmrc">2042721</identifier>
            <name type="primary">
                <namePart>Cutting-Edge CRISPR Therapy Targeting a Wide Range of Duchenne Muscular Dystrophy Mutations</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2163-0514</identifier>
                <title>Dr Fatwa Adikusuma</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03e3kts03</identifier>
                <title>South Australian Health and Medical Research Institute Limited</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Synthetic biology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical biotechnology</subject>
            <subject type="anzsrc-for">Gene and molecular therapy BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical biotechnology</subject>
            <subject type="anzsrc-for">Medical molecular engineering of nucleic acids and proteins</subject>
            <subject type="local">clustered regularly interspaced short palindromic repeats (crispr)</subject>
            <subject type="local">molecular biology</subject>
            <subject type="local">gene therapy</subject>
            <subject type="local">duchenne muscular dystrophy</subject>
            <subject type="local">genetic engineering</subject>
            <description type="Chief Investigator Team">Dr Fatwa Adikusuma&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">My research is focused on advancing CRISPR-based gene editing techniques and strategies to address a wide range of mutations associated with DMD. I also aim to optimize delivery methods to get the most effective therapy. Using our existing DMD cell and humanized mouse models, I will develop innovative solutions for this devastating disease. I aspire to enhance Australia's capabilities in the field of gene editing and CRISPR therapy, fostering a collaborative effort to combat genetic diseases.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042722</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042722</identifier>
            <identifier type="nhmrc">2042722</identifier>
            <name type="primary">
                <namePart>In situ studies of the immune synapse</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_James_Whisstock</identifier>
                <title>Prof James Whisstock</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling)</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">immune function</subject>
            <subject type="local">electron microscopy</subject>
            <subject type="local">immune complex</subject>
            <subject type="local">natural killer cells</subject>
            <description type="Chief Investigator Team">Prof James Whisstock&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Immune cell killing is essential for the destruction of virally infected and cancerous cells. Conversely aberrant immune function drives inflammatory and autoimmune diseases. This application will use electron microscopy and related techniques to visualise and characterise the molecular interactions (synapse) that are made between immune cells and their targets. I will use this information to develop new immunotherapeutics to treat inflammatory diseases and cancer.</description>
            <description type="fundingAmount">$2,000,000.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042760</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042760</identifier>
            <identifier type="nhmrc">2042760</identifier>
            <name type="primary">
                <namePart>Design of Retromer Stabilisers for the Treatment of Neurodegeneration</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Mr_Michael_Healy</identifier>
                <title>Mr Michael Healy</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01rxfrp27</identifier>
                <title>Institute for Molecular Bioscience</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Protein trafficking BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling)</subject>
            <subject type="local">machine learning</subject>
            <subject type="local">cell biology</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">basic science</subject>
            <subject type="local">membrane trafficking</subject>
            <description type="Chief Investigator Team">Mr Michael Healy&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Imagine our cells as bustling cities, like any city waste is produce and needs to be effectively removed. When this fails, cell death can occur. Retromer is central to the process of waste removal and is often destabilised in neurodegenerative disease. Using machine learning techniques, I will design a suite of molecules that stabilise Retromer. If successful, this could lead to novel therapies for Parkinson’s disease as well as Alzheimer’s and related dementias.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042772</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042772</identifier>
            <identifier type="nhmrc">2042772</identifier>
            <name type="primary">
                <namePart>Parsing sleep and circadian factors in risk for psychosis to inform pathways and phenotypes</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0029-1525</identifier>
                <title>Assoc Prof Vanessa Cropley</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Psychiatry (incl. psychotherapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Adolescent health</subject>
            <subject type="local">mental health</subject>
            <subject type="local">sleep</subject>
            <subject type="local">early psychosis</subject>
            <subject type="local">brain imaging</subject>
            <subject type="local">circadian rhythms</subject>
            <description type="Chief Investigator Team">Assoc Prof Vanessa Cropley&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Disturbances in sleep and circadian rhythms, or ‘body clock’, are common in people who experience psychosis. However, the mechanisms underlying this are unclear. My 5 year program will conduct a series of studies that leverage advances in wearable technology, clinical phenotyping and computational approaches to understand whether and how sleep and circadian markers can predict young people who will develop psychosis or other poor outcomes. This information can be used to inform treatment.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042773</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042773</identifier>
            <identifier type="nhmrc">2042773</identifier>
            <name type="primary">
                <namePart>Reducing low value care to reduce healthcare's carbon emissions</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8702-6374</identifier>
                <title>Dr Scott McAlister</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">ENVIRONMENTAL SCIENCES</subject>
            <subject type="anzsrc-for">Environmental management</subject>
            <subject type="anzsrc-for">Environmental management HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems</subject>
            <subject type="local">environment</subject>
            <subject type="local">costs</subject>
            <subject type="local">health services research</subject>
            <subject type="local">evidence-based clinical practice</subject>
            <subject type="local">environmental monitoring</subject>
            <description type="Chief Investigator Team">Dr Scott McAlister&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Healthcare produces 7% of Australia's greenhouse gas emissions. The Australian Government has committed to net-zero healthcare by 2050. This needs to come from reducing emissions of clinical care, with a first step being reducing low value care. This research will 1) quantify emissions of 3 common surgeries and procedures that are potentially low value, 2) quantify emissions of low value treatments for lower back pain, and 3) develop a carbon database of medical devices and interventions.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042774</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042774</identifier>
            <identifier type="nhmrc">2042774</identifier>
            <name type="primary">
                <namePart>Profiling protective antibody responses against infectious diseases</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0020-9704</identifier>
                <title>Assoc Prof Amy Chung</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Humoural immunology and immunochemistry BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Virology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)</subject>
            <subject type="local">antibody</subject>
            <subject type="local">virology</subject>
            <subject type="local">fc receptors</subject>
            <subject type="local">vaccination immunology</subject>
            <subject type="local">malaria</subject>
            <description type="Chief Investigator Team">Assoc Prof Amy Chung&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Antibodies are a vital component of the immune response required for protection and control of infectious diseases. My research program will determine how antibodies contribute to protection and control of some of the world’s most deadly infectious pathogens (COVID-19, Influenza, Malaria and Mycobacterium Tuberculosis) in order to develop improved antibody-based vaccines, therapies and diagnostic tools.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042792</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042792</identifier>
            <identifier type="nhmrc">2042792</identifier>
            <name type="primary">
                <namePart>Enabling Immune Checkpoint Inhibitor Treatment for Triple Negative Breast Cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3707-0785</identifier>
                <title>Prof Chengzhong Yu</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology ENGINEERING</subject>
            <subject type="anzsrc-for">Nanotechnology</subject>
            <subject type="anzsrc-for">Nanomaterials</subject>
            <subject type="local">breast cancer</subject>
            <subject type="local">macrophage activation</subject>
            <subject type="local">immunotherapy</subject>
            <subject type="local">adjuvant</subject>
            <subject type="local">antigen presentation</subject>
            <description type="Chief Investigator Team">Prof Chengzhong Yu&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Immunotherapy uses the body’s own immune system to fight cancer. This project aims to develop an adjuvant that can be combined with current immunotherapy for triple-negative breast cancer (TNBC), the most dangerous form of breast cancer that is difficult to treat by current methods. Expected outcomes include improved anti-tumour efficacy of immunotherapy for TNBC, ultimately leading to better patient outcomes and potentially offering a new treatment option for TNBC patients.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042837</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042837</identifier>
            <identifier type="nhmrc">2042837</identifier>
            <name type="primary">
                <namePart>Boosting the efficacy of BH3-mimetic drugs for p53-deficient blood cancers and beyond</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1946-5161</identifier>
                <title>Dr Sarah Diepstraten</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Haematological tumours BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Cell development, proliferation and death</subject>
            <subject type="local">p53</subject>
            <subject type="local">acute myeloid leukaemia (aml)</subject>
            <subject type="local">apoptosis</subject>
            <subject type="local">non-hodgkin lymphoma</subject>
            <subject type="local">bcl-2</subject>
            <description type="Chief Investigator Team">Dr Sarah Diepstraten&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Many patients with aggressive blood cancers still have no effective treatment options. I have discovered an exciting new treatment strategy for these patients, combining drugs called BH3-mimetics with drugs that activate a protein called STING. My research will find genetic factors that can predict patient response and determine the best way to use these drugs to fight blood cancer. This information will inform future clinical trials to improve outcomes for people with aggressive blood cancers.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042847</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042847</identifier>
            <identifier type="nhmrc">2042847</identifier>
            <name type="primary">
                <namePart>Allosteric modulation of muscarinic receptors for the treatment of neurocognitive deficits</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4442-3294</identifier>
                <title>Prof Arthur Christopoulos</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Basic pharmacology</subject>
            <subject type="local">muscarinic receptors</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">drug discovery</subject>
            <subject type="local">molecular pharmacology</subject>
            <subject type="local">translational research</subject>
            <description type="Chief Investigator Team">Prof Arthur Christopoulos&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Schizophrenia (SCZ) and Alzheimer’s Disease (AD) are major global health burdens that share the common feature of poorly treated memory impairment. This project focuses on a specific family of brain receptor proteins that are well-validated in the control of cognition. I will leverage groundbreaking discoveries that I have made of novel binding sites on these proteins to overcome current medicinal limitations to yield more targeted, safer and efficacious medicines to treat SCZ and AD.</description>
            <description type="fundingAmount">$2,000,000.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042887</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042887</identifier>
            <identifier type="nhmrc">2042887</identifier>
            <name type="primary">
                <namePart>Better sleep for better mental health: Implementing sleep disorder education into mental healthcare training</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0448-3567</identifier>
                <title>Dr Hailey Meaklim</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Clinical and health psychology</subject>
            <subject type="anzsrc-for">Health psychology PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Clinical and health psychology</subject>
            <subject type="anzsrc-for">Clinical psychology</subject>
            <subject type="local">sleep disturbance</subject>
            <subject type="local">health psychology</subject>
            <subject type="local">sleep disorders</subject>
            <subject type="local">insomnia</subject>
            <subject type="local">mental health</subject>
            <description type="Chief Investigator Team">Dr Hailey Meaklim&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">It is well known that poor sleep worsens mental health. Despite this knowledge, mental healthcare clinicians receive almost no training in treating sleep problems. This project will launch an Australia-wide online training initiative to upskill mental healthcare clinicians to deliver effective sleep treatments. This project will ensure clinicians have the knowledge and skills needed to treat sleep problems and improve sleep and mood outcomes in individuals experiencing mental health disorders.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042893</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042893</identifier>
            <identifier type="nhmrc">2042893</identifier>
            <name type="primary">
                <namePart>Adaptive Platform Trials: Expanding impact</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Steve_Webb</identifier>
                <title>Prof Steve Webb</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Intensive care BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Neonatology</subject>
            <subject type="local">pneumonia</subject>
            <subject type="local">staphylococcus aureus</subject>
            <subject type="local">influenza</subject>
            <subject type="local">pre-term delivery</subject>
            <subject type="local">joint replacement</subject>
            <description type="Chief Investigator Team">Prof Steve Webb&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">I am an intensive care physician who leads clinical trials. I have world leading expertise in a new type of trial design, termed an adaptive platform trial, that generates reliable evidence to guide care faster and at lower cost than previous methods. I will generate new knowledge by leadership of REMAP-CAP, a trial that has generated evidence about best treatment for patients with severe COVID-19 infection and apply adaptive platform trial methods to other disease areas.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042896</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042896</identifier>
            <identifier type="nhmrc">2042896</identifier>
            <name type="primary">
                <namePart>What determines the longevity of antibody production after infection or vaccination?</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_David_Tarlinton</identifier>
                <title>Prof David Tarlinton</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Humoural immunology and immunochemistry BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Other biomedical and clinical sciences</subject>
            <subject type="anzsrc-for">Other biomedical and clinical sciences not elsewhere classified</subject>
            <subject type="local">antibody production</subject>
            <subject type="local">allogeneic transplantation</subject>
            <subject type="local">vaccination</subject>
            <subject type="local">adaptive immunity</subject>
            <subject type="local">autoimmune disease</subject>
            <description type="Chief Investigator Team">Prof David Tarlinton&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The production of antibodies is critical to health, protecting us from infectious agents and their toxic products. In some cases protection lasts for months, in others for a lifetime, and new protective specificities are able to be added without overwhelming the system. The aim of this research project is to understand how the survival of the cells that make antibodies is determined and its relationship to age, specificity and the overall immune status.</description>
            <description type="fundingAmount">$2,414,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042906</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042906</identifier>
            <identifier type="nhmrc">2042906</identifier>
            <name type="primary">
                <namePart>Shaping early-life Immunity: The role of microbes in immune development from the womb to the world</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0497-2160</identifier>
                <title>Dr Archita Mishra</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Genomics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Clinical microbiology</subject>
            <subject type="local">maternal and child health</subject>
            <subject type="local">immune development</subject>
            <subject type="local">t cell activation</subject>
            <subject type="local">mucosal immunology</subject>
            <subject type="local">clinical microbiology</subject>
            <description type="Chief Investigator Team">Dr Archita Mishra&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Our research focuses on how microbes shape a baby’s immune system even before birth. We study how a mother’s beneficial bacteria affect her baby's health, aiming to create new ways to support infants from birth. We also look at how human migration impacts maternal-child health. By employing special models that mimic early gut interactions, we hope to develop better immunity for infants, ensuring they have a healthy start in life.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042923</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042923</identifier>
            <identifier type="nhmrc">2042923</identifier>
            <name type="primary">
                <namePart>Decoding synucleinopathy by linking genomic variation to function</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0825-7786</identifier>
                <title>Dr Carlos Gantner</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Cell development, proliferation and death BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Neurology and neuromuscular diseases BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Genome structure and regulation</subject>
            <subject type="local">stem cell biology</subject>
            <subject type="local">alpha-synuclein</subject>
            <subject type="local">parkinson disease</subject>
            <subject type="local">gene regulation</subject>
            <subject type="local">disease modelling</subject>
            <description type="Chief Investigator Team">Dr Carlos Gantner&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">As the population ages, there is increasing need to develop therapies to slow or reverse neurodegeneration. This project focuses on decoding the genetic risk factors that predispose individuals to Parkinson’s disease and related disorders. How these DNA variations lead to disease is almost entirely unknown. This project will deliver: 1) mechanistic insight into how gene variants predispose patients to disease; and 2) identify new therapeutic targets to treat Parkinson’s and related diseases.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042936</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042936</identifier>
            <identifier type="nhmrc">2042936</identifier>
            <name type="primary">
                <namePart>Transforming Sexual Health through co-design with LGBTQ+ People with Intellectual Disability</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9434-3941</identifier>
                <title>Dr Rosalie Power</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03t52dk35</identifier>
                <title>Western Sydney University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03t52dk35</identifier>
                <title>Western Sydney University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">People with disability HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified</subject>
            <subject type="local">sexual health</subject>
            <subject type="local">gender differences</subject>
            <subject type="local">intellectual disability</subject>
            <subject type="local">homosexuality</subject>
            <subject type="local">health education</subject>
            <description type="Chief Investigator Team">Dr Rosalie Power&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This project will examine the sexual health and healthcare needs of LGBTQ+ people with intellectual disability using arts-based qualitative research methods. The findings will be translated into actionable practice guidelines, accessible sexual health resources and an exhibition to enhance sexual health promotion, healthcare delivery, and health literacy within this community. This will be achieved through co-design with LGBTQ+ people with intellectual disability and other key stakeholders.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042979</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042979</identifier>
            <identifier type="nhmrc">2042979</identifier>
            <name type="primary">
                <namePart>Novel biomarkers for the diagnosis and prevention of high-burden infections in children and adults</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3446-4594</identifier>
                <title>Prof Nigel Curtis</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/35655720546</identifier>
                <title>The Royal Children's Hospital Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Infant and child health BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Neonatology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Immunology not elsewhere classified</subject>
            <subject type="local">diagnosis</subject>
            <subject type="local">respiratory infection</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">tuberculosis</subject>
            <subject type="local">disease susceptibility</subject>
            <description type="Chief Investigator Team">Prof Nigel Curtis&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">I lead a research team committed to reducing the global burden of infectious diseases. Our current focus is on improving diagnostic tests and vaccines for tuberculosis (TB), using a unique collection of samples from children and adults worldwide. Additionally, we aim to identify blood markers that can predict which individuals are at highest risk of severe illness or death if they develop a respiratory infection so that targeted preventative interventions can be implemented to save lives.</description>
            <description type="fundingAmount">$2,811,220.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042999</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042999</identifier>
            <identifier type="nhmrc">2042999</identifier>
            <name type="primary">
                <namePart>Cell therapies for the injured perinatal brain</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8421-461X</identifier>
                <title>Dr Courtney McDonald</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0083mf965</identifier>
                <title>Hudson Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Foetal development and medicine</subject>
            <subject type="local">cerebral palsy</subject>
            <subject type="local">neuroinflammation</subject>
            <subject type="local">cell therapy</subject>
            <subject type="local">cord blood</subject>
            <subject type="local">brain injury</subject>
            <description type="Chief Investigator Team">Dr Courtney McDonald&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Preterm brain injury can lead to life-long disability, with limited treatments. I have shown that application of umbilical cord blood cells reduces preterm brain injury, but optimising therapy for human use is difficult because we don’t understand how they work and there is limited availability of cells. Using state-of-the-art preclinical models of preterm brain damage, I will determine how the cells reduce injury, allowing me to develop optimal cell therapies to treat preterm brain injury.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043012</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043012</identifier>
            <identifier type="nhmrc">2043012</identifier>
            <name type="primary">
                <namePart>Investigating programmed cell death and the tumour suppressor p53 to develop improved therapies for cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5020-4891</identifier>
                <title>Prof Andreas Strasser</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Cell development, proliferation and death</subject>
            <subject type="local">cell death</subject>
            <subject type="local">novel therapeutic agents</subject>
            <subject type="local">p53</subject>
            <subject type="local">translational research</subject>
            <subject type="local">haematological malignancy</subject>
            <description type="Chief Investigator Team">Prof Andreas Strasser&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Cancer is a leading cause of morbidity and mortality in worldwide, imposing a substantial burden on affected individuals, their families and the health care system. We will build on our previous success of delivering a highly successful anti-cancer drug (Venetoclax) to market by determining the mechanisms that control the killing of cancer cells and suppress tumour development. Our vision is to kick-start the development of new anti-cancer drugs that enhance the effects of existing therapies.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043021</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043021</identifier>
            <identifier type="nhmrc">2043021</identifier>
            <name type="primary">
                <namePart>Antecedents and lifelong consequences of perinatal brain injuries</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Claire_Kelly</identifier>
                <title>Dr Claire Kelly</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Neonatology</subject>
            <subject type="local">premature infant</subject>
            <subject type="local">brain imaging</subject>
            <subject type="local">very preterm birth</subject>
            <subject type="local">magnetic resonance imaging (mri)</subject>
            <subject type="local">neurodevelopment</subject>
            <description type="Chief Investigator Team">Dr Claire Kelly&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">My research will focus on infants born very preterm (less than 32 weeks of gestation) and at term (greater than or equal to 37 weeks of gestation) who suffer brain injuries in the perinatal period. I will create tools from brain scans that can be used to discover the precise causes and consequences of perinatal brain injuries in these infants. This could help to improve the clinical management and health and development of these infants over their lifetimes.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043044</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043044</identifier>
            <identifier type="nhmrc">2043044</identifier>
            <name type="primary">
                <namePart>Innovations in anaemia research: from trials to translation</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5502-0434</identifier>
                <title>Prof Sant-Rayn Pasricha</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Nutritional epidemiology HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Community child health</subject>
            <subject type="local">anaemia</subject>
            <subject type="local">public health</subject>
            <subject type="local">iron deficiency</subject>
            <subject type="local">maternal and child health</subject>
            <subject type="local">paediatric</subject>
            <description type="Chief Investigator Team">Prof Sant-Rayn Pasricha&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Anaemia is one of the most common health conditions globally. I lead the world's foremost anaemia research program aiming to reduce the anaemia burden especially in low income countries. I will undertake large trials of innovative anaemia solutions for adolescent girls and pregnant women in low income countries and apply cutting-edge lab techniques to make biologic discoveries on the impacts of iron on health. My findings will support global health, via synthesis of WHO policies and guidelines.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043045</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043045</identifier>
            <identifier type="nhmrc">2043045</identifier>
            <name type="primary">
                <namePart>Understanding mechanisms of inflammation in long COVID</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7901-9833</identifier>
                <title>Dr Stefanie Mendes Bader</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Infectious agents BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology</subject>
            <subject type="local">long covid</subject>
            <subject type="local">chronic inflammation</subject>
            <subject type="local">covid-19</subject>
            <subject type="local">immunology</subject>
            <subject type="local">pre-clinical studies</subject>
            <description type="Chief Investigator Team">Dr Stefanie Mendes Bader&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Long COVID is a multifaceted condition and represents a significant health concern. Correlations have been made in attempts to understand its causes, but molecular mechanisms remain unknown. This project will utilise my unique mouse models of COVID-19 for a detailed interrogation of long-term disease outcomes, focusing on understanding the role and regulation of chronic inflammation in long COVID. My model and discoveries will provide rationale and a platform for testing future therapies.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043055</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043055</identifier>
            <identifier type="nhmrc">2043055</identifier>
            <name type="primary">
                <namePart>Artificial intelligence-enabled quantitative atherosclerosis imaging by computed tomography to guide personalised management of coronary artery disease: a randomised clinical trial</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0348-7697</identifier>
                <title>Dr Andrew Lin</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02pammg90</identifier>
                <title>Cedars Sinai</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02t1bej08</identifier>
                <title>Monash Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases)</subject>
            <subject type="local">coronary artery disease</subject>
            <subject type="local">artificial intelligence</subject>
            <subject type="local">atherosclerosis</subject>
            <subject type="local">imaging</subject>
            <subject type="local">cardiovascular risk</subject>
            <description type="Chief Investigator Team">Dr Andrew Lin&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United States of America&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Coronary heart disease (CHD) occurs due to fatty plaque build-up in the coronary arteries, and the risk of heart attack or death increases in proportion to the amount of plaque. CT scans are a low-radiation test routinely used to assess for CHD. I aim to apply a rapid and accurate artificial intelligence (AI)-powered solution for measuring the total amount of coronary plaque on CT scans in a randomised clinical trial, where it will guide personalised testing and treatment of patients with CHD.</description>
            <description type="fundingAmount">$513,043.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043056</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043056</identifier>
            <identifier type="nhmrc">2043056</identifier>
            <name type="primary">
                <namePart>Leveraging data-driven computational platforms to accelerate the effective prevention, treatment and surveillance of viral infectious diseases</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-8086-2545</identifier>
                <title>Prof Matthew McKay</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Sequence analysis PHYSICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical and biological physics</subject>
            <subject type="anzsrc-for">Biological physics BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Virology</subject>
            <subject type="local">sequence analysis</subject>
            <subject type="local">mathematical modelling</subject>
            <subject type="local">t cell epitope</subject>
            <subject type="local">covid-19</subject>
            <subject type="local">vaccine design</subject>
            <description type="Chief Investigator Team">Prof Matthew McKay&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Viruses pose constant threats to human health. Based on our pioneering studies, cutting-edge engineering technologies for processing large and complex biological data sets, this project will leverage Big Data and AI methods to define platforms that accelerate discovery of effective vaccines and therapeutics, and for enhancing surveillance of viral infectious diseases. This highly multidisciplinary work will involve collaboration with virology, immunology, and public health experts.</description>
            <description type="fundingAmount">$2,618,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043057</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043057</identifier>
            <identifier type="nhmrc">2043057</identifier>
            <name type="primary">
                <namePart>Clearing roadblocks to therapeutically target kinases &amp; pseudokinases for treating inflammatory diseases</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Katherine_Davies</identifier>
                <title>Dr Katherine Davies</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling)</subject>
            <subject type="local">cell death</subject>
            <subject type="local">cellular mechanisms</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">kinases</subject>
            <subject type="local">x-ray crystallography</subject>
            <description type="Chief Investigator Team">Dr Katherine Davies&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Programmed cell death is essential for maintaining healthy biological processes. However, when dysregulated it can contribute to disease. My program of research focusses on RIPK3 and MLKL, the final effector proteins of a highly inflammatory form of cell death called necroptosis. I will characterise the structural transitions that these proteins undergo during the execution of cell death, rendering them highly attractive targets for development of new therapies to treat inflammatory diseases.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043072</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043072</identifier>
            <identifier type="nhmrc">2043072</identifier>
            <name type="primary">
                <namePart>Improving the quality of evidence in nutrition during recovery from critical illness</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7922-5717</identifier>
                <title>Assoc Prof Emma Ridley</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04scfb908</identifier>
                <title>Alfred Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science not elsewhere classified BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Intensive care BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Clinical nutrition</subject>
            <subject type="local">intensive care</subject>
            <subject type="local">allied health</subject>
            <subject type="local">nutrition</subject>
            <subject type="local">outcomes research</subject>
            <subject type="local">clinical trial</subject>
            <description type="Chief Investigator Team">Assoc Prof Emma Ridley&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Globally, an estimated 45 million people become critically ill each year. Survival is common; however, quality of survival is a defining challenge. My program is investigating the crucial role of nutrition in patient recovery. I will target consumer prioritised evidence gaps, define preferred outcomes and use novel research design to enhance the quality of recovery for survivors of critical illness using nutrition interventions.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043075</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043075</identifier>
            <identifier type="nhmrc">2043075</identifier>
            <name type="primary">
                <namePart>'We don’t get paid to keep people healthy’: Optimising Indigenous Patient-Centred Care through Coordinated and Comprehensive Health Management and Decision-making</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-1206-8072</identifier>
                <title>Prof Roxanne Bainbridge</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health services INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander public health and wellbeing INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health policy</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">health policy</subject>
            <subject type="local">health services</subject>
            <subject type="local">patient outcomes</subject>
            <subject type="local">implementation</subject>
            <description type="Chief Investigator Team">Prof Roxanne Bainbridge&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Value Based Care (VBC) promises a significant leap in the quality of care, patient outcomes and system efficiencies that traditional models have struggled to achieve for Indigenous Australians. My research aims to develop, implement and evaluate a culturally aligned VBC model incorporating Patient Reported Outcome Measures in 3 chronic conditions and surgical specialities. My work is expected to improve patient health outcomes and satisfaction and reduce hospital admissions.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043078</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043078</identifier>
            <identifier type="nhmrc">2043078</identifier>
            <name type="primary">
                <namePart>A temporary “bloodstream”: human oxygenating hydrogels for the treatment of brain injuries</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Yi_Wang</identifier>
                <title>Dr Yi Wang</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Tissue engineering ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Biomaterials</subject>
            <subject type="local">biomaterials</subject>
            <subject type="local">cell transplantation</subject>
            <subject type="local">protein engineering</subject>
            <subject type="local">oxygen</subject>
            <subject type="local">biomedical engineering</subject>
            <description type="Chief Investigator Team">Dr Yi Wang&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Approximately 700,000 Australians suffer from brain injuries, and cell transplantation therapies are the only way to replace damaged tissue. This research develops a novel biomaterial technology specifically designed to overcome the lack of vascular networks supplying oxygen critically limiting cell survival and integration post-transplantation. The work of my program will address this challenge, providing a fundamental new treatment approach for those Australians living with brain injury.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043104</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043104</identifier>
            <identifier type="nhmrc">2043104</identifier>
            <name type="primary">
                <namePart>Working Toward a Better Regulatory Framework for Medical Cannabis</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-8559-6995</identifier>
                <title>Dr Thomas Arkell</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/031rekg67</identifier>
                <title>Swinburne University of Technology</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/031rekg67</identifier>
                <title>Swinburne University of Technology</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Biological psychology</subject>
            <subject type="anzsrc-for">Psychopharmacology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Clinical sciences not elsewhere classified</subject>
            <subject type="local">cannabinoid analgesics</subject>
            <subject type="local">neurocognitive assessment</subject>
            <subject type="local">cannabis</subject>
            <subject type="local">lived experiences</subject>
            <subject type="local">driving</subject>
            <description type="Chief Investigator Team">Dr Thomas Arkell&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Hundreds of thousands of Australians are now using prescribed medical cannabis, most often for chronic pain which is notoriously difficult to treat. Though medical cannabis is a promising treatment alternative, we lack essential information about its efficacy and safety due to a lack of research. This project aims to address this knowledge gap through a series of multidisciplinary patient-focused investigations. The results will have direct implications for health and road safety policy.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043108</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043108</identifier>
            <identifier type="nhmrc">2043108</identifier>
            <name type="primary">
                <namePart>Solving the surveillance challenges for malaria elimination in high burden countries</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6115-6135</identifier>
                <title>Prof Karen Day</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical microbiology</subject>
            <subject type="anzsrc-for">Medical parasitology</subject>
            <subject type="local">plasmodium falciparum</subject>
            <subject type="local">drug resistance</subject>
            <subject type="local">surveillance</subject>
            <subject type="local">molecular epidemiology</subject>
            <subject type="local">disease modelling</subject>
            <description type="Chief Investigator Team">Prof Karen Day&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Where malaria transmission is extremely high in Africa and India, virtually everyone is infected with diverse parasite species and strains. Most people do not have symptoms so they will not come to the clinic to be diagnosed. To eliminate malaria, we have to be proactive and find these infected people with no symptoms by using sensitive molecular diagnostics. This project will use such diagnostics to define better strategies to eliminate malaria where transmission is high.</description>
            <description type="fundingAmount">$2,000,000.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043111</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043111</identifier>
            <identifier type="nhmrc">2043111</identifier>
            <name type="primary">
                <namePart>Integrating single-cell omics with genetics: Novel statistical methods to enhance biological understanding and risk prediction of common diseases</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8801-5220</identifier>
                <title>Dr Jian Zeng</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Statistical and quantitative genetics</subject>
            <subject type="local">statistical genetics</subject>
            <subject type="local">genetics</subject>
            <subject type="local">bioinformatics</subject>
            <subject type="local">risk prediction</subject>
            <subject type="local">genomics</subject>
            <description type="Chief Investigator Team">Dr Jian Zeng&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The future of medicine involves big data to inform disease prevention, diagnosis and treatment strategies. My research program aims to develop statistical methods and software tools to integrate and analyse individual disease risk profiles with genome sequencing data at the level of single cells. This work is expected to enhance our understanding of the biological mechanisms of common diseases and prediction of individual disease risk based on their genetic makeup.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043112</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043112</identifier>
            <identifier type="nhmrc">2043112</identifier>
            <name type="primary">
                <namePart>Expanding the role of immunotherapy in cutaneous and mucosal head and neck squamous cell carcinomas</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Danny_Rischin</identifier>
                <title>Prof Danny Rischin</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy)</subject>
            <subject type="local">non-melanoma skin cancer</subject>
            <subject type="local">human papillomavirus (hpv)</subject>
            <subject type="local">head and neck cancer</subject>
            <subject type="local">cancer immunotherapy</subject>
            <subject type="local">clinical trial</subject>
            <description type="Chief Investigator Team">Prof Danny Rischin&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Immunotherapy has improved survival of patients with incurable advanced skin and head and neck squamous cell cancers. My research is focused on further improving outcomes including determining the role of adding immunotherapy in patients with earlier stages of these cancers that are curable with major surgery and/or radiotherapy combined with chemotherapy. These approaches may improve survival in skin cancer, and decrease the intensity of treatment for skin and base of tongue/tonsil cancers.</description>
            <description type="fundingAmount">$2,763,660.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043119</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043119</identifier>
            <identifier type="nhmrc">2043119</identifier>
            <name type="primary">
                <namePart>A more integrated, responsive and sustainable learning musculoskeletal health system</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0597-0933</identifier>
                <title>Prof Rachelle Buchbinder</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Rheumatology and arthritis</subject>
            <subject type="local">musculoskeletal disorders</subject>
            <subject type="local">rheumatoid arthritis</subject>
            <subject type="local">implementation</subject>
            <subject type="local">evidence-based</subject>
            <subject type="local">clinical trial</subject>
            <description type="Chief Investigator Team">Prof Rachelle Buchbinder&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Musculoskeletal conditions place a huge burden on the world’s population. Poor care and research waste are major contributors to this burden. My focus for the next five years will be to improve outcomes for people with musculoskeletal conditions by embedding living guidelines into usual care, ensuring better value care for challenging musculoskeletal problems, and ensuring the most important research is prioritised.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043120</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043120</identifier>
            <identifier type="nhmrc">2043120</identifier>
            <name type="primary">
                <namePart>Harnessing nanotechnology to develop next-generation mRNA intracellular cancer therapy</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0103-1207</identifier>
                <title>Dr Yi Ju</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04ttjf776</identifier>
                <title>RMIT University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04ttjf776</identifier>
                <title>RMIT University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">ENGINEERING</subject>
            <subject type="anzsrc-for">Nanotechnology</subject>
            <subject type="anzsrc-for">Nanomaterials BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical biotechnology</subject>
            <subject type="anzsrc-for">Nanomedicine</subject>
            <subject type="local">nanotechnology</subject>
            <subject type="local">messenger rna (mrna)</subject>
            <subject type="local">biomedical engineering</subject>
            <subject type="local">drug delivery systems</subject>
            <subject type="local">antibody cancer therapy</subject>
            <description type="Chief Investigator Team">Dr Yi Ju&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Many cancer targets exist inside cells, and despite the development of effective antibodies against them, they remain undruggable due to the delivery challenges. By developing mRNA-encoded antibodies, I will leverage our lipid nanoparticle technology to deliver therapeutic antibodies inside cancer cells, creating drugs for previously undruggable targets. This will expand the applicability of antibodies beyond surface targets and enable modulation of internal targets within cancer cells.</description>
            <description type="fundingAmount">$615,377.54</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043155</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043155</identifier>
            <identifier type="nhmrc">2043155</identifier>
            <name type="primary">
                <namePart>Phenotyping of Inherited Cerebellar Ataxias in Indigenous Australians: Genetic, Clinical, and Diagnostic Insights</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Assoc_Prof_David_Szmulewicz</identifier>
                <title>Assoc Prof David Szmulewicz</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05e4f1b55</identifier>
                <title>The Bionics Institute of Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05e4f1b55</identifier>
                <title>The Bionics Institute of Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/65159208867</identifier>
                <title>MJD Foundation</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Neurosciences not elsewhere classified</subject>
            <subject type="local">cerebellar disorders</subject>
            <subject type="local">ataxia</subject>
            <subject type="local">vestibular dysfunction</subject>
            <subject type="local">clinical</subject>
            <subject type="local">measurement</subject>
            <description type="Chief Investigator Team">Assoc Prof David Szmulewicz&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Spinocerebellar Ataxia type 3 (SCA3) and SCA7 are brain diseases which impair coordination and balance, and are increasingly affecting Aboriginal communities. These diseases manifest differently among Aboriginal people, potentially complicating their participation in medical trials. Our research strives to enhance understanding of these diseases within Aboriginal populations, aiming to pave the way for tailored treatments and improved access to healthcare interventions.</description>
            <description type="fundingAmount">$1,174,220.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043165</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043165</identifier>
            <identifier type="nhmrc">2043165</identifier>
            <name type="primary">
                <namePart>Preventing cancer-related lymphoedema and its associated burden</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7005-5184</identifier>
                <title>Prof Sandra Hayes</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03g5d6c96</identifier>
                <title>Cancer Council Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03g5d6c96</identifier>
                <title>Cancer Council Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05p52kj31</identifier>
                <title>Royal Brisbane and Women's Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03w94w157</identifier>
                <title>Mater Private Hospital Brisbane</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05wqhv079</identifier>
                <title>Mater Hospital Brisbane</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Behavioural epidemiology HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health services and systems not elsewhere classified</subject>
            <subject type="local">lymphoedema</subject>
            <subject type="local">cancer epidemiology</subject>
            <subject type="local">secondary prevention</subject>
            <subject type="local">health behaviours</subject>
            <subject type="local">health services</subject>
            <description type="Chief Investigator Team">Prof Sandra Hayes&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Other</description>
            <description type="full">Cancer-related swelling of the limbs––lymphoedema––is a persistent and painful condition that &gt;10,000 Australians treated for breast or pelvic cancer develop each year. There is no cure and treatment can be difficult to access. My research aims to drive improvements in cancer care, ensuring equitable integration of evidence-based lymphoedema prevention and management. This work is expected to reduce health inequities and improve quality of life for Australians living with lymphoedema.</description>
            <description type="fundingAmount">$2,000,000.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043167</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043167</identifier>
            <identifier type="nhmrc">2043167</identifier>
            <name type="primary">
                <namePart>Delivering the tools for eliminating rheumatic heart disease</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1182-9792</identifier>
                <title>Prof Jonathan Carapetis</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01dbmzx78</identifier>
                <title>The Kids Research Institute Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander child health and wellbeing BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Clinical sciences not elsewhere classified</subject>
            <subject type="local">rheumatic heart disease</subject>
            <subject type="local">diagnosis</subject>
            <subject type="local">rheumatic fever</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">infectious diseases</subject>
            <description type="Chief Investigator Team">Prof Jonathan Carapetis&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Within five years, our goals include advancing a Strep A vaccine trial, evidence-based guidelines for environmental health interventions targeting Strep A infections, improving penicillin delivery for RHD prevention, develop new formulations and finalise a diagnostic test for ARF. These efforts aim to enhance management of Strep A diseases, address critical gaps in healthcare access and outcomes, particularly among First Nations communities and marginalised populations globally.</description>
            <description type="fundingAmount">$2,000,000.00</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043180</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043180</identifier>
            <identifier type="nhmrc">2043180</identifier>
            <name type="primary">
                <namePart>Women’s Heart Disease: overcoming health disparities</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Assoc_Prof_Sarah_Zaman</identifier>
                <title>Assoc Prof Sarah Zaman</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/48702394764</identifier>
                <title>Western Sydney Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases)</subject>
            <subject type="local">cardiovascular disease prevention</subject>
            <subject type="local">sex differences</subject>
            <subject type="local">coronary heart disease (chd)</subject>
            <subject type="local">women</subject>
            <subject type="local">clinical trial</subject>
            <description type="Chief Investigator Team">Assoc Prof Sarah Zaman&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Heart disease is the leading killer of women and affects 275 million women globally. Despite this, heart disease in women remains under-recognised, under-treated and under-researched. This research program will tackle inequities in care for women by improving prevention and early diagnosis of coronary heart disease as well as better understanding and treatment of female-dominant types of heart attacks.</description>
            <description type="fundingAmount">$1,311,850.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043188</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043188</identifier>
            <identifier type="nhmrc">2043188</identifier>
            <name type="primary">
                <namePart>New Hormone Treatments for Women with Depression Across the Life Cycle</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3875-5623</identifier>
                <title>Prof Jayashri Kulkarni</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Psychiatry (incl. psychotherapy)</subject>
            <subject type="local">women's health</subject>
            <subject type="local">female menopause</subject>
            <subject type="local">depressive disorder</subject>
            <subject type="local">estradiol</subject>
            <subject type="local">hormone action</subject>
            <description type="Chief Investigator Team">Prof Jayashri Kulkarni&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The goal of my research program is to develop life-changing, new hormone treatments for women with premenstrual, perinatal and perimenopausal depression. I will study new gonadal hormones in clinical trials to develop new treatments and further the understanding of how these hormones impact mental health. Successful new treatments will be rapidly translated into practice to improve women’s mental health.</description>
            <description type="fundingAmount">$2,811,220.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043191</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043191</identifier>
            <identifier type="nhmrc">2043191</identifier>
            <name type="primary">
                <namePart>Towards Innovative Deep Brain Stimulation Strategies: Exploiting the Diffuse Thalamus</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Eli_Muller</identifier>
                <title>Dr Eli Muller</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Neurology and neuromuscular diseases BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Computational neuroscience (incl. mathematical neuroscience and theoretical neuroscience)</subject>
            <subject type="local">parkinson disease</subject>
            <subject type="local">neuroimaging</subject>
            <subject type="local">basal ganglia</subject>
            <subject type="local">thalamus</subject>
            <subject type="local">disease modelling</subject>
            <description type="Chief Investigator Team">Dr Eli Muller&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This project aims to improve our understanding of Parkinson's disease (PD) and the effectiveness of Deep Brain Stimulation (DBS) treatment. It challenges traditional ideas about brain circuits, using advanced techniques to explore how PD affects brain systems. Three goals: 1) Study how PD affects these non-traditional brain systems. 2) Look at brain changes during invasive stimulation of these systems in monkeys. 3) Create better DBS models to improve clinical treatment strategies.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043192</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043192</identifier>
            <identifier type="nhmrc">2043192</identifier>
            <name type="primary">
                <namePart>Advancing non-drug treatments to improve lung health</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2061-845X</identifier>
                <title>Prof Anne Holland</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/96269526412</identifier>
                <title>Central Adelaide Local Health Network Incorporated</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n5e6456</identifier>
                <title>Peninsula Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00my0hg66</identifier>
                <title>Barwon Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05p52kj31</identifier>
                <title>Royal Brisbane and Women's Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02j1m6098</identifier>
                <title>Duke-NUS Graduate Medical School</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04scfb908</identifier>
                <title>Alfred Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/54003222080</identifier>
                <title>Mt Wilga Private Rehabilitation Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/022arq532</identifier>
                <title>Prince of Wales Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02t1bej08</identifier>
                <title>Monash Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05dbj6g52</identifier>
                <title>Austin Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science</subject>
            <subject type="anzsrc-for">Physiotherapy BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Respiratory diseases</subject>
            <subject type="local">adult respiratory diseases</subject>
            <subject type="local">chronic obstructive pulmonary disease (copd)</subject>
            <subject type="local">clinical trial</subject>
            <subject type="local">physiotherapy</subject>
            <subject type="local">pulmonary fibrosis</subject>
            <description type="Chief Investigator Team">Prof Anne Holland&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;Singapore&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Over 7 million Australians live with a chronic lung condition, characterised by distressing breathlessness, poor physical function and frequent hospital admissions. My vision is to reduce the burden of chronic lung disease using highly effective non-drug treatments - exercise-based rehabilitation, oxygen therapy and self-management. My research will improve lung health outcomes by developing, testing and personalising non-drug treatments, and driving excellence in healthcare delivery.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043211</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043211</identifier>
            <identifier type="nhmrc">2043211</identifier>
            <name type="primary">
                <namePart>There’s no place like home: keeping kids out of hospital through smarter antibiotic use</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Laila_Ibrahim</identifier>
                <title>Dr Laila Ibrahim</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Paediatrics not elsewhere classified</subject>
            <subject type="local">bacterial infection</subject>
            <subject type="local">acute infective illnesses</subject>
            <subject type="local">antibiotic use</subject>
            <subject type="local">child</subject>
            <subject type="local">home-based care</subject>
            <description type="Chief Investigator Team">Dr Laila Ibrahim&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">For many children in Australian hospitals, admission to hospital could be prevented or treatment could have been given at home. Unnecessary hospitalisations reduce children's quality of life and delay care for others. Children are commonly hospitalised due to infections requiring intravenous antibiotics. My research focuses on changing how we use intravenous antibiotics so that more children can be at home. By developing national guidelines, I will ensure children benefit from my findings.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043220</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043220</identifier>
            <identifier type="nhmrc">2043220</identifier>
            <name type="primary">
                <namePart>Sleep after Cancer: Scalable, Precision, and Personalised Treatment of Insomnia</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0271-6702</identifier>
                <title>Dr Joshua Wiley</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Clinical and health psychology</subject>
            <subject type="anzsrc-for">Health psychology</subject>
            <subject type="local">insomnia</subject>
            <subject type="local">mental health</subject>
            <subject type="local">psycho-oncology</subject>
            <subject type="local">sleep</subject>
            <subject type="local">clinical trial</subject>
            <description type="Chief Investigator Team">Dr Joshua Wiley&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">About 1 in 2 Australians will be diagnosed with cancer in their life, and about half of these will experience poor sleep. Poor sleep hurts their quality of life and costs the Australian economy. We have treatments, but they are costly and not available to most people with cancer. I will lead a program to work with the community, healthcare, and researchers to build and test treatments for sleep after cancer that can be delivered across Australia at low cost.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043223</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043223</identifier>
            <identifier type="nhmrc">2043223</identifier>
            <name type="primary">
                <namePart>Targeting malignant stem cells: the path towards a cure for deadly blood cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1325-7943</identifier>
                <title>Assoc Prof Jenny Wang</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer cell biology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Haematological tumours</subject>
            <subject type="local">haematopoietic stem cells</subject>
            <subject type="local">drug resistance</subject>
            <subject type="local">targeted therapy</subject>
            <subject type="local">g protein-coupled receptors</subject>
            <subject type="local">signalling pathways</subject>
            <description type="Chief Investigator Team">Assoc Prof Jenny Wang&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Acute myeloid leukaemia remains difficult to treat with a 5-year overall survival rate of only 27.4%. Malignant stem cells are believed to be the root cause for cancer treatment failure. This research program aims to develop innovative therapies targeting malignant stem cells that are more effective and less toxic than current first-line cancer treatments.</description>
            <description type="fundingAmount">$2,954,575.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043227</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043227</identifier>
            <identifier type="nhmrc">2043227</identifier>
            <name type="primary">
                <namePart>Improving outcomes for patients with melanoma</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8908-6071</identifier>
                <title>Prof Grant McArthur</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis not elsewhere classified BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Predictive and prognostic markers</subject>
            <subject type="local">melanoma</subject>
            <subject type="local">cancer immunotherapy</subject>
            <subject type="local">molecular oncology</subject>
            <subject type="local">targeted therapy</subject>
            <subject type="local">cancer metastasis</subject>
            <description type="Chief Investigator Team">Prof Grant McArthur&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Drug therapies that target molecules that initiate the growth of melanoma have been highly successful but suffer from the limitation that resistance often develops. The project will investigate why cells are not eradicated and develop new and specific treatment approaches to reverse this. The project will also discover new markers predicting the risk of development of metastases to allow personalised follow up and carefully tailored use of therapies to prevent metastases.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043233</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043233</identifier>
            <identifier type="nhmrc">2043233</identifier>
            <name type="primary">
                <namePart>Deciphering mechanisms underpinning tobacco-unassociated lung cancer development to improve patient outcomes</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Rachel_Joyce</identifier>
                <title>Dr Rachel Joyce</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Solid tumours</subject>
            <subject type="local">chemoprevention</subject>
            <subject type="local">sex differences</subject>
            <subject type="local">stem cell biology</subject>
            <subject type="local">solid tumours</subject>
            <subject type="local">targeted therapy</subject>
            <description type="Chief Investigator Team">Dr Rachel Joyce&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Tobacco-unassociated lung cancer is a leading cause of cancer-related death that predominantly arises in female people, for reasons that are currently unknown. I will examine healthy and cancerous lung tissues to uncover how sex and aging influence the ways in which tobacco-unassociated lung cancers develop in never-smokers, and reveal new, targeted strategies for disease treatment and prevention in at-risk patients.</description>
            <description type="fundingAmount">$680,958.12</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043281</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043281</identifier>
            <identifier type="nhmrc">2043281</identifier>
            <name type="primary">
                <namePart>Harnessing protein allostery to accelerate drug discovery</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0325-2524</identifier>
                <title>Dr David Thal</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Basic pharmacology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Receptors and membrane biology</subject>
            <subject type="local">g protein-coupled receptors</subject>
            <subject type="local">molecular mechanisms</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">molecular pharmacology</subject>
            <subject type="local">drug discovery</subject>
            <description type="Chief Investigator Team">Dr David Thal&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Drug discovery research is plagued by high failure rates. Targeting allosteric sites on proteins offers a new approach to drug discovery. However, allosteric sites are more difficult to investigate because they can be located anywhere on a protein. This project aims to explore how different types of drug-like molecules interact with cell proteins to regulate their function. The outcomes of this research will inform future academic and industrial drug discovery programs.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043294</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043294</identifier>
            <identifier type="nhmrc">2043294</identifier>
            <name type="primary">
                <namePart>Investigating post-transcriptional control of T cell immunity against infection and cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8823-9718</identifier>
                <title>Dr Julia Marchingo</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Proteomics and intermolecular interactions (excl. medical proteomics) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Cell metabolism</subject>
            <subject type="local">cd8 t cells</subject>
            <subject type="local">in vivo</subject>
            <subject type="local">post-transcriptional</subject>
            <subject type="local">proteomics</subject>
            <subject type="local">cell metabolism</subject>
            <description type="Chief Investigator Team">Dr Julia Marchingo&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Specialised immune cells, called T cells, recognise and kill virus infected and tumour cells. Sometimes T cells fail, resulting in chronic infection and cancer. Proteins are the building blocks that determine a cell’s function. This proposal uses new cutting-edge technology to measure the thousands of proteins that make up a T cell. By comparing how proteins differ between successful and failed responses we will identify and test new ways to improve T cell defence against cancer and infection.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043305</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043305</identifier>
            <identifier type="nhmrc">2043305</identifier>
            <name type="primary">
                <namePart>Driving discovery with statistical and AI methods for spatial ‘omics and related data</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2218-6833</identifier>
                <title>Dr Davis McCarthy</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/52004705640</identifier>
                <title>St Vincent's Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/52004705640</identifier>
                <title>St Vincent's Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Bioinformatic methods development BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Translational and applied bioinformatics BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Statistical and quantitative genetics</subject>
            <subject type="local">bioinformatics</subject>
            <subject type="local">control of gene expression</subject>
            <subject type="local">genomics</subject>
            <subject type="local">image analysis</subject>
            <subject type="local">genetics</subject>
            <description type="Chief Investigator Team">Dr Davis McCarthy&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">New technologies make it possible to measure important features of cells, like the activity of genes, from slices of tissue. The potential for these technologies is enormous, but we need new computational tools to take full advantage. Here, we propose to develop new statistical and AI methods to address key data analysis challenges in the field and work with national and international colleagues to link genetics to the behaviour of cells in tissues in diseases like pulmonary fibrosis.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043314</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043314</identifier>
            <identifier type="nhmrc">2043314</identifier>
            <name type="primary">
                <namePart>Breaking the cycle: building knowledge and strengthening health care to address the intergenerational diabetes epidemic among Aboriginal and Torres Strait Islander peoples</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9364-3368</identifier>
                <title>Dr Matthew Hare</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04jq72f57</identifier>
                <title>Royal Darwin Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/96843428729</identifier>
                <title>Miwatj Health Aboriginal Corporation</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/84085734992</identifier>
                <title>Gove District Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Endocrinology INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander epidemiology INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander lifecourse</subject>
            <subject type="local">diabetes</subject>
            <subject type="local">health services research</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">clinical epidemiology</subject>
            <subject type="local">data linkage</subject>
            <description type="Chief Investigator Team">Dr Matthew Hare&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Aboriginal and Torres Strait Islander communities are facing an intergenerational epidemic of diabetes and related chronic conditions. This collaborative research program will investigate early life risk factors for diabetes and related conditions, establish the burden of diabetes complications among Aboriginal people in the NT, and investigate new treatments and models of care to both prevent the development of diabetes and improve health outcomes for people living with diabetes.</description>
            <description type="fundingAmount">$438,043.00</description>
            <coverage>
                <spatial type="text">NT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043334</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043334</identifier>
            <identifier type="nhmrc">2043334</identifier>
            <name type="primary">
                <namePart>Natural Killer T cells to treat Inflammatory Bowel Disease</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Praveena_Thirunavukkarasu</identifier>
                <title>Dr Praveena Thirunavukkarasu</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology</subject>
            <subject type="local">x-ray crystallography</subject>
            <subject type="local">gut immunity</subject>
            <subject type="local">t cell receptor</subject>
            <subject type="local">antigen presentation</subject>
            <subject type="local">lipid</subject>
            <description type="Chief Investigator Team">Dr Praveena Thirunavukkarasu&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Inflammatory bowel diseases are an emerging health burden which affects &gt;6.8 million people with no cure. In order to design effective therapeutic agents, it is important to understand how our gut microbiota interacts with the immune system. This research will provide a basic fundamental understanding of the link between one kind of immune cells called T cells and gut microbes to aid in treating inflammatory bowel diseases.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043340</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043340</identifier>
            <identifier type="nhmrc">2043340</identifier>
            <name type="primary">
                <namePart>Advanced neuroimaging to improve the lives of infants at risk of brain injury or maldevelopment</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8017-5756</identifier>
                <title>Assoc Prof Deanne Thompson</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Neonatology</subject>
            <subject type="local">magnetic resonance imaging (mri)</subject>
            <subject type="local">neuroimaging</subject>
            <subject type="local">neurodevelopment</subject>
            <subject type="local">paediatric</subject>
            <subject type="local">neonate</subject>
            <description type="Chief Investigator Team">Assoc Prof Deanne Thompson&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">My research program will develop urgently needed tools for identifying brain abnormalities on babies’ medical images. This will improve outcomes for babies at high risk of neurodevelopmental impairments by helping doctors improve diagnosis, and helping researchers evaluate new therapies. I will also use advanced image analyses to study brain abnormalities in at-risk fetuses, to harness brain plasticity at the earliest age possible, enabling very early interventions to improve patient outcomes.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043344</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043344</identifier>
            <identifier type="nhmrc">2043344</identifier>
            <name type="primary">
                <namePart>Telomere biology in human health and disease</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9840-4841</identifier>
                <title>Prof Hilda Pickett</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01bsaey45</identifier>
                <title>Children's Medical Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology not elsewhere classified</subject>
            <subject type="local">telomeres</subject>
            <subject type="local">dna damage</subject>
            <subject type="local">telomerase</subject>
            <subject type="local">dna replication</subject>
            <subject type="local">dna repair</subject>
            <description type="Chief Investigator Team">Prof Hilda Pickett&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Telomeres are specialised structures at the ends of human chromosomes that function to regulate cellular proliferation. Loss of telomere integrity promotes aging, while telomere maintenance is a pre-requisite for cancer cell immortality. The project aims to elucidate the DNA damage and repair mechanisms that exist at telomeres in normal cells, during cellular aging, and in immortal cancer cells. The overarching aim is to improve health outcomes for cancer and age-associated diseases.</description>
            <description type="fundingAmount">$2,554,575.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043352</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043352</identifier>
            <identifier type="nhmrc">2043352</identifier>
            <name type="primary">
                <namePart>Molecular innovations to decode tauopathies at the nanoscale</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0898-875</identifier>
                <title>Dr Amandeep Kaur</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">CHEMICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medicinal and biomolecular chemistry</subject>
            <subject type="anzsrc-for">Biologically active molecules CHEMICAL SCIENCES</subject>
            <subject type="anzsrc-for">Analytical chemistry</subject>
            <subject type="anzsrc-for">Sensor technology (incl. chemical aspects)</subject>
            <subject type="local">molecular imaging</subject>
            <subject type="local">biosensor</subject>
            <subject type="local">neurodegeneration</subject>
            <subject type="local">fluorescence spectroscopy</subject>
            <subject type="local">alzheimer disease</subject>
            <description type="Chief Investigator Team">Dr Amandeep Kaur&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Proteins are the backbone of the biological world. As we age, some proteins misfold and accumulate in the brain causing devastating diseases like Alzheimer’s Disease. The fine details of how and why this happens are unknown. I plan to develop molecules that will allow us to 1) detect the identity and 2) see the molecular-level details of the misfolded proteins to unravel some of these mysteries. This research could lead to better diagnostics and effective treatments for Alzheimer’s Disease.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043354</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043354</identifier>
            <identifier type="nhmrc">2043354</identifier>
            <name type="primary">
                <namePart>EQUiP-Australia: Co-designing an Equitable Model of Care for Musculoskeletal pain in Australia</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9817-5372</identifier>
                <title>Dr Saurab Sharma</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02gs2e959</identifier>
                <title>Royal North Shore Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science</subject>
            <subject type="anzsrc-for">Physiotherapy HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Social determinants of health</subject>
            <subject type="local">low back pain</subject>
            <subject type="local">osteoarthritis</subject>
            <subject type="local">musculoskeletal disorders</subject>
            <subject type="local">equity</subject>
            <subject type="local">chronic pain</subject>
            <description type="Chief Investigator Team">Dr Saurab Sharma&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Culturally and Linguistically Diverse (CALD) consumers suffer health care disparities in Australia. EQUIP-Australia will use a 3-staged process to co-design culturally tailored guideline-recommended pain education programs for and with CALD Australians with musculoskeletal pain and test them in general practices across Australia. Newly developed interventions will support 5 million CALD people’s pain care needs to understand and self-manage their pain.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043356</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043356</identifier>
            <identifier type="nhmrc">2043356</identifier>
            <name type="primary">
                <namePart>Long-acting therapies to treat hypertension and organ injury</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5929-4387</identifier>
                <title>Prof Kate Denton</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical physiology</subject>
            <subject type="anzsrc-for">Systems physiology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Nephrology and urology</subject>
            <subject type="local">hypertension</subject>
            <subject type="local">sympathetic nerves</subject>
            <subject type="local">kidney</subject>
            <subject type="local">renin-angiotensin system (ras)</subject>
            <subject type="local">pregnancy</subject>
            <description type="Chief Investigator Team">Prof Kate Denton&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">New approaches for the treatment of hypertension are needed. In this program, "a short burst of treatment early in life," "a one-off treatment," or "periodic intermittent treatment" are being advanced with the potential to cause a seismic shift in the way hypertension is treated and, more importantly, controlled.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043357</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043357</identifier>
            <identifier type="nhmrc">2043357</identifier>
            <name type="primary">
                <namePart>Blood and bone: pathogenic leukocytes and acquired mutations within arthritic joints.</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9355-8027</identifier>
                <title>Dr Etienne Masle-Farquhar</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b3dvp57</identifier>
                <title>The Garvan Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Immunogenetics (incl. genetic immunology) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Rheumatology and arthritis</subject>
            <subject type="local">immune tolerance</subject>
            <subject type="local">cellular immunology</subject>
            <subject type="local">somatic mutation</subject>
            <subject type="local">arthritis</subject>
            <subject type="local">inflammatory cytokines</subject>
            <description type="Chief Investigator Team">Dr Etienne Masle-Farquhar&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">1 in 10 people develop arthritis. A major hurdle for effective treatments is distinguishing "Rogue" disease-causing cells from normal cells. To study arthritic joints, I have built a national network collecting clinical samples that are otherwise discarded in hospitals, from &gt;100 arthritis patients. I am applying cutting-edge methods, to identify and deeply interrogate immune cells that go "rogue" to drive flares and joint inflammation. Our knowledge gains will inform future targeted therapies.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043365</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043365</identifier>
            <identifier type="nhmrc">2043365</identifier>
            <name type="primary">
                <namePart>Nutritional Psychiatry: supporting healthy eating in pregnancy to benefit child mental and brain health</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-4701-1220</identifier>
                <title>Dr Samantha Dawson</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Nutrition and dietetics not elsewhere classified BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Psychiatry (incl. psychotherapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Infant and child health</subject>
            <subject type="local">maternal nutrition</subject>
            <subject type="local">microbiology</subject>
            <subject type="local">maternal mental health</subject>
            <subject type="local">infant mental health</subject>
            <subject type="local">randomised controlled trial (rct)</subject>
            <description type="Chief Investigator Team">Dr Samantha Dawson&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Poor diet quality in pregnancy is linked to perinatal depression, and both are linked to poorer mental and brain health in children. To help families lead healthier, happier lives, we need a better understanding of how diet during pregnancy affects child mental health and brain development. My research will generate critical knowledge to inform targeted prenatal dietary advice that can be easily implemented in pregnancy care, supporting better outcomes in families.</description>
            <description type="fundingAmount">$652,131.49</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043381</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043381</identifier>
            <identifier type="nhmrc">2043381</identifier>
            <name type="primary">
                <namePart>Advancing Implantable Medical Devices Through Nanotechnology</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9780-8844</identifier>
                <title>Assoc Prof Rona Chandrawati</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">ENGINEERING</subject>
            <subject type="anzsrc-for">Biomedical engineering</subject>
            <subject type="anzsrc-for">Biomaterials BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Industrial biotechnology</subject>
            <subject type="anzsrc-for">Nanobiotechnology</subject>
            <subject type="local">biomaterials</subject>
            <subject type="local">implants</subject>
            <subject type="local">drug delivery</subject>
            <subject type="local">nitric oxide</subject>
            <subject type="local">biotechnology</subject>
            <description type="Chief Investigator Team">Assoc Prof Rona Chandrawati&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Medical devices such as catheters and stents are critical for patient care worldwide, but they often fail due to blood clotting and bacterial infections. This project aims to improve the performance of these devices by developing innovative bioactive coatings that continuously generate nitric oxide, a potent molecule that prevents both blood clotting and infections. The outcome of this research will significantly reduce implant failures, leading to better patient outcomes.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043397</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043397</identifier>
            <identifier type="nhmrc">2043397</identifier>
            <name type="primary">
                <namePart>Innovating bacteriophage diagnostics and therapy to combat antimicrobial resistance: A cell-free synthetic biology approach</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Sue_Chin_Nang</identifier>
                <title>Dr Sue Chin Nang</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences not elsewhere classified</subject>
            <subject type="local">pharmacology</subject>
            <subject type="local">antimicrobial therapy</subject>
            <subject type="local">molecular biology</subject>
            <subject type="local">bacteriophage</subject>
            <subject type="local">bacterial infection</subject>
            <description type="Chief Investigator Team">Dr Sue Chin Nang&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Antibiotic-resistant bacteria are predicted to kill 10 million people annually by 2050. Bacteriophages (phages, bacteria-eating viruses) are a promising treatment option against these ‘superbugs’. However, phage therapy is in its infancy and its therapeutic potential is severely limited by inefficient phage production and a lack of pharmacological data. My project addresses these major knowledge gaps by developing a clinically adaptable phage therapy platform to treat ‘superbug’ infections.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043407</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043407</identifier>
            <identifier type="nhmrc">2043407</identifier>
            <name type="primary">
                <namePart>Decoding the Mechanisms of Signal Propagation through the Wnt Signaling Pathway</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Alisa_Glukhova</identifier>
                <title>Dr Alisa Glukhova</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Structural biology (incl. macromolecular modelling) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Basic pharmacology BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Biochemistry and cell biology</subject>
            <subject type="anzsrc-for">Signal transduction</subject>
            <subject type="local">wnt signalling</subject>
            <subject type="local">electron microscopy</subject>
            <subject type="local">g protein-coupled receptors</subject>
            <subject type="local">structural biology</subject>
            <subject type="local">pharmacology</subject>
            <description type="Chief Investigator Team">Dr Alisa Glukhova&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Cells sense and respond to a variety of stimuli by activating different signaling pathways. The Wnt pathway is important in embryonic development as it controls cell division and specialization. In adults, dysregulation of this pathway can lead to aberrant cell division and cancer. This proposal will use structural biology to look at several steps of this pathway at the molecular level. This will provide answers on how this pathway works and will lead to new ways to target it therapeutically.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043411</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043411</identifier>
            <identifier type="nhmrc">2043411</identifier>
            <name type="primary">
                <namePart>From Bedside to Bench: Improving Clinical Care Using Insights from the Small Intestinal Microbiome.</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0710-1691</identifier>
                <title>Dr Ayesha Shah</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04mqb0968</identifier>
                <title>Princess Alexandra Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Gastroenterology and hepatology</subject>
            <subject type="local">gastroenterology</subject>
            <subject type="local">clinical trial</subject>
            <subject type="local">small intestine</subject>
            <subject type="local">diagnostic methods</subject>
            <subject type="local">gastrointestinal disease</subject>
            <description type="Chief Investigator Team">Dr Ayesha Shah&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Small intestinal bacterial overgrowth (SIBO) is a condition where there are too many bacteria in the small intestine which can negatively impact many diseases. It is common in people with functional gut disorders (e.g. irritable bowel syndrome) causing similar symptoms. Current tests are unreliable, so treatment is often based on trial and error. My research aims to develop better techniques for diagnosing SIBO and create new therapies to modify the gut bacteria to treat or even eradicate SIBO.</description>
            <description type="fundingAmount">$250,000.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043417</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043417</identifier>
            <identifier type="nhmrc">2043417</identifier>
            <name type="primary">
                <namePart>Wearable and High-Sensitivity X-ray Detectors for Managing Respiratory Diseases in Infants and Children</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9139-9835</identifier>
                <title>Assoc Prof Jingwei Hou</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">ENGINEERING</subject>
            <subject type="anzsrc-for">Nanotechnology</subject>
            <subject type="anzsrc-for">Nanomaterials ENGINEERING</subject>
            <subject type="anzsrc-for">Nanotechnology</subject>
            <subject type="anzsrc-for">Nanoelectronics ENGINEERING</subject>
            <subject type="anzsrc-for">Materials engineering</subject>
            <subject type="anzsrc-for">Functional materials</subject>
            <subject type="local">nanotechnology</subject>
            <subject type="local">monitoring</subject>
            <subject type="local">medical imaging</subject>
            <subject type="local">imaging</subject>
            <subject type="local">diagnostic imaging</subject>
            <description type="Chief Investigator Team">Assoc Prof Jingwei Hou&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">X-ray imaging is the gold standard for diagnosing paediatric respiratory infections, but it carries significant risks, including high radiation exposure and discomfort during tomography. This project seeks to develop sensitive, flexible, and wearable X-ray detectors using my innovative hybrid quantum dot glass materials, featuring a record high light conversion efficiency. The new technology promises greater accuracy, enhanced comfort, and reduced risk for paediatric X-ray imaging.</description>
            <description type="fundingAmount">$1,623,700.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043452</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043452</identifier>
            <identifier type="nhmrc">2043452</identifier>
            <name type="primary">
                <namePart>Innovation to impact in cardiovascular disease prevention and healthcare</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Clara_Chow</identifier>
                <title>Prof Clara Chow</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases) HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care</subject>
            <subject type="local">cardiovascular disease prevention</subject>
            <subject type="local">health behaviours</subject>
            <subject type="local">hypertension</subject>
            <subject type="local">population health</subject>
            <subject type="local">health services</subject>
            <description type="Chief Investigator Team">Prof Clara Chow&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">CVD is the leading cause of mortality &amp; morbidity, yet there are large gaps in management. In the next 5 years, I aim to conduct large scale research studies on innovative interventions to prevent cardiovascular disease across 3 areas: 1) E-prevention for CVD, 2) Remote care for patients with implanted cardiac devices &amp; 3) Single pill ultra-low dose combination treatment for hypertension. The goal is to apply these innovations to transform how we deliver healthcare for the future.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043453</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043453</identifier>
            <identifier type="nhmrc">2043453</identifier>
            <name type="primary">
                <namePart>Novel methods for causal analyses of longitudinal data to inform interventions for improving health</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-8818-3125</identifier>
                <title>Prof Margarita Moreno-Betancur</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">MATHEMATICAL SCIENCES</subject>
            <subject type="anzsrc-for">Statistics</subject>
            <subject type="anzsrc-for">Biostatistics</subject>
            <subject type="local">biostatistics</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">epidemiological research methods</subject>
            <subject type="local">longitudinal study</subject>
            <subject type="local">data linkage</subject>
            <description type="Chief Investigator Team">Prof Margarita Moreno-Betancur&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Modern health research studies are enriched with data from various sources (e.g. biosamples) that could in principle provide key insights into disease causality. However, the analytical tools and expertise for realising this potential are lacking. This program aims to address these gaps by developing, disseminating, and applying novel data analysis methods, and building national biostatistical capacity. Outcomes will be urgently needed tools, expertise and new knowledge for improving health.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043464</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043464</identifier>
            <identifier type="nhmrc">2043464</identifier>
            <name type="primary">
                <namePart>Next-generation therapeutics for malaria designed using systems-based approaches</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7354-8817</identifier>
                <title>Prof Denise Doolan</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical microbiology</subject>
            <subject type="anzsrc-for">Medical parasitology</subject>
            <subject type="local">malaria</subject>
            <subject type="local">diagnostic</subject>
            <subject type="local">therapeutic target</subject>
            <subject type="local">systems biology</subject>
            <subject type="local">adaptive immunity</subject>
            <description type="Chief Investigator Team">Prof Denise Doolan&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This program aims to transform health with a system-based interdisciplinary approach to develop effective therapeutics against malaria that will save lives, enhance quality of life, and boost economic growth. It will generate knowledge to predict personalised immunity at the individual and population level, inform host-directed therapies, develop a T cell inducing vaccine from genomic sequence information, and provide a disease-agnostic framework for solutions to other complex diseases.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043504</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043504</identifier>
            <identifier type="nhmrc">2043504</identifier>
            <name type="primary">
                <namePart>Translating precision antibiotic dosing into better outcomes for severe infections</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6218-435X</identifier>
                <title>Prof Jason Roberts</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Clinical pharmacology and therapeutics BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Intensive care</subject>
            <subject type="local">bacterial infection</subject>
            <subject type="local">pharmacokinetics</subject>
            <subject type="local">critical care medicine</subject>
            <subject type="local">antimicrobial resistance</subject>
            <subject type="local">therapeutic drug monitoring</subject>
            <description type="Chief Investigator Team">Prof Jason Roberts&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Patients with severe infections are prone to antimicrobial failure caused by suboptimal drug dosing. My research program represents a game-changer with the use of precision antimicrobial dosing to rapidly kill the pathogen, based on both pathogen susceptibility and target drug concentrations (pharmacokinetics [PK]) in the patient. My VISION is to prevent AMR with precision antimicrobial dosing in infected patients and save lives</description>
            <description type="fundingAmount">$2,381,830.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043505</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043505</identifier>
            <identifier type="nhmrc">2043505</identifier>
            <name type="primary">
                <namePart>Connectomics approaches to understanding anxiety and depression</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Barry_Dickson</identifier>
                <title>Prof Barry Dickson</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Neurosciences</subject>
            <subject type="anzsrc-for">Central nervous system</subject>
            <subject type="local">brain</subject>
            <subject type="local">mouse models</subject>
            <subject type="local">neuron</subject>
            <subject type="local">synapse</subject>
            <subject type="local">anxiety</subject>
            <description type="Chief Investigator Team">Prof Barry Dickson&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The human brain connectome, the complete set of ~100 trillion synaptic connections between ~100 billion neurons, is constantly changing. Some changes are beneficial, allowing us to learn. Others are harmful, resulting in neuropsychiatric disorders. This project examines anxiety and depression as "connectopathies" caused by chronic stress. Using an innovative new method, it will chart how stress changes brain connectivity in animal models, and explain what makes females the more vulnerable sex.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043524</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043524</identifier>
            <identifier type="nhmrc">2043524</identifier>
            <name type="primary">
                <namePart>Strengthening Transparent Reporting and Improving Visibility and Equity for Aboriginal and Torres Strait Islander Health</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6233-3439</identifier>
                <title>Assoc Prof Kalinda Griffiths</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health informatics and information systems INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Other Indigenous data, methodologies and global Indigenous studies</subject>
            <subject type="anzsrc-for">Other Indigenous data, methodologies and global Indigenous studies not elsewhere classified INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander epidemiology</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">measurement</subject>
            <subject type="local">public health</subject>
            <subject type="local">health policy</subject>
            <subject type="local">international comparisons</subject>
            <description type="Chief Investigator Team">Assoc Prof Kalinda Griffiths&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This program aims to improve the quality, usability, and governance of Aboriginal and Torres Strait Islander health data in Australia to address health inequities. Aboriginal led, it focuses on data quality, governance, workforce development, and health measurement. The program will empower Indigenous communities to control their data and train researchers to support culturally responsive practices, ultimately enhancing the health and wellbeing of Aboriginal and Torres Strait Islander people.</description>
            <description type="fundingAmount">$1,634,700.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043525</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043525</identifier>
            <identifier type="nhmrc">2043525</identifier>
            <name type="primary">
                <namePart>Diet for food allergy prevention</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-8412-5657</identifier>
                <title>Dr Victoria Soriano</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiology not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified</subject>
            <subject type="local">infant feeding</subject>
            <subject type="local">public health impact</subject>
            <subject type="local">infant nutrition</subject>
            <subject type="local">allergy prevention</subject>
            <subject type="local">epidemiology</subject>
            <description type="Chief Investigator Team">Dr Victoria Soriano&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">My research builds on an internationally recognised platform of studies that seek to prevent and understand the epidemiology of food allergy. One in 10 Australian infants are at risk of life-threatening anaphylaxis. My research project will examine the link between infant diet and food allergy. My research aims to understand and address these gaps and develop more effective strategies to reduce the prevalence of food allergies across all populations in Australia and propose equitable solutions.</description>
            <description type="fundingAmount">$688,405.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043549</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043549</identifier>
            <identifier type="nhmrc">2043549</identifier>
            <name type="primary">
                <namePart>Epidemiology, evolution and prevention of streptococcal pandemics</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6141-5179</identifier>
                <title>Assoc Prof Mark Davies</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Genomics and transcriptomics HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Disease surveillance BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Microbial genetics</subject>
            <subject type="local">bacterial population biology</subject>
            <subject type="local">group a streptococcal disease</subject>
            <subject type="local">comparative genomics</subject>
            <subject type="local">streptococcal disease</subject>
            <subject type="local">bacterial evolution</subject>
            <description type="Chief Investigator Team">Assoc Prof Mark Davies&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Group A Streptococcus (GAS) is a human bacterial pathogen that is one of the Top 10 infectious disease killers worldwide. My research program will apply genome sequencing approaches to improve health outcomes by tracking the spread of scarlet fever and invasive disease outbreaks, developing new diagnostic tools for improved detection of pandemic GAS strains, and expedite vaccine development of GAS infections globally, with a focus on low-middle income settings where disease burden is highest.</description>
            <description type="fundingAmount">$2,818,905.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043554</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043554</identifier>
            <identifier type="nhmrc">2043554</identifier>
            <name type="primary">
                <namePart>Enhancing Reproductive Health by New Evidence-synthesis Methods based on Trustworthiness Assessment</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8337-550X</identifier>
                <title>Prof Ben Willem Mol</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Reproductive medicine</subject>
            <subject type="anzsrc-for">Foetal development and medicine</subject>
            <subject type="local">randomised controlled trial (rct)</subject>
            <subject type="local">obstetrics</subject>
            <subject type="local">meta-analysis</subject>
            <subject type="local">in vitro fertilisation (ivf)</subject>
            <subject type="local">infertility</subject>
            <description type="Chief Investigator Team">Prof Ben Willem Mol&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Clinical guidelines rely on trustworthy data. I have revealed that 25% of Randomised Clinical Trials (RCTs) in women’s health are untrustworthy. As a world first I developed methods to detect such problematic RCTs. This Fellowship aims to apply these novel methods, applicable to other disciplines, on existing reproductive health literature, and update it with my ongoing RCTs. This will ensure patient care is based on reliable evidence and create better outcomes for women and babies.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043588</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043588</identifier>
            <identifier type="nhmrc">2043588</identifier>
            <name type="primary">
                <namePart>Immunotherapy for type 1 diabetes</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Thomas_Kay</identifier>
                <title>Prof Thomas Kay</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/52004705640</identifier>
                <title>St Vincent's Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/52004705640</identifier>
                <title>St Vincent's Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Autoimmunity</subject>
            <subject type="local">type 1 diabetes mellitus (insulin-dependent diabetes mellitus)</subject>
            <subject type="local">clinical research</subject>
            <subject type="local">immunotherapy</subject>
            <subject type="local">autoimmunity</subject>
            <subject type="local">t cell response</subject>
            <description type="Chief Investigator Team">Prof Thomas Kay&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Type 1 diabetes (T1D) is a common autoimmune disease with onset usually in childhood or young adulthood that has been treated with insulin for over 100 years. Insulin is not a cure and T1D treatment remains burdensome. The recent development of numerous drugs that affect the immune system means that the treatment of T1D is poised to be transformed. My VISION is to challenge insulin replacement therapy by implementing disease-modifying immunotherapies to improve outcomes for those with T1D.</description>
            <description type="fundingAmount">$3,014,025.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043598</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043598</identifier>
            <identifier type="nhmrc">2043598</identifier>
            <name type="primary">
                <namePart>Harnessing MAIT cell biology and therapeutics to improve immunotherapy</namePart>
            </name>
            <name type="alternative">
                <namePart>Investigator Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7020</identifier>
                <title>2025 Investigator Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3236-9609</identifier>
                <title>Dr Hui-Fern Koay</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Basic Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Cellular immunology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)</subject>
            <subject type="local">t cell immunotherapy</subject>
            <subject type="local">t cell activation</subject>
            <subject type="local">t cell immunity</subject>
            <subject type="local">t cell response</subject>
            <subject type="local">therapeutic antibodies</subject>
            <description type="Chief Investigator Team">Dr Hui-Fern Koay&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-24T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">There is great potential for MAIT cells to overcome current obstacles impeding conventional T cell immunotherapies, where their biology can be exploited to target tumours in a safe, universal manner unrestricted by donor and recipient mismatch. This program combines our ongoing knowledge, data and expertise on MAIT cell biology and therapeutics engineering to generate novel, efficacious MAIT cell therapies to combat cancer.</description>
            <description type="fundingAmount">$1,423,700.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2026-01-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-12-31T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040733</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040733</identifier>
            <identifier type="nhmrc">2040733</identifier>
            <name type="primary">
                <namePart>REBUILD: Reducing the Burden of Healthcare Associated Infection Using a Learning Health Systems Approach</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5406-9519</identifier>
                <title>Dr Jessica Schults</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03pnv4752</identifier>
                <title>Queensland University of Technology</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00c1dt378</identifier>
                <title>Queensland Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/18496277942</identifier>
                <title>Metro North Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02sc3r913</identifier>
                <title>Griffith University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health surveillance HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Nursing</subject>
            <subject type="anzsrc-for">Acute care BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases</subject>
            <subject type="local">infection control</subject>
            <subject type="local">surveillance</subject>
            <subject type="local">bacterial infection</subject>
            <subject type="local">acute care</subject>
            <subject type="local">consumer participation</subject>
            <description type="Chief Investigator Team">Dr Jessica Schults&lt;br/&gt;Prof Claire Rickard&lt;br/&gt;Dr Sally Havers&lt;br/&gt;Prof Philip Russo&lt;br/&gt;Belinda Henderson&lt;br/&gt;Prof Joshua Byrnes&lt;br/&gt;Mrs Sarah Smith&lt;br/&gt;Prof Lisa Hall&lt;br/&gt;Prof Clair Sullivan&lt;br/&gt;Assoc Prof Nicole White&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United States of America&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">1 in 10 people admitted to hospital develop an infection as a complication of their healthcare. These infections lead to significant patient suffering and unnecessary deaths. Current methods for infection prevention and control are complex, inefficient and costly. In partnership with Queensland Health services and patients, we will develop state-of-the-art systems and knowledge translation solutions that inform infection control programs and combat rising infection associated death rates.</description>
            <description type="fundingAmount">$999,040.80</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042073</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042073</identifier>
            <identifier type="nhmrc">2042073</identifier>
            <name type="primary">
                <namePart>Addressing the health needs of Tasmania: The Tasmanian Collaboration for Health Improvement (TCHI)</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Assoc_Prof_Dawn_Aitken</identifier>
                <title>Assoc Prof Dawn Aitken</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01nfmeh72</identifier>
                <title>University of Tasmania</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/47082572629</identifier>
                <title>Primary Health Tasmania</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/15359196040</identifier>
                <title>Tasmanian Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/11255872006</identifier>
                <title>Department of Health TAS</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01nfmeh72</identifier>
                <title>University of Tasmania</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Primary health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems</subject>
            <subject type="local">collaboration</subject>
            <subject type="local">implementation</subject>
            <subject type="local">health systems</subject>
            <subject type="local">primary care</subject>
            <subject type="local">health</subject>
            <description type="Chief Investigator Team">Assoc Prof Dawn Aitken&lt;br/&gt;Assoc Prof Dinesh Arya&lt;br/&gt;Ms Susan Powell&lt;br/&gt;Prof James Sharman&lt;br/&gt;Prof Tania Winzenberg&lt;br/&gt;Assoc Prof Viet Tran&lt;br/&gt;Assoc Prof Jennifer Evans&lt;br/&gt;Miss Belinda Donovan&lt;br/&gt;Dr Andrew Ridge&lt;br/&gt;Prof Janette Radford&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Tasmania has the most rapidly ageing population in Australia and some of the poorest health outcomes of any Australian state or territory. The Tasmanian Collaboration for Health Improvement (TCHI) is a partnership between the Tasmanian Department of Health and Tasmanian Health Services, the University of Tasmania, Primary Health Tasmania and Health Consumers Tasmania. Together, five priority projects have been co-developed to address the health needs and regional health challenges in Tasmania.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">TAS</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042403</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042403</identifier>
            <identifier type="nhmrc">2042403</identifier>
            <name type="primary">
                <namePart>SHIELD: Surveillance of Healthcare-associated Infections for Effective Local Data</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2049-3087</identifier>
                <title>Dr N Deborah Friedman</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02r276210</identifier>
                <title>Avondale University Limited</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04z4kmw33</identifier>
                <title>Melbourne Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health surveillance HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health informatics and information systems HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health services and systems not elsewhere classified</subject>
            <subject type="local">bacterial infection</subject>
            <subject type="local">health surveillance</subject>
            <subject type="local">antimicrobial therapy</subject>
            <subject type="local">electronic health information</subject>
            <subject type="local">patient outcomes</subject>
            <description type="Chief Investigator Team">Dr N Deborah Friedman&lt;br/&gt;Prof Allen Cheng&lt;br/&gt;Assoc Prof Leon Worth&lt;br/&gt;Dr Michael Lydeamore&lt;br/&gt;Assoc Prof Noleen Bennett&lt;br/&gt;Assoc Prof Daniel Capurro&lt;br/&gt;Assoc Prof Stephane Bouchoucha&lt;br/&gt;Dr Courtney IERANO&lt;br/&gt;Ms Stephanie Curtis&lt;br/&gt;Mr Keith Donohoe&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Infections that develop in patients when they are receiving healthcare are called healthcare-associated infections (HAIs). They occur in about 10% of Australian patients and are responsible for serious illness and sometimes death. Continuous surveillance that measures all HAIs in a hospital is too time-consuming to do continuously, and therefore this study would count all HAIs in several Victorian hospitals at a particular time, providing important information about how best to prevent them.</description>
            <description type="fundingAmount">$952,655.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042767</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042767</identifier>
            <identifier type="nhmrc">2042767</identifier>
            <name type="primary">
                <namePart>Working to the TOP-of-Scope of Registered Nurses Practice to Enhance Community Access to Essential MEDicines (TOP-MED study)</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-4947-339X</identifier>
                <title>Assoc Prof Amanda Fox</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03pnv4752</identifier>
                <title>Queensland University of Technology</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03pnv4752</identifier>
                <title>Queensland University of Technology</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Nursing</subject>
            <subject type="anzsrc-for">Nursing not elsewhere classified</subject>
            <subject type="local">access to health care</subject>
            <subject type="local">prescribing</subject>
            <subject type="local">health service accessibility</subject>
            <subject type="local">equity</subject>
            <subject type="local">rural and remote health services</subject>
            <description type="Chief Investigator Team">Assoc Prof Amanda Fox&lt;br/&gt;Prof Frances Fengzhi Lin&lt;br/&gt;Prof Patsy Yates&lt;br/&gt;Prof Raymond Chan&lt;br/&gt;Prof Steven McPhail&lt;br/&gt;Dr Suzanne Williams&lt;br/&gt;Assoc Prof Carolyn Ee&lt;br/&gt;Assoc Prof Shelley Nowlan&lt;br/&gt;Jennifer Hurley&lt;br/&gt;Jessica Taylor&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This research, consists of five projects that aim to support implementation of practices that enable RN prescribing under certain conditions. Governments are introducing policies to enable this practice to improve medicine access across communities. We will partner with consumers, nurses, medical practitioners and governments to co-design an implementation model for RN prescribing in metropolitan and rural and remote health settings and, provide a preliminary economic evaluation of the model.</description>
            <description type="fundingAmount">$999,588.60</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042799</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042799</identifier>
            <identifier type="nhmrc">2042799</identifier>
            <name type="primary">
                <namePart>Strengthening PLace-based health services research collaboration and capacity in Mparntwe (Alice Springs): an important strategy to close the gap in Health outcomes (SPLASH)!</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2221-7334</identifier>
                <title>Assoc Prof Deborah Russell</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/76210591710</identifier>
                <title>Central Australian Aboriginal Congress Aboriginal Corporation</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/021ctjg87</identifier>
                <title>Northern Territory Department of Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/76210591710</identifier>
                <title>Researcherenye Wappayalawangka-Central Australia Academic Health Science Network</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/17158970480</identifier>
                <title>Northern Territory Primary Health Network</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Rural and remote health services</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">rural and remote health services</subject>
            <subject type="local">capacity building</subject>
            <subject type="local">health systems</subject>
            <subject type="local">health services research</subject>
            <description type="Chief Investigator Team">Assoc Prof Deborah Russell&lt;br/&gt;Dr Richard Johnson&lt;br/&gt;Mrs Rebecca Schultz&lt;br/&gt;Ms Donna Lemon&lt;br/&gt;Assoc Prof Alexandra Edelman&lt;br/&gt;Prof John Wakerman&lt;br/&gt;Dr Paul Secombe&lt;br/&gt;Assoc Prof Supriya Mathew&lt;br/&gt;Dr Prabhakar Veginadu&lt;br/&gt;Katherine Coulthard&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">SPLASH will increase research capability in Central Australia and produce health systems research tailored to the needs and experiences of local Aboriginal peoples which is essential for health and wellbeing. SPLASH tackles five key issues: improving hospital discharge, emergency department triage, and ICU patient experiences and outcomes and better understanding barriers to continuous glucose monitoring following kidney transplant and bleeding complications after tooth extraction.</description>
            <description type="fundingAmount">$999,919.50</description>
            <coverage>
                <spatial type="text">NT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043704</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043704</identifier>
            <identifier type="nhmrc">2043704</identifier>
            <name type="primary">
                <namePart>Paediatric Post Sepsis Care: Enhancing Research Innovation and Health Outcomes through Partnerships and Translation.</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0984-9559</identifier>
                <title>Prof Deborah Long</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03pnv4752</identifier>
                <title>Queensland University of Technology</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03pnv4752</identifier>
                <title>Queensland University of Technology</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/023331s46</identifier>
                <title>The George Institute for Global Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00be8mn93</identifier>
                <title>Children's Health Queensland Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health services and systems not elsewhere classified HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science</subject>
            <subject type="anzsrc-for">Rehabilitation HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Nursing</subject>
            <subject type="anzsrc-for">Nursing not elsewhere classified</subject>
            <subject type="local">sepsis</subject>
            <subject type="local">follow-up</subject>
            <subject type="local">paediatric</subject>
            <subject type="local">implementation</subject>
            <subject type="local">primary care</subject>
            <description type="Chief Investigator Team">Prof Deborah Long&lt;br/&gt;Assoc Prof Naomi Hammond&lt;br/&gt;Assoc Prof Adam Irwin&lt;br/&gt;Prof Kristen Gibbons&lt;br/&gt;Prof Bala Venkatesh&lt;br/&gt;Ms Mary Steele&lt;br/&gt;Mrs Dawn Foster&lt;br/&gt;Assoc Prof Zephanie Tyack&lt;br/&gt;Dr Hannah Carter&lt;br/&gt;Dr Sainath Raman&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Survivors of paediatric sepsis often develop new morbidities and deterioration in quality of life after sepsis, leading to a need for improved follow-up for children who survive sepsis and their families. Bereaved families also need ongoing support. This research will transform the way in which paediatric post-sepsis follow-up services are delivered by co-designing, developing and tailoring care plans, primary health clinician guidelines, and prioritising outcomes and reporting.</description>
            <description type="fundingAmount">$999,456.60</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043753</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043753</identifier>
            <identifier type="nhmrc">2043753</identifier>
            <name type="primary">
                <namePart>BRIDGE - Building Rural medication safety through Interdisciplinary, Data-driven, clinical Governance focused on Equity</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1322-1895</identifier>
                <title>Prof Lucie Walters</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01p93h210</identifier>
                <title>University of South Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Pharmacology and pharmaceutical sciences</subject>
            <subject type="anzsrc-for">Clinical pharmacy and pharmacy practice HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Rural and remote health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health informatics and information systems</subject>
            <subject type="local">rural and remote health services</subject>
            <subject type="local">health informatics</subject>
            <subject type="local">hospitals</subject>
            <subject type="local">primary care</subject>
            <subject type="local">adverse drug reactions</subject>
            <description type="Chief Investigator Team">Prof Lucie Walters&lt;br/&gt;Assoc Prof David Gonzalez-Chica&lt;br/&gt;Dr Simon Lockwood&lt;br/&gt;Dr Lindy Washington&lt;br/&gt;Miss Antoinette Liddell&lt;br/&gt;Mr Kym Thomas&lt;br/&gt;Mr Joel Taggart&lt;br/&gt;Prof Elizabeth Roughead&lt;br/&gt;Assoc Prof Elizabeth Hoon&lt;br/&gt;Dr Carla Bernardo&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United Kingdom&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Medications can sometimes cause serious problems, like ending up in hospital or even death. People living in rural and deprived areas are more vulnerable to these problems. We aim to work with rural consumers and healthcare providers to develop a new computer support tool that will help health professionals find people who might be at risk because of their medicines. Then, doctors, nurses, and pharmacists can check these medications and make necessary changes to keep rural Australians safe.</description>
            <description type="fundingAmount">$999,556.80</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043931</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043931</identifier>
            <identifier type="nhmrc">2043931</identifier>
            <name type="primary">
                <namePart>Boosting collaborative research translation for healthier north Queenslanders: the TAAHC Accelerator</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7561-3202</identifier>
                <title>Prof Sarah Larkins</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04gsp2c11</identifier>
                <title>James Cook University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/25285907786</identifier>
                <title>Cairns and Hinterland Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/60821496581</identifier>
                <title>Torres and Cape Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/86747187217</identifier>
                <title>Townsville Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/15010112580</identifier>
                <title>Wuchopperen Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/52633876936</identifier>
                <title>Tropical Australian Academic Health Centre Limited</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Rural and remote health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health services</subject>
            <subject type="local">health services research</subject>
            <subject type="local">indigenous health</subject>
            <subject type="local">rural and remote health services</subject>
            <subject type="local">rural workforce</subject>
            <subject type="local">capacity building</subject>
            <description type="Chief Investigator Team">Prof Sarah Larkins&lt;br/&gt;Prof Edward Strivens&lt;br/&gt;Prof Jonathan Golledge&lt;br/&gt;Prof Andrew Mallett&lt;br/&gt;Assoc Prof Rae Thomas&lt;br/&gt;Ms Tara Watters&lt;br/&gt;Rosh Samuel&lt;br/&gt;Mrs Larissa Brown&lt;br/&gt;Dr Jennifer Mann&lt;br/&gt;Nicolette Roux&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This grant brings together health service partners and consumers across north Queensland to progress better care closer to home in diabetes, kidney care, rheumatic heart disease, dementia and babies with heart disease. We will strengthen the ability to apply best practice in north Queensland contexts and improve the ability of health service researchers and consumers to work together for better health care.</description>
            <description type="fundingAmount">$995,582.26</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043966</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043966</identifier>
            <identifier type="nhmrc">2043966</identifier>
            <name type="primary">
                <namePart>Leaky Legs - Leg Edema Assessment and Knowledge Yield in Leg Edema and Gait Study</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0318-3936</identifier>
                <title>Prof Keryln Carville</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n415q13</identifier>
                <title>Curtin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n415q13</identifier>
                <title>Curtin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/77119417018</identifier>
                <title>Silverchain</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05jhnwe22</identifier>
                <title>Edith Cowan University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00zc2xc51</identifier>
                <title>Royal Perth Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01hhqsm59</identifier>
                <title>Sir Charles Gairdner Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Clinical nutrition HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Nursing</subject>
            <subject type="anzsrc-for">Community and primary care</subject>
            <subject type="local">wounds</subject>
            <subject type="local">delayed wound repair</subject>
            <subject type="local">oedema</subject>
            <subject type="local">community care</subject>
            <subject type="local">aged health</subject>
            <description type="Chief Investigator Team">Prof Keryln Carville&lt;br/&gt;Prof Karen Smith&lt;br/&gt;Prof Shirley Jansen&lt;br/&gt;Prof Joshua Lewis&lt;br/&gt;Dr Sharon Boxall&lt;br/&gt;Helena Jakupovic&lt;br/&gt;Dr Liezhou Zhong&lt;br/&gt;Dr Sharmani Barnard&lt;br/&gt;Vicki Patton&lt;br/&gt;Ms Joanna Smith&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Patients with venous leg ulcers suffer from prolonged healing times and poor quality of life. We will conduct 6 projects within a community healthcare service, providing evidence to an innovative model of care for VLU patients. The projects will cover the development of a VLU specific co-morbidity index, investigation into the optimal compression for treatment, patient concordance with compression therapy, gait improvement, nutritional therapies and validation of symptoms of wound infection.</description>
            <description type="fundingAmount">$999,802.50</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043973</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043973</identifier>
            <identifier type="nhmrc">2043973</identifier>
            <name type="primary">
                <namePart>Enhancing Acute Coronary Syndrome (ACS) Clinical Pathway Use in Emergency Departments</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-1565-4130</identifier>
                <title>Dr Claire Seaman</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00wfvh315</identifier>
                <title>Charles Sturt University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/71172428618</identifier>
                <title>Murrumbidgee Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/89809648636</identifier>
                <title>Agency for Clinical Innovation</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00wfvh315</identifier>
                <title>Charles Sturt University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Rural and remote health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Nursing</subject>
            <subject type="anzsrc-for">Acute care</subject>
            <subject type="local">clinical practice guidelines</subject>
            <subject type="local">cardiovascular disease</subject>
            <subject type="local">rural and remote health services</subject>
            <subject type="local">health information management</subject>
            <subject type="local">emergency medicine</subject>
            <description type="Chief Investigator Team">Dr Claire Seaman&lt;br/&gt;Mrs Cindy Earl&lt;br/&gt;Ms Penelope Patterson&lt;br/&gt;Dr Elyce Green&lt;br/&gt;Ms Lucinda Derrick&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">When patients present to emergency departments with a suspected heart attack (acute coronary syndrome (ACS)), administering the right interventions quickly is vital. Clinical pathways guide clinicians on what to do and are considered best-practice, however, ACS Pathway use is known to be low. This study aims to understand why this is and what can be done to improve its use to support appropriate and timely healthcare for ACS patients, with a focus on the unique characteristics of rural services.</description>
            <description type="fundingAmount">$252,071.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043995</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043995</identifier>
            <identifier type="nhmrc">2043995</identifier>
            <name type="primary">
                <namePart>The Communicate Study Partnership: supporting culturally safe healthcare across the Northern Territory</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6863-1528</identifier>
                <title>Dr Victoria Kerrigan</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health services and systems not elsewhere classified</subject>
            <subject type="local">communication</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">doctor-patient interaction</subject>
            <subject type="local">patient/doctor communication</subject>
            <subject type="local">clinical competence / skills</subject>
            <description type="Chief Investigator Team">Dr Victoria Kerrigan&lt;br/&gt;Jeremy Chin&lt;br/&gt;Camille Lew Fatt&lt;br/&gt;Prof Anna Ralph&lt;br/&gt;Ms Rarrtjiwuy Melanie Herdman&lt;br/&gt;Pirrawayingi Puruntatameri&lt;br/&gt;Nathan Warren&lt;br/&gt;Patricia Paterson&lt;br/&gt;Kelly Clark&lt;br/&gt;Verity Powell&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">The goal of the Communicate Study Partnership is to improve cultural safety in healthcare for First Nations peoples. In partnership with NT Health, other government services and community organisations, the program has transformed healthcare delivery through cultural safety training and improved interpreter access. A new collaborative health systems grant will expand efforts in five areas, addressing ongoing demand for culturally safe care, workforce training, and improved patient experience.</description>
            <description type="fundingAmount">$993,939.42</description>
            <coverage>
                <spatial type="text">NT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044007</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044007</identifier>
            <identifier type="nhmrc">2044007</identifier>
            <name type="primary">
                <namePart>Artificial Intelligence in Medical Imaging: Ensuring sustainable implementation</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0374-0026</identifier>
                <title>Prof Paula Brough</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02sc3r913</identifier>
                <title>Griffith University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04zt8gw89</identifier>
                <title>Gold Coast Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02sc3r913</identifier>
                <title>Griffith University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">COMMERCE, MANAGEMENT, TOURISM AND SERVICES</subject>
            <subject type="anzsrc-for">Human resources and industrial relations</subject>
            <subject type="anzsrc-for">Human resources management COMMERCE, MANAGEMENT, TOURISM AND SERVICES</subject>
            <subject type="anzsrc-for">Human resources and industrial relations</subject>
            <subject type="anzsrc-for">Workforce planning COMMERCE, MANAGEMENT, TOURISM AND SERVICES</subject>
            <subject type="anzsrc-for">Human resources and industrial relations</subject>
            <subject type="anzsrc-for">Workplace wellbeing and quality of working life</subject>
            <subject type="local">artificial intelligence</subject>
            <subject type="local">diagnostic imaging</subject>
            <subject type="local">health systems</subject>
            <subject type="local">health service management</subject>
            <subject type="local">workplace</subject>
            <description type="Chief Investigator Team">Prof Paula Brough&lt;br/&gt;Salim Memon&lt;br/&gt;Ashlea Troth&lt;br/&gt;Prof Paul Scuffham&lt;br/&gt;Jennifer Loy&lt;br/&gt;Luke Houghton&lt;br/&gt;Dr Rachael Smithson&lt;br/&gt;Letisha Living&lt;br/&gt;Maria Khan&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The acute shortage of radiologists within the Queensland public health system, has produced an urgent need for a refinement to their role, to increase the speed and accuracy of their diagnoses. The use of Artificial Intelligence (AI) to assist radiologists with their diagnoses of medical images has proven to be viable and highly advantageous. This project trials the first implementation of an AI medical imaging diagnostic system within a Queensland public healthcare service.</description>
            <description type="fundingAmount">$999,023.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044008</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044008</identifier>
            <identifier type="nhmrc">2044008</identifier>
            <name type="primary">
                <namePart>Health services in the spaces that matter most: Cross-sector collaborations in the provision of health services for young children and their families who experience disadvantage</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7812-8077</identifier>
                <title>Prof Rebekah Grace</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03t52dk35</identifier>
                <title>Western Sydney University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03f0f6041</identifier>
                <title>University of Technology Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03t52dk35</identifier>
                <title>Western Sydney University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Social determinants of health HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science</subject>
            <subject type="anzsrc-for">Speech pathology HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Nursing</subject>
            <subject type="anzsrc-for">Community and primary care</subject>
            <subject type="local">early childhood</subject>
            <subject type="local">social determinants of health</subject>
            <subject type="local">family care</subject>
            <subject type="local">collaboration</subject>
            <subject type="local">social disadvantage</subject>
            <description type="Chief Investigator Team">Prof Rebekah Grace&lt;br/&gt;Prof Lynn Kemp&lt;br/&gt;Assoc Prof Elise Baker&lt;br/&gt;Assoc Prof Shanti Raman&lt;br/&gt;Dr Nicole Peel&lt;br/&gt;Dr Kate Short&lt;br/&gt;Prof Stacy Blythe&lt;br/&gt;Dr Betty Luu&lt;br/&gt;Dr Elisabeth Duursma&lt;br/&gt;Ms Amanda Haslem&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">We know that families who experience adversity are more likely to engage with health services delivered in places that are comfortable for them, and they value collaboration between service professionals. Our research will explore five different initiatives, all delivered in home and community settings, and all working in integrated ways with other service systems. Collectively they will inform understanding of the mechanisms that best support place-based and integrated models of care.</description>
            <description type="fundingAmount">$951,799.40</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044028</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044028</identifier>
            <identifier type="nhmrc">2044028</identifier>
            <name type="primary">
                <namePart>Translating clinical evidence to improved outcomes for people with substance use disorders</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8915-8872</identifier>
                <title>Prof Paul Haber</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/050b31k83</identifier>
                <title>Hunter New England Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/000ed3w25</identifier>
                <title>St Vincent's Hospital Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04w6y2z35</identifier>
                <title>Sydney Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03w28pb62</identifier>
                <title>South Eastern Sydney Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation</subject>
            <subject type="local">translational research</subject>
            <subject type="local">substance use disorders</subject>
            <subject type="local">addiction treatment</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">access to health care</subject>
            <description type="Chief Investigator Team">Prof Paul Haber&lt;br/&gt;Prof Adrian Dunlop&lt;br/&gt;Assoc Prof Michael Doyle&lt;br/&gt;Dr Mary Ellen Harrod&lt;br/&gt;Prof Nicholas Lintzeris&lt;br/&gt;Dr Karen Waller&lt;br/&gt;Prof Nadine Ezard&lt;br/&gt;Prof Kirsten Morley&lt;br/&gt;Dr Bethany White&lt;br/&gt;Dr Eva Louie&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Substance use disorders have a major impact on the health of Australians, particularly in the most productive period of life. Some interventions that clearly make a difference are not widely implemented. This project will expand effective treatment for hepatitis C, will expand the naloxone program to prevent overdose, improve treatment for alcohol related liver disease, work to reduce length of hospital stay for treatment of withdrawal, and keep people in opioid treatment after leaving custody.</description>
            <description type="fundingAmount">$984,831.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044066</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044066</identifier>
            <identifier type="nhmrc">2044066</identifier>
            <name type="primary">
                <namePart>Community informed implementation of the What Matters 2 Adults wellbeing measure into chronic care services in an urban health service for Aboriginal and Torres Strait Islander health consumers.</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0713-7803</identifier>
                <title>Prof Michelle Dickson</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04w6y2z35</identifier>
                <title>Sydney Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Mental health services INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander public health and wellbeing INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health services</subject>
            <subject type="local">health services research</subject>
            <subject type="local">indigenous health</subject>
            <subject type="local">aboriginal mental health</subject>
            <subject type="local">implementation</subject>
            <subject type="local">community-based</subject>
            <description type="Chief Investigator Team">Prof Michelle Dickson&lt;br/&gt;Mrs Amy Traeger&lt;br/&gt;Prof Gail Garvey&lt;br/&gt;Prof Kirsten Howard&lt;br/&gt;Mrs Candace Angelo&lt;br/&gt;Assoc Prof Fiona Stanaway&lt;br/&gt;Dr Shanshan Lin&lt;br/&gt;Mrs Louise Brown&lt;br/&gt;Mr Anthony Nicholls&lt;br/&gt;Ms Matilde Petersen&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">We will implement the What Matters 2 Adults measure (WM2Adults), with the Sydney Local Health District Aboriginal complex and chronic care services. Guided by strong consumer and service staff voices, we seek to determine the best way of using WM2Adults in clinical care to measure and address patients’ wellbeing needs. This project will guideevidence-based implementation of WM2Adults, a wellbeing measure grounded in the values and preferences of Aboriginal and Torres Strait Islander people.</description>
            <description type="fundingAmount">$999,751.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044089</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044089</identifier>
            <identifier type="nhmrc">2044089</identifier>
            <name type="primary">
                <namePart>Healthcare Environmental Sustainability: Creating the evidence to drive adoption of high value initiatives in Australian Hospitals</namePart>
            </name>
            <name type="alternative">
                <namePart>Collaborations in Health Services Research</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6986</identifier>
                <title>2024 Collaborations in Health Services Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-1977-9072</identifier>
                <title>Assoc Prof Forbes McGain</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02p4mwa83</identifier>
                <title>Western Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04z4kmw33</identifier>
                <title>Melbourne Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/051wnqr14</identifier>
                <title>Department of Defence</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/74410330756</identifier>
                <title>Department of Health VIC</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02swcnz29</identifier>
                <title>Department of Health and Aged Care</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03tb4gf50</identifier>
                <title>NSW Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05dbj6g52</identifier>
                <title>Austin Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems</subject>
            <subject type="local">health care delivery</subject>
            <subject type="local">health economics</subject>
            <subject type="local">environment</subject>
            <subject type="local">health service utilisation</subject>
            <subject type="local">implementation</subject>
            <description type="Chief Investigator Team">Assoc Prof Forbes McGain&lt;br/&gt;Assoc Prof Stephanie Best&lt;br/&gt;Prof Kirsty Buising&lt;br/&gt;Dr Alisa Higgins&lt;br/&gt;Dr Rebecca Patrick&lt;br/&gt;Prof Jason Monty&lt;br/&gt;Assoc Prof Marion Kainer&lt;br/&gt;Dr Scott McAlister&lt;br/&gt;Prof Richard Sinnott&lt;br/&gt;Ms Caroline Walshe&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-02-26T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Healthcare is a complex, expensive industry that contrubutes to carbon emissions, pollution and waste. Budget constraints and legal requirements to transition to low carbon systems are driving the need for healthcare systems to change. Our research will provide evidence to guide strategies to reduce low value, wasteful hospital activities in operating rooms and hospital wards, while maintaining safe high quality patient care.</description>
            <description type="fundingAmount">$995,919.80</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041832</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041832</identifier>
            <identifier type="nhmrc">2041832</identifier>
            <name type="primary">
                <namePart>The Prison Outcomes STudy (POST): Using data linkage to quantify and optimise the effect of post-release health care on health and social outcomes in people released from incarceration</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Louisa_Degenhardt</identifier>
                <title>Prof Louisa Degenhardt</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Forensic epidemiology HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health services and systems not elsewhere classified</subject>
            <subject type="local">opioid dependence</subject>
            <subject type="local">mortality</subject>
            <subject type="local">morbidity</subject>
            <subject type="local">mental health services</subject>
            <subject type="local">prison population</subject>
            <description type="Chief Investigator Team">Prof Louisa Degenhardt&lt;br/&gt;Dr Thomas Santo Jr&lt;br/&gt;Prof Michael Farrell&lt;br/&gt;Assoc Prof Michael Doyle&lt;br/&gt;Assoc Prof Jack Stone&lt;br/&gt;Dr Chrianna Bharat&lt;br/&gt;Prof Matthew Hickman&lt;br/&gt;Dr Marianne Martinello&lt;br/&gt;Dr Don Weatherburn&lt;br/&gt;Prof Kimberlie Dean&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">People who leave prison frequently encounter serious health and social difficulties related to mental health and drug use. Our project will provide world-first data on the effects of interventions to address these issues, and provide specific data on the impacts for women and First Nations people. We will demonstrate the potential impact of making sure that more people are connected to mental health and substance use treatments most effective for them after their release.</description>
            <description type="fundingAmount">$2,237,881.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2041836</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2041836</identifier>
            <identifier type="nhmrc">2041836</identifier>
            <name type="primary">
                <namePart>Can Aspirin reduce the risk of Hepatocellular Carcinoma (HCC) in subjects with cirrhosis: a multi-centre, placebo-controlled clinical trial</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0417-3411</identifier>
                <title>Prof John Olynyk</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n415q13</identifier>
                <title>Curtin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n415q13</identifier>
                <title>Curtin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/027p0bm56</identifier>
                <title>Fiona Stanley Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048emj907</identifier>
                <title>Queen Elizabeth Hospital Birmingham</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05gpvde20</identifier>
                <title>Royal Prince Alfred Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/020aczd56</identifier>
                <title>Flinders Medical Centre</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00r4sry34</identifier>
                <title>Murdoch University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://www.odsdatasearchandexport.nhs.uk/?search=advorg&amp;code=5C197</identifier>
                <title>Royal Free Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00zc2xc51</identifier>
                <title>Royal Perth Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01hhqsm59</identifier>
                <title>Sir Charles Gairdner Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Gastroenterology and hepatology</subject>
            <subject type="local">hepatocellular cancer</subject>
            <subject type="local">liver cancer</subject>
            <subject type="local">liver cirrhosis</subject>
            <subject type="local">clinical trial</subject>
            <subject type="local">aspirin</subject>
            <description type="Chief Investigator Team">Prof John Olynyk&lt;br/&gt;Prof Christopher Reid&lt;br/&gt;Dr Oyekoya Ayonrinde&lt;br/&gt;Prof Leon Adams&lt;br/&gt;Assoc Prof Khurshid Alam&lt;br/&gt;Prof Alan Wigg&lt;br/&gt;Prof Simone Strasser&lt;br/&gt;Aileen Marshall&lt;br/&gt;Tahir Shah&lt;br/&gt;Prof Janina Tirnitz-Parker&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United Kingdom&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Hepatocellular carcinoma (HCC) is a rapidly increasing causes of morbidity and death globally. Over 90% of cases of HCC occur as a consequence of cirrhosis of the liver. Retrospective studies show aspirin therapy can reduce the risk of HCC in cirrhosis. We will conduct a randomised clinical trial of aspirin vs placebo therapy in people with cirrhosis in order to determine whether aspirin can prevent HCC. The findings will change practice and result in substantial savings in health care costs.</description>
            <description type="fundingAmount">$5,115,622.70</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042052</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042052</identifier>
            <identifier type="nhmrc">2042052</identifier>
            <name type="primary">
                <namePart>A multi-site randomised controlled trial of cannabidiol versus placebo for the management of treatment-resistant alcohol use disorder (the CAN-AUD trial)</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0868-9928</identifier>
                <title>Prof Kirsten Morley</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05gpvde20</identifier>
                <title>Royal Prince Alfred Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03w28pb62</identifier>
                <title>South Eastern Sydney Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Psychiatry (incl. psychotherapy)</subject>
            <subject type="local">alcohol use disorders</subject>
            <subject type="local">alcohol addiction</subject>
            <subject type="local">addiction treatment</subject>
            <subject type="local">alcohol dependence</subject>
            <subject type="local">pharmacotherapy</subject>
            <description type="Chief Investigator Team">Prof Kirsten Morley&lt;br/&gt;Prof Paul Haber&lt;br/&gt;Prof Nicholas Lintzeris&lt;br/&gt;Assoc Prof Michael Doyle&lt;br/&gt;Prof Daniel Lubman&lt;br/&gt;Assoc Prof Shalini Arunogiri&lt;br/&gt;Prof Jason Connor&lt;br/&gt;Dr Yong Yi Lee&lt;br/&gt;Dr Paul Clark&lt;br/&gt;Prof Timothy Slade&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Alcohol misuse is a leading cause of preventable death in Australia. However, treatment options for alcohol problems have limited efficacy. This will be the first human trial of cannabidiol (CBD) for the management of treatment-resistant alcohol use disorder (CAN-AUD). The CAN-AUD project will evaluate the efficacy and cost-efficacy of CBD to reduce alcohol consumption. The results will generate high level clinical evidence for a safe new treatment for a common life threatening problem.</description>
            <description type="fundingAmount">$2,493,196.50</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042278</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042278</identifier>
            <identifier type="nhmrc">2042278</identifier>
            <name type="primary">
                <namePart>An ultra-short course of primaquine for the radical cure of vivax malaria</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7536-7497</identifier>
                <title>Prof Kamala Ley-Thriemer</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n415q13</identifier>
                <title>Curtin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01x6n0t15</identifier>
                <title>Papua New Guinea Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03gd0dm95</identifier>
                <title>Aga Khan University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00ssp9h11</identifier>
                <title>Arba Minch University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kknrc90</identifier>
                <title>Universitas Sumatera Utara</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Public health not elsewhere classified</subject>
            <subject type="local">antimalarial</subject>
            <subject type="local">plasmodium</subject>
            <subject type="local">malaria control</subject>
            <subject type="local">relapse prevention</subject>
            <subject type="local">clinical malaria</subject>
            <description type="Chief Investigator Team">Prof Kamala Ley-Thriemer&lt;br/&gt;Assoc Prof Brioni Moore&lt;br/&gt;Assoc Prof Tamiru Shibiru Degaga&lt;br/&gt;Prof Moses Laman&lt;br/&gt;Prof Ayodhia Pasaribu&lt;br/&gt;Mohammad Asim Beg&lt;br/&gt;Prof Richard Price&lt;br/&gt;Dr Benedikt Ley&lt;br/&gt;Dr Megha Rajasekhar&lt;br/&gt;Prof Richard Norman&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;Papua New Guinea&lt;br/&gt;Indonesia&lt;br/&gt;Pakistan&lt;br/&gt;Ethiopia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Current treatment regimens to prevent relapsing malaria are too long. A shorter higher dose treatment could improve treatment outcomes but this needs to be balanced against increased risk of side effects. Recent data from a trial in children in PNG suggests a shortened treatment of 3 days is safe and effective. Our multicentre trial will assess the safety and efficacy of an ultra-short primaquine course. This trial is expected to directly influence global treatment policies.</description>
            <description type="fundingAmount">$4,999,499.60</description>
            <coverage>
                <spatial type="text">NT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042432</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042432</identifier>
            <identifier type="nhmrc">2042432</identifier>
            <name type="primary">
                <namePart>EARSHOT: An international, multicentre prospective cohort study evaluating the risk of hearing loss in children receiving antibiotic treatment</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Assoc_Prof_Amanda_Gwee</identifier>
                <title>Assoc Prof Amanda Gwee</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n415q13</identifier>
                <title>Curtin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Starship_Children's_Hospital</identifier>
                <title>Starship Children's Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/82616992416</identifier>
                <title>Gold Coast University Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/015zx6n37</identifier>
                <title>Perth Children's Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02tj04e91</identifier>
                <title>Sydney Children's Hospital, Randwick</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/35655720546</identifier>
                <title>The Royal Children's Hospital Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00be8mn93</identifier>
                <title>Children's Health Queensland Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05k0s5494</identifier>
                <title>Children's Hospital at Westmead</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Paediatrics not elsewhere classified</subject>
            <subject type="local">antibiotics</subject>
            <subject type="local">drug toxicity</subject>
            <subject type="local">hearing loss</subject>
            <subject type="local">child</subject>
            <subject type="local">biomarkers</subject>
            <description type="Chief Investigator Team">Assoc Prof Amanda Gwee&lt;br/&gt;Prof Thomas Snelling&lt;br/&gt;Prof John Christodoulou&lt;br/&gt;Assoc Prof Cornelia Landersdorfer&lt;br/&gt;Assoc Prof Rachel Conyers&lt;br/&gt;Assoc Prof Susan Donath&lt;br/&gt;Prof Richard Norman&lt;br/&gt;Dr Nicole Messina&lt;br/&gt;Dr Shivanthan Shanthikumar&lt;br/&gt;Dr Peter Carew&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;New Zealand&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">One in every 10 children admitted to hospital with an infection receives an aminoglycoside antibiotic. A serious risk of these drugs is permanent hearing loss for which no effective prevention method exists. This study will discover how to prevent hearing loss from aminoglycosides in children by finding out the risk of hearing loss with different treatment doses or lengths, identifying if early hearing damage can be detected using novel blood markers, and testing for genetic risk factors.</description>
            <description type="fundingAmount">$2,959,311.81</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042686</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042686</identifier>
            <identifier type="nhmrc">2042686</identifier>
            <name type="primary">
                <namePart>The 18 and Up Study: Determining the causes, patterns and implications of intergenerational changes in mental health</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Martin_McNamara</identifier>
                <title>Dr Martin McNamara</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/008cfxd05</identifier>
                <title>The Sax Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/008cfxd05</identifier>
                <title>The Sax Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological modelling HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Mental health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Social determinants of health</subject>
            <subject type="local">mental health</subject>
            <subject type="local">public health</subject>
            <subject type="local">health economics</subject>
            <subject type="local">multi-generation study</subject>
            <subject type="local">health care utilisation</subject>
            <description type="Chief Investigator Team">Dr Martin McNamara&lt;br/&gt;Dr Kerrin Bleicher&lt;br/&gt;Prof Jane Pirkis&lt;br/&gt;Prof Sharon Lawn&lt;br/&gt;Dr Xenia Dolja-Gore&lt;br/&gt;Prof Timothy Slade&lt;br/&gt;Prof Craig Olsson&lt;br/&gt;Prof Matthew Spittal&lt;br/&gt;Prof Cathrine Mihalopoulos&lt;br/&gt;Prof Samuel Harvey&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Poor mental health is a growing problem in Australia, particularly for young people. There are big gaps in the information we need to understand and tackle these issues. Participants from the 45 and Up Study will invite their children and grandchildren to participate in a new study - the 18 and Up Study - involving almost 300,000 people. The 18 and Up Study will explore the causes and impacts of poor mental health across generations, and identify how Australia can tackle this problem.</description>
            <description type="fundingAmount">$4,512,965.40</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042707</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042707</identifier>
            <identifier type="nhmrc">2042707</identifier>
            <name type="primary">
                <namePart>Transforming HEalth and Wellbeing Outcomes from Injury for Aboriginal and Torres Strait IsLander Children - The HEAL Cohort Study</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6511-1965</identifier>
                <title>Assoc Prof Courtney Ryder</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01kpzv902</identifier>
                <title>Flinders University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Injury prevention INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander epidemiology INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander child health and wellbeing</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">aboriginal child</subject>
            <subject type="local">injury</subject>
            <subject type="local">injury prevention</subject>
            <subject type="local">injury epidemiology</subject>
            <description type="Chief Investigator Team">Assoc Prof Courtney Ryder&lt;br/&gt;Assoc Prof Julieann Coombes&lt;br/&gt;Dr Rhiannon Pilkington&lt;br/&gt;Dr Kathleen Falster&lt;br/&gt;Dr Hayley Williams&lt;br/&gt;Prof Maree Toombs&lt;br/&gt;Dr Murthy Mittinty&lt;br/&gt;Assoc Prof Nicole Williams&lt;br/&gt;Prof Belinda Gabbe&lt;br/&gt;Prof Rebecca Ivers&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Indigenous children have high rates of injury, these rates are not decreasing and impact on their family and community. We need new connected data to generate new knowledge on the injury journey for Indigenous children. We will do this is SA and NSW through the HEAL cohort, with &gt;180,000 Indigenous children. The new knowledge we create will allow policy makers and health systems to know when the best place and timing is for Indigenous focussed prevention and support strategies.</description>
            <description type="fundingAmount">$4,998,544.50</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2042777</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2042777</identifier>
            <identifier type="nhmrc">2042777</identifier>
            <name type="primary">
                <namePart>A randomised controlled trial investigating ventilation imaging to improve the quality of life for patients with lung cancer</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4803-6507</identifier>
                <title>Prof Paul Keall</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04ttjf776</identifier>
                <title>RMIT University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03sxgeg61</identifier>
                <title>GenesisCare</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02a8bt934</identifier>
                <title>Peter MacCallum Cancer Centre</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03zzzks34</identifier>
                <title>Liverpool Cancer Therapy Centre</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04scfb908</identifier>
                <title>Alfred Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04rq5mt64</identifier>
                <title>University of Maryland, Baltimore</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02gs2e959</identifier>
                <title>Royal North Shore Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Radiation therapy</subject>
            <subject type="local">radiation therapy</subject>
            <subject type="local">non-small cell lung cancer</subject>
            <subject type="local">medical imaging</subject>
            <subject type="local">functional imaging</subject>
            <subject type="local">quality of life</subject>
            <description type="Chief Investigator Team">Prof Paul Keall&lt;br/&gt;Prof Shalini Vinod&lt;br/&gt;Assoc Prof Sashendra Senthi&lt;br/&gt;Prof Val Gebski&lt;br/&gt;Prof Ricky O'Brien&lt;br/&gt;Assoc Prof Nicholas Hardcastle&lt;br/&gt;Dr Mbathio Dieng&lt;br/&gt;Dr Rebecca Mercieca-Bebber&lt;br/&gt;Prof Amit Sawant&lt;br/&gt;Dr Surein Arulananda&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United States of America&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This randomised controlled trial will test whether patients receiving healthy lung sparing treatment have better quality of life than patients receiving standard treatment. Additional hypotheses include whether patients will have reduced treatment side-effects, better lung function, and be more likely to receive and complete post-RT immunotherapy. A health economics assessment will provide evidence that will expedite clinical and commercial translation. 165 patients will be recruited.</description>
            <description type="fundingAmount">$1,861,323.82</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043029</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043029</identifier>
            <identifier type="nhmrc">2043029</identifier>
            <name type="primary">
                <namePart>RELIEF trial – Radiofrequency ablation for chronic low back pain, a randomised placebo controlled trial</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3479-0683</identifier>
                <title>Prof Manuela Ferreira</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/023331s46</identifier>
                <title>The George Institute for Global Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Anaesthesiology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Rheumatology and arthritis</subject>
            <subject type="local">chronic back pain</subject>
            <subject type="local">clinical trial</subject>
            <subject type="local">pain management</subject>
            <subject type="local">efficacy</subject>
            <subject type="local">disability</subject>
            <description type="Chief Investigator Team">Prof Manuela Ferreira&lt;br/&gt;Prof Paulo Ferreira&lt;br/&gt;Prof Chris Maher&lt;br/&gt;Prof Lyn March&lt;br/&gt;Prof Laurent Billot&lt;br/&gt;Prof Michael Nicholas&lt;br/&gt;Dr Giovanni Ferreira&lt;br/&gt;Dr Bethan Richards&lt;br/&gt;Dr Emily Atkins&lt;br/&gt;Prof Paul Hodges&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Back pain is highly prevalent in Australia and associated with functional and work loss, and decreased quality of life. While many treatments are offered to manage back pain, only few are known to work. RFA is a popular approach that can lead to pain relief by acting directly on the nerve supply from the joints. But we do not know if this treatment works. The RELIEF trial will test if RFA is better than placebo in terms of pain relief, medication use and increase in function.</description>
            <description type="fundingAmount">$3,629,899.80</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043051</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043051</identifier>
            <identifier type="nhmrc">2043051</identifier>
            <name type="primary">
                <namePart>The Chronic kidney disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect (CAPTIVATE) – Glucagon-like peptide-1 domain</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3294-4087</identifier>
                <title>Assoc Prof Sradha Kotwal</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/023331s46</identifier>
                <title>The George Institute for Global Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Nephrology and urology</subject>
            <subject type="local">kidney disease</subject>
            <subject type="local">albuminuria</subject>
            <subject type="local">novel therapeutic agents</subject>
            <subject type="local">evidence-based</subject>
            <subject type="local">randomised controlled trial (rct)</subject>
            <description type="Chief Investigator Team">Assoc Prof Sradha Kotwal&lt;br/&gt;Assoc Prof Clare Arnott&lt;br/&gt;Prof Hiddo Lambers Heerspink&lt;br/&gt;Prof Vlado Perkovic&lt;br/&gt;Prof Laurent Billot&lt;br/&gt;Prof Vivekanand Jha&lt;br/&gt;Ms Vicki Grey&lt;br/&gt;Prof Jose Luis Górriz&lt;br/&gt;Peter Rossing&lt;br/&gt;Dr Enmoore Lin&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Chronic kidney disease (CKD) is becoming more common. It can lead to kidney failure, heart problems, disability, and early death. It is important to find medicines that stop CKD from getting worse without spending too much money, using too many resources or taking too long. This project builds on the recently funded CAPTIVATE platform trial. A second medicine, semaglutide, will be added to this trial to test which combination treatments are best.</description>
            <description type="fundingAmount">$5,658,973.60</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043244</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043244</identifier>
            <identifier type="nhmrc">2043244</identifier>
            <name type="primary">
                <namePart>CoRticostEroids in SepTic Shock (CREST)</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3234-5244</identifier>
                <title>Prof Bala Venkatesh</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/023331s46</identifier>
                <title>The George Institute for Global Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Intensive care</subject>
            <subject type="local">sepsis</subject>
            <subject type="local">corticosteroids</subject>
            <subject type="local">intensive care medicine</subject>
            <subject type="local">mineralocorticoid</subject>
            <subject type="local">septic shock</subject>
            <description type="Chief Investigator Team">Prof Bala Venkatesh&lt;br/&gt;Assoc Prof Naomi Hammond&lt;br/&gt;Prof Simon Finfer&lt;br/&gt;Dr Sarah Sasson&lt;br/&gt;Assoc Prof Jeremy Cohen&lt;br/&gt;Prof Laurent Billot&lt;br/&gt;Prof Sandra Peake&lt;br/&gt;Dr Alisa Higgins&lt;br/&gt;Dr Brett Abbenbroek&lt;br/&gt;Miss Caitlin Alsop&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Sepsis is a major global public health problem. Corticosteroids, a commonly used drug in clinical practice, has been evaluated in patients with septic shock with inconsistent results. We propose to conduct a blinded, 2 arm randomized clinical trial: a) Hydrocortisone and b) hydrocortisone plus fludrocortisone in patients with septic shock to determine if there are any differences on survival and functional recovery in patients with septic shock.</description>
            <description type="fundingAmount">$5,502,820.05</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043361</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043361</identifier>
            <identifier type="nhmrc">2043361</identifier>
            <name type="primary">
                <namePart>BabyCCINO: An Adaptive Trial of Caffeine Dosing to Improve Outcomes for Very Preterm Infants</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-0212-7956</identifier>
                <title>Prof Brett Manley</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03b94tp07</identifier>
                <title>University of Auckland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01nfmeh72</identifier>
                <title>University of Tasmania</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Neonatology</subject>
            <subject type="local">very preterm birth</subject>
            <subject type="local">neonatal intensive care (nicu)</subject>
            <subject type="local">neonatal respiratory distress syndrome</subject>
            <subject type="local">apnoea of prematurity</subject>
            <subject type="local">neonatal survival</subject>
            <description type="Chief Investigator Team">Prof Brett Manley&lt;br/&gt;Dr Clare Whitehead&lt;br/&gt;Dr Kate Hodgson&lt;br/&gt;Prof Peter Davis&lt;br/&gt;Assoc Prof Christopher McKinlay&lt;br/&gt;Assoc Prof Jane Alsweiler&lt;br/&gt;Prof Adrienne Gordon&lt;br/&gt;Ms Melinda Cruz&lt;br/&gt;Prof Jeanie Cheong&lt;br/&gt;Prof Katherine Lee&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;New Zealand&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Preterm birth (before 37 weeks of pregnancy are complete) is a huge worldwide issue. "Very preterm" infants are those born more than 2 months early and are at the highest risk of complications. Caffeine (yes, as in coffee!) is one of the best medications we have for very preterm babies - it helps with their breathing and has benefits that persist into later childhood. However, we are not sure of the best dose of caffeine for very preterm babies, and the BabyCCINO trial will answer that question.</description>
            <description type="fundingAmount">$3,014,066.40</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043671</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043671</identifier>
            <identifier type="nhmrc">2043671</identifier>
            <name type="primary">
                <namePart>Understanding and tackling intergenerational diabetes: PANDORA Wave 3</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Anna_Wood</identifier>
                <title>Dr Anna Wood</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02t1bej08</identifier>
                <title>Monash Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Endocrinology</subject>
            <subject type="local">diabetes mellitus</subject>
            <subject type="local">diabetes prevention</subject>
            <subject type="local">gestational diabetes</subject>
            <subject type="local">indigenous health</subject>
            <subject type="local">health promotion</subject>
            <description type="Chief Investigator Team">Dr Anna Wood&lt;br/&gt;Prof Louise Maple-Brown&lt;br/&gt;Ms Sian Graham&lt;br/&gt;Prof Christine Connors&lt;br/&gt;Dr Elizabeth Barr&lt;br/&gt;Prof Jonathan Shaw&lt;br/&gt;Prof Alex Brown&lt;br/&gt;Ms Sumaria Corpus&lt;br/&gt;Assoc Prof Federica Barzi&lt;br/&gt;Dr Angela Titmuss&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">1,139 Aboriginal and non-Indigenous women and their children with and without diabetes in pregnancy from across the NT are in the PANDORA study. We are planning Wave 3 of this study, 12-18 years after pregnancy with clinical assessments on women and their children. We aim to find out how many women and their children have type 2 diabetes or are at risk of diabetes and how much diabetes in pregnancy contributes to this risk for the children.</description>
            <description type="fundingAmount">$3,550,778.40</description>
            <coverage>
                <spatial type="text">NT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043677</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043677</identifier>
            <identifier type="nhmrc">2043677</identifier>
            <name type="primary">
                <namePart>Real-world risk-benefit balancing in cancer immunotherapy</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7550-6837</identifier>
                <title>Prof Christine Lu</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiology not elsewhere classified</subject>
            <subject type="local">cancer immunotherapy</subject>
            <subject type="local">drug safety</subject>
            <subject type="local">cohort study</subject>
            <subject type="local">population-based</subject>
            <subject type="local">health outcomes</subject>
            <description type="Chief Investigator Team">Prof Christine Lu&lt;br/&gt;Prof Sallie-Anne Pearson&lt;br/&gt;Dr Benjamin Daniels&lt;br/&gt;Prof Andrew Wilson&lt;br/&gt;Dr Firouzeh Noghrehchi&lt;br/&gt;Dr Jacques Raubenheimer&lt;br/&gt;Prof Stephen Clarke&lt;br/&gt;Prof Chee Khoon Lee&lt;br/&gt;Assoc Prof Alexander Menzies&lt;br/&gt;Assoc Prof Alexander Guminski&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Immunotherapies have improved the prognosis for many cancer patients but their benefits are tempered by immune-related adverse events. This project will establish the first Australian cohort of patients using immunotherapy in the real-world clinic. Population-based cohort studies will investigate how patient factors and prescribing patterns intersect and affect the health outcomes of patients using immunotherapy so that the benefits of these medicines can be maximised and the harms minimised.</description>
            <description type="fundingAmount">$1,221,849.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043689</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043689</identifier>
            <identifier type="nhmrc">2043689</identifier>
            <name type="primary">
                <namePart>Glioblastoma Immunotherapy Advancement with Nivolumab and Relatlimab</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_James_Whittle</identifier>
                <title>Dr James Whittle</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04z4kmw33</identifier>
                <title>Melbourne Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02jxrhq31</identifier>
                <title>Melanoma Institute Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00qeks103</identifier>
                <title>Chris O'Brien Lifehouse</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02a8bt934</identifier>
                <title>Peter MacCallum Cancer Centre</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03njmea73</identifier>
                <title>Duke University Medical Centre</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05gpvde20</identifier>
                <title>Royal Prince Alfred Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b6kha49</identifier>
                <title>The Walter and Eliza Hall Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05dbj6g52</identifier>
                <title>Austin Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02gs2e959</identifier>
                <title>Royal North Shore Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Immunology</subject>
            <subject type="anzsrc-for">Tumour immunology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy) BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Bioinformatics and computational biology</subject>
            <subject type="anzsrc-for">Genomics and transcriptomics</subject>
            <subject type="local">glioblastoma</subject>
            <subject type="local">immunotherapy</subject>
            <subject type="local">clinical trial</subject>
            <subject type="local">bioinformatics</subject>
            <subject type="local">neurosurgery</subject>
            <description type="Chief Investigator Team">Dr James Whittle&lt;br/&gt;Prof Georgina Long&lt;br/&gt;Assoc Prof Mustafa Khasraw&lt;br/&gt;Assoc Prof Hao-Wen Sim&lt;br/&gt;Dr Laveniya Satgunaseelan&lt;br/&gt;Prof Katharine Drummond&lt;br/&gt;Dr Saskia Freytag&lt;br/&gt;Prof Misty Jenkins&lt;br/&gt;Dr Joseph Sia&lt;br/&gt;Assoc Prof Emma Link&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United States of America&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Glioblastoma (GBM) is a brain cancer with poor survival rates and no major treatment advancements in 20 years. Immune checkpoint inhibitors (ICIs) have succeeded in other cancers by boosting the immune response. Nivolumab, targeting PD-1, combined with relatlimab, blocking LAG-3, shows promise. The GIANT trial tests this combination in newly diagnosed GBM patients, aiming to improve outcomes by using these drugs before surgery.</description>
            <description type="fundingAmount">$2,490,186.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043735</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043735</identifier>
            <identifier type="nhmrc">2043735</identifier>
            <name type="primary">
                <namePart>Skin cancer UNCUT: Beyond 'if in doubt, cut it out'. A randomised controlled trial of adjunctive in vivo reflectance confocal microscopy for skin cancer diagnosis</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9519-110X</identifier>
                <title>Prof Pascale Guitera</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02jxrhq31</identifier>
                <title>Melanoma Institute Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Dermatology BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer diagnosis</subject>
            <subject type="local">malignant skin melanoma</subject>
            <subject type="local">non-melanocytic skin cancer</subject>
            <subject type="local">diagnostic techniques</subject>
            <subject type="local">confocal microscopy</subject>
            <subject type="local">cost-effectiveness</subject>
            <description type="Chief Investigator Team">Prof Pascale Guitera&lt;br/&gt;Prof Rachael Morton&lt;br/&gt;Assoc Prof Linda Martin&lt;br/&gt;Dr Peter Ferguson&lt;br/&gt;Assoc Prof Serigne Lo&lt;br/&gt;Assoc Prof Victoria Mar&lt;br/&gt;Prof Kiarash Khosrotehrani&lt;br/&gt;Prof Anne Cust&lt;br/&gt;Dr Jordana McLoone&lt;br/&gt;Mr Craig Lawn&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Skin cancer is Australia's most common and expensive cancer. However, for every skin cancer diagnosed, many benign lesions are unnecessarily removed, causing scarring and expense. This study measures the impact of a special confocal microscope (CM) to diagnose skin cancer without surgery. CM is a highly accurate technology but is not widely available. We will measure the reduction in unnecessary biopsies and cost savings of CM, and aim to improve accurate skin cancer diagnosis in Australia.</description>
            <description type="fundingAmount">$2,723,560.25</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043738</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043738</identifier>
            <identifier type="nhmrc">2043738</identifier>
            <name type="primary">
                <namePart>New passive immunisation, nirsevimab, to prevent severe respiratory infections among First Nations children in the Northern Territory: a pragmatic randomised controlled trial</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Bianca_Middleton</identifier>
                <title>Dr Bianca Middleton</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander child health and wellbeing</subject>
            <subject type="local">clinical trial</subject>
            <subject type="local">respiratory syncytial virus</subject>
            <subject type="local">immunotherapy</subject>
            <subject type="local">aboriginal child</subject>
            <subject type="local">rural and remote health</subject>
            <description type="Chief Investigator Team">Dr Bianca Middleton&lt;br/&gt;Dr Michael Binks&lt;br/&gt;Prof Thomas Snelling&lt;br/&gt;Prof Anne Chang&lt;br/&gt;Assoc Prof Jane Davies&lt;br/&gt;Prof Margaret Danchin&lt;br/&gt;Dr Kiarna Brown&lt;br/&gt;Mr Mark Mayo&lt;br/&gt;Dr Nicholas Fancourt&lt;br/&gt;Dr Khandoker Shuvo Bakar&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Respiratory Syncytial Virus (RSV) is a leading cause of severe respiratory infections in children. The NT will fund a new RSV immunisation program (nirsevimab) for all First Nations newborns. Nirsevimab protects against RSV for five months, but First Nations children have high levels of RSV-infections for up to 12 months. We will test if a second dose of nirsevimab at six months, versus no dose (single birth dose only), will better protect First Nations children against respiratory infections.</description>
            <description type="fundingAmount">$4,668,126.73</description>
            <coverage>
                <spatial type="text">NT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043758</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043758</identifier>
            <identifier type="nhmrc">2043758</identifier>
            <name type="primary">
                <namePart>Optimal Evaluation of Acute Limb Pain in Children Presenting to the Emergency Department</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2594-1643</identifier>
                <title>Prof Simon Craig</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Emergency medicine BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Orthopaedics</subject>
            <subject type="local">orthopaedic surgery</subject>
            <subject type="local">child</subject>
            <subject type="local">emergency medicine</subject>
            <subject type="local">diagnosis</subject>
            <subject type="local">arthritis</subject>
            <description type="Chief Investigator Team">Prof Simon Craig&lt;br/&gt;Prof Franz Babl&lt;br/&gt;Prof Stuart Dalziel&lt;br/&gt;Prof Asha Bowen&lt;br/&gt;Dr Natalie Phillips&lt;br/&gt;Assoc Prof Mohammad Asghari-Jafarabadi&lt;br/&gt;Assoc Prof AMIT KOCHAR&lt;br/&gt;Dr Stewart Morrison&lt;br/&gt;Dr Mark Lyttle&lt;br/&gt;Assoc Prof Peter Snelling&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Children sometimes develop a limp, or difficulty moving a limb. Most of the time this is caused by inflammation, which resolves after a few days. However, a small number of children have more serious causes, such as infection, acute rheumatic fever (with Indigenous children at higher risk), or cancer. This project will collect data and follow up children presenting to 18 Emergency Departments across Australia and NZ to identify the best way to make an accurate and rapid diagnosis.</description>
            <description type="fundingAmount">$3,108,662.10</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043771</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043771</identifier>
            <identifier type="nhmrc">2043771</identifier>
            <name type="primary">
                <namePart>AUTOMATEd risk assessment and screening for MElanoma and skin cancer (AUTOMATE ME)</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-9423-3435</identifier>
                <title>Assoc Prof Victoria Mar</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer diagnosis INFORMATION AND COMPUTING SCIENCES</subject>
            <subject type="anzsrc-for">Artificial intelligence</subject>
            <subject type="anzsrc-for">Planning and decision making HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health surveillance</subject>
            <subject type="local">artificial intelligence</subject>
            <subject type="local">melanoma</subject>
            <subject type="local">skin cancer</subject>
            <subject type="local">cancer screening</subject>
            <subject type="local">risk assessment</subject>
            <description type="Chief Investigator Team">Assoc Prof Victoria Mar&lt;br/&gt;Prof Monika Janda&lt;br/&gt;Prof H Peter Soyer&lt;br/&gt;Prof Anne Cust&lt;br/&gt;Harald Kittler&lt;br/&gt;Assoc Prof Zongyuan Ge&lt;br/&gt;Prof Pablo Fernandez Peñas&lt;br/&gt;Prof Richard Scolyer&lt;br/&gt;Prof Rachael Morton&lt;br/&gt;Prof Rory Wolfe&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Using high-resolution 3D skin imaging data together with clinical data collected in a large scale cohort study across 3 states, we have developed novel artificial intelligence algorithms to automate risk assessments and screening for melanoma. In this cluster randomised trial we will prospectively test the accuracy and acceptability of these models to determine whether components of a melanoma screening intervention can be safely automated.</description>
            <description type="fundingAmount">$5,694,746.91</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043780</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043780</identifier>
            <identifier type="nhmrc">2043780</identifier>
            <name type="primary">
                <namePart>A Phase III, International, Multicentre, Randomised Controlled Trial of Selective Index Lymph Node Resection versus Therapeutic Lymph Node Dissection after Neoadjuvant Immunotherapy for Stage IIIB-D Melanoma (MSLT-3)</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3262-6935</identifier>
                <title>Assoc Prof Alexander Van Akkooi</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02jxrhq31</identifier>
                <title>Melanoma Institute Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/25285907786</identifier>
                <title>Cairns and Hinterland Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02jxrhq31</identifier>
                <title>Melanoma Institute Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00carf720</identifier>
                <title>Royal Adelaide Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04gp5yv64</identifier>
                <title>Westmead Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02xz7d723</identifier>
                <title>Harry Perkins Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/041c7s516</identifier>
                <title>Calvary Health Care Canberra</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02a8bt934</identifier>
                <title>Peter MacCallum Cancer Centre</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04scfb908</identifier>
                <title>Alfred Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04mqb0968</identifier>
                <title>Princess Alexandra Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01b05bn14</identifier>
                <title>Ramsay Health Care</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/031382m70</identifier>
                <title>Royal Hobart Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Pathology (excl. oral pathology) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Surgery BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy)</subject>
            <subject type="local">randomised controlled trial (rct)</subject>
            <subject type="local">cutaneous melanoma</subject>
            <subject type="local">surgery</subject>
            <subject type="local">cost-effectiveness</subject>
            <subject type="local">patient outcomes</subject>
            <description type="Chief Investigator Team">Assoc Prof Alexander Van Akkooi&lt;br/&gt;Prof Georgina Long&lt;br/&gt;Prof Richard Scolyer&lt;br/&gt;Assoc Prof Serigne Lo&lt;br/&gt;Assoc Prof Chi Kin Law&lt;br/&gt;Prof Andrew Barbour&lt;br/&gt;Assoc Prof Robyn Saw&lt;br/&gt;Prof Andrew Spillane&lt;br/&gt;Prof Helen Rizos&lt;br/&gt;Dr Julia Lai-Kwon&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Immunotherapy before surgery has been established as best practice in stage III melanoma. The surgery is extensive, with frequent complications, significantly impacting quality of life (QoL), at high costs to patients &amp; society. The goal of the trial is to demonstrate that the smaller surgery leads to a similar relapse-free survival, while reducing complications, costs &amp; improving QoL. We aim to provide a less invasive treatment option for patients without compromising their outcomes.</description>
            <description type="fundingAmount">$3,218,571.65</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043828</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043828</identifier>
            <identifier type="nhmrc">2043828</identifier>
            <name type="primary">
                <namePart>Using placental transcriptomics for molecular detection and improved outcomes in autism</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6580-0346</identifier>
                <title>Prof Peter Vuillermin</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00my0hg66</identifier>
                <title>Barwon Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03a2tac74</identifier>
                <title>Florey Institute of Neuroscience and Mental Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Community child health BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Genetics</subject>
            <subject type="anzsrc-for">Gene expression (incl. microarray and other genome-wide approaches) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Paediatrics</subject>
            <subject type="anzsrc-for">Infant and child health</subject>
            <subject type="local">autism spectrum disorders</subject>
            <subject type="local">gene transcription</subject>
            <subject type="local">placental function</subject>
            <subject type="local">mitochondria</subject>
            <subject type="local">neuroendocrine</subject>
            <description type="Chief Investigator Team">Prof Peter Vuillermin&lt;br/&gt;Prof Anne-Louise Ponsonby&lt;br/&gt;Dr Luba Sominsky&lt;br/&gt;Prof Richard Saffery&lt;br/&gt;Dr Katherine Drummond&lt;br/&gt;Dr Samantha Dawson&lt;br/&gt;Dr Martin O'Hely&lt;br/&gt;Assoc Prof David Stroud&lt;br/&gt;Prof Peter Sly&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">We have followed 85% of 1074 babies in the Barwon Infant Study to 9 years, and more than 7% have been diagnosed with autism spectrum disorder (autism). Gene expression in placental samples of children diagnosed with autism is strikingly different. We now propose a program of research to create knowledge about how modifiable factors during pregnancy, such as exposure to plastic pollutants and diet, impact the risk of autism via placental function.</description>
            <description type="fundingAmount">$937,221.80</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043854</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043854</identifier>
            <identifier type="nhmrc">2043854</identifier>
            <name type="primary">
                <namePart>Simple oral immunotherapy versus standard intravenous chemotherapy for Kaposi sarcoma in resource-limited settings: the IMPALA-KS randomised trial of pomalidomide versus liposomal doxorubicin in advanced Kaposi sarcoma</namePart>
            </name>
            <name type="alternative">
                <namePart>Clinical Trials and Cohort Studies Grants</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7022</identifier>
                <title>2024 Clinical Trials and Cohort Studies Grants</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6446-183X</identifier>
                <title>Prof Mark Polizzotto</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/019wvm592</identifier>
                <title>Australian National University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01nrxwf90</identifier>
                <title>University of Edinburgh</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04ze6rb18</identifier>
                <title>University of Zimbabwe</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01encsj80</identifier>
                <title>University of Botswana</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/019wvm592</identifier>
                <title>Australian National University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://www.lshtm.ac.uk/research/units/mrc-uganda</identifier>
                <title>MRC/UVRI Uganda Research Unit on AIDS</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/001mm6w73</identifier>
                <title>Medical Research Council Clinical Trials Unit</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03dmz0111</identifier>
                <title>Makerere University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Cancer therapy (excl. chemotherapy and radiation therapy) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Oncology and carcinogenesis</subject>
            <subject type="anzsrc-for">Solid tumours BIOLOGICAL SCIENCES</subject>
            <subject type="anzsrc-for">Microbiology</subject>
            <subject type="anzsrc-for">Infectious agents</subject>
            <subject type="local">kaposi's sarcoma</subject>
            <subject type="local">human immunodeficiency virus (hiv)</subject>
            <subject type="local">cancer immunotherapy</subject>
            <subject type="local">herpes</subject>
            <subject type="local">cancer therapy</subject>
            <description type="Chief Investigator Team">Prof Mark Polizzotto&lt;br/&gt;Dr Sarah Pett&lt;br/&gt;Dr Margaret Borok&lt;br/&gt;Aggrey Semeere&lt;br/&gt;Surbhi Grover&lt;br/&gt;Chelsea Morroni&lt;br/&gt;Joseph Lutaakome&lt;br/&gt;Assoc Prof Nhung Nghiem&lt;br/&gt;Dr Syed Adnan Ali&lt;br/&gt;Dr Jonathan Roco Alegre&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United Kingdom&lt;br/&gt;Botswana&lt;br/&gt;Uganda&lt;br/&gt;Zimbabwe&lt;br/&gt;</description>
            <description type="Date Announced">2025-05-09T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Kaposi sarcoma (KS) is a common deadly cancer in sub-Saharan Africa. Up to half of people with KS in Africa die within a year, and many survivors are left with long term disability. In rich countries, chemotherapy is used as effective treatment. However, in Africa this too complex and costly. My work showed that a simple oral immune therapy is an effective treatment of Kaposi sarcoma, and it is now used in rich countries. We will compare this new oral therapy to standard chemotherapy in Africa.</description>
            <description type="fundingAmount">$4,927,623.00</description>
            <coverage>
                <spatial type="text">ACT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044217</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044217</identifier>
            <identifier type="nhmrc">2044217</identifier>
            <name type="primary">
                <namePart>Implementation and evaluation of a novel Codesigned Integrated Multimorbidity Management by Community Health Workers (CIMM-CHW) in eastern Nepal- Type II hybrid implementation trial</namePart>
            </name>
            <name type="alternative">
                <namePart>International Collaborations</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6806</identifier>
                <title>2024 GACD Management of Multiple Long-Term Conditions</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-6626-1604</identifier>
                <title>Dr Uday Yadav</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/019wvm592</identifier>
                <title>Australian National University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/019wvm592</identifier>
                <title>Australian National University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Multimorbidity HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Primary health care</subject>
            <subject type="local">chronic diseases</subject>
            <subject type="local">primary care</subject>
            <subject type="local">implementation</subject>
            <subject type="local">indigenous health</subject>
            <subject type="local">community health care</subject>
            <description type="Chief Investigator Team">Dr Uday Yadav&lt;br/&gt;Prof Rohina Joshi&lt;br/&gt;Prof David Peiris&lt;br/&gt;Saruna Ghimire&lt;br/&gt;Dr Son Nghiem&lt;br/&gt;Mr Narendra Bhatta&lt;br/&gt;Bhim Prasad Sapkota&lt;br/&gt;Mr Sabuj Kanti Mistry&lt;br/&gt;Dr Haribondhu Sarma&lt;br/&gt;Rawa Majhi&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-19T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Our novel co-designed community health worker (CHW) model of care will improve the health and well-being of multimorbidity people from disadvantaged communities in Nepal. The model will enhance the capacity of CHWs to improve patient and family health literacy and confidence for self-management practices and assist with coordination, and referral within primary healthcare. The lessons will inform multimorbidity management policy and practice in Nepal and similar contexts.</description>
            <description type="fundingAmount">$1,667,375.00</description>
            <coverage>
                <spatial type="text">ACT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044237</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044237</identifier>
            <identifier type="nhmrc">2044237</identifier>
            <name type="primary">
                <namePart>Optimising mobility for older adults with multiple chronic conditions in Brazil: implementation of a co-designed evidence-based digital solution</namePart>
            </name>
            <name type="alternative">
                <namePart>International Collaborations</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6806</identifier>
                <title>2024 GACD Management of Multiple Long-Term Conditions</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8934-4368</identifier>
                <title>Prof Catherine Sherrington</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/012gg9483</identifier>
                <title>City University of Sao Paulo</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04w6y2z35</identifier>
                <title>Sydney Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Aged health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Major global burdens of disease</subject>
            <subject type="local">chronic diseases</subject>
            <subject type="local">physical activity</subject>
            <subject type="local">immobility</subject>
            <subject type="local">falls prevention</subject>
            <subject type="local">physical disability</subject>
            <description type="Chief Investigator Team">Prof Catherine Sherrington&lt;br/&gt;Monica Rodrigues Perracini&lt;br/&gt;Prof Jaime Miranda&lt;br/&gt;Prof Anne Tiedemann&lt;br/&gt;Assoc Prof Leanne Hassett&lt;br/&gt;Dr Marina de Barros Pinheiro&lt;br/&gt;Prof Andrew Milat&lt;br/&gt;Dr Abigail Haynes&lt;br/&gt;Dr Rik Dawson&lt;br/&gt;Prof Ian Cameron&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;Brazil&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-19T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The applicants collaboratively developed an intervention that improved mobility (i.e., the ability to stand and walk) and prevented falls in people with multiple chronic conditions in Australia. They now plan to collaboratively adapt (i.e., co-design) this program with input from diverse stakeholders, including public health managers, and implement and evaluate it among older people in Brazil with multiple long-term conditions. The program could reach many people with diverse backgrounds.</description>
            <description type="fundingAmount">$1,478,124.44</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044252</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044252</identifier>
            <identifier type="nhmrc">2044252</identifier>
            <name type="primary">
                <namePart>HEAL-PNG Hybrid Effectiveness, feasibility and Acceptability for Long-term conditions in PNG: a hybrid type II effectiveness-implementation stepped-wedge randomised controlled trial</namePart>
            </name>
            <name type="alternative">
                <namePart>International Collaborations</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6806</identifier>
                <title>2024 GACD Management of Multiple Long-Term Conditions</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Philipp_du_Cros</identifier>
                <title>Dr Philipp du Cros</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05ktbsm52</identifier>
                <title>Burnet Institute</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01x6n0t15</identifier>
                <title>Papua New Guinea Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05ktbsm52</identifier>
                <title>Burnet Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health and community services</subject>
            <subject type="local">mycobacterium tuberculosis</subject>
            <subject type="local">human immunodeficiency virus (hiv)</subject>
            <subject type="local">randomised controlled trial (rct)</subject>
            <subject type="local">cost-effectiveness</subject>
            <subject type="local">diabetes</subject>
            <description type="Chief Investigator Team">Dr Philipp du Cros&lt;br/&gt;Yi dan Lin&lt;br/&gt;Prof William Pomat&lt;br/&gt;Dr Helen Cox&lt;br/&gt;Nalisa Neuendorf&lt;br/&gt;Dr Rowan Martin-Hughes&lt;br/&gt;Kiran Jobanputra&lt;br/&gt;Kudakwashe Chani&lt;br/&gt;Dr Tim Spelman&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;Papua New Guinea&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-19T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Non-communicable diseases such as diabetes and heart disease are a major cause of death in Papua New Guinea. We will undertake a study in 2 provinces in Papua New Guinea to assess whether integrating diabetes, heart disease and chronic lung disease care into HIV and TB programs improves care. We will also assess whether the intervention provides value for money. Finally, we will build capacity for non-communicable disease care and research in PNG.</description>
            <description type="fundingAmount">$1,511,397.32</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2028-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044289</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044289</identifier>
            <identifier type="nhmrc">2044289</identifier>
            <name type="primary">
                <namePart>Rehabilitation with embedded mental health and diabetes services to address multiple long-term conditions among people with tuberculosis (RESTORE)</namePart>
            </name>
            <name type="alternative">
                <namePart>International Collaborations</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6806</identifier>
                <title>2024 GACD Management of Multiple Long-Term Conditions</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-7628-8408</identifier>
                <title>Assoc Prof Sarah Bernays</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0130vhy65</identifier>
                <title>Biomedical Research and Training Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00a0jsq62</identifier>
                <title>London School of Hygiene &amp; Tropical Medicine</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03svjbs84</identifier>
                <title>Liverpool School of Tropical Medicine</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Major global burdens of disease</subject>
            <subject type="local">chronic diseases</subject>
            <subject type="local">chronic illness prevention</subject>
            <subject type="local">tuberculosis</subject>
            <subject type="local">randomised controlled trial (rct)</subject>
            <subject type="local">population health</subject>
            <description type="Chief Investigator Team">Assoc Prof Sarah Bernays&lt;br/&gt;Prof Katharina Kranzer&lt;br/&gt;Dr Collins Timire&lt;br/&gt;Dr Joni Lariat&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United Kingdom&lt;br/&gt;Zimbabwe&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-19T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The RESTORE project aims to reduce the impact of multiple-long-term conditions (MLTCs) on the long-term health and wellbeing of people with TB in Zimbabwe, by integrating a range of treatments for MTLCs within their 6-month TB treatment period. Usual TB care (control) will be compared to integrated MLTC/TB care (intervention) to assess whether i)the intervention improves the lives and health of people recovering from TB and ii)implementing integrated care is feasible, acceptable and scalable.</description>
            <description type="fundingAmount">$184,490.20</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-05-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-04-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046125</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046125</identifier>
            <identifier type="nhmrc">2046125</identifier>
            <name type="primary">
                <namePart>Monash Partners</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Prof_Carol_Hodgson</identifier>
                <title>Prof Carol Hodgson</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03rke0285</identifier>
                <title>Baker Heart and Diabetes Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/18128843652</identifier>
                <title>Latrobe Regional Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n5e6456</identifier>
                <title>Peninsula Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00vyyx863</identifier>
                <title>Eastern Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04scfb908</identifier>
                <title>Alfred Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05ktbsm52</identifier>
                <title>Burnet Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01rxfrp27</identifier>
                <title>La Trobe University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02t1bej08</identifier>
                <title>Monash Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/33370684005</identifier>
                <title>Cabrini Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/86129637412</identifier>
                <title>Outcome Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0083mf965</identifier>
                <title>Hudson Institute of Medical Research</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems</subject>
            <subject type="local">consumer participation</subject>
            <subject type="local">health consumers</subject>
            <subject type="local">health systems</subject>
            <subject type="local">health care worker education</subject>
            <subject type="local">quality improvement</subject>
            <description type="Chief Investigator Team">Prof Carol Hodgson&lt;br/&gt;Dr Angela Jones&lt;br/&gt;Dr Nikolajs Zeps&lt;br/&gt;Prof Grant Russell&lt;br/&gt;Ms Ainslie Cahill&lt;br/&gt;Dr Sandra Reeder&lt;br/&gt;Prof Diana Egerton-Warburton&lt;br/&gt;Prof Velandai Srikanth&lt;br/&gt;Dr Ashley Ng&lt;br/&gt;Robab Abdolkhani&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Monash Partners, an accredited NHMRC Australian Health Research Alliance member, is recognised for excellence and collaboration in health and medical research, research translation, research-infused education and training, and outstanding healthcare. This grant will enable Monash Partners continue to CONNECT | SUPPORT | IMPACT health services and systems through engaging consumers and community, workforce capacity building, responding to health service priorities in data and transitions in care.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046126</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046126</identifier>
            <identifier type="nhmrc">2046126</identifier>
            <name type="primary">
                <namePart>NHMRC 2025-26 Supporting RTC_SPHERE</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-5363-3694</identifier>
                <title>Prof Cheryl Jones</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation EDUCATION</subject>
            <subject type="anzsrc-for">Education systems</subject>
            <subject type="anzsrc-for">Professional education and training EDUCATION</subject>
            <subject type="anzsrc-for">Education systems</subject>
            <subject type="anzsrc-for">Professional education and training</subject>
            <subject type="local">outcomes research</subject>
            <subject type="local">consumer participation</subject>
            <subject type="local">translational research</subject>
            <subject type="local">clinical research</subject>
            <subject type="local">health services research</subject>
            <description type="Chief Investigator Team">Prof Cheryl Jones&lt;br/&gt;Prof Georgina Hold&lt;br/&gt;Prof Josephine Chow&lt;br/&gt;Assoc Prof Paula Bray&lt;br/&gt;Assoc Prof Philip Cunningham&lt;br/&gt;Prof Janette Perz&lt;br/&gt;Dr Nicola Straiton&lt;br/&gt;Prof Angela Dawson&lt;br/&gt;Prof Michelle Haber&lt;br/&gt;Prof Jason Kovacic&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">SPHERE will build workforce capacity through a refreshed Launchpad Clinician Researcher Fellowship scheme. This initiative continues our ongoing commitment to build capacity among early- to mid-career health professionals. We will also run the RIPE for Translation grant program across partners to improve health outcomes in priority populations.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046134</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046134</identifier>
            <identifier type="nhmrc">2046134</identifier>
            <name type="primary">
                <namePart>Health Translation Queensland</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0131-623X</identifier>
                <title>Prof Danny Liew</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Mental health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation</subject>
            <subject type="local">translation</subject>
            <subject type="local">health services research</subject>
            <subject type="local">clinical trial</subject>
            <subject type="local">mental health</subject>
            <subject type="local">consumer participation</subject>
            <description type="Chief Investigator Team">Prof Danny Liew&lt;br/&gt;Frank Tracey&lt;br/&gt;Hannah Bloch&lt;br/&gt;Prof Patsy Yates&lt;br/&gt;Prof Maher Gandhi&lt;br/&gt;Prof Fabienne Mackay&lt;br/&gt;Dr David Hansen&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Health Translation Queensland (HTQ) is a partnership that supports the translation of health research into real-world benefits for Queensland communities. HTQ brings together health care, research, and community partners to remove barriers preventing the translation of research into clinical practice. With support from the NHMRC, HTQ will expand its programs to streamline health research processes, build skills in the workforce, and ensure research delivers better health outcomes for everyone.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046143</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046143</identifier>
            <identifier type="nhmrc">2046143</identifier>
            <name type="primary">
                <namePart>Support for Western Australian Health Translation Network</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Debra_Turner</identifier>
                <title>Dr Debra Turner</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems</subject>
            <subject type="local">translation</subject>
            <subject type="local">translational research</subject>
            <subject type="local">implementation</subject>
            <subject type="local">consumers</subject>
            <subject type="local">consumer participation</subject>
            <description type="Chief Investigator Team">Dr Debra Turner&lt;br/&gt;Dr Jason Lenzo&lt;br/&gt;Steve Arnott&lt;br/&gt;Prof Romola Bucks&lt;br/&gt;Prof Caroline Finch&lt;br/&gt;Ms Debra Langridge&lt;br/&gt;Prof Desiree Silva&lt;br/&gt;Assoc Prof Stacey Waters&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Following consultation with our Partners, WAHTN will conduct four programs of work that address challenges in the health research translation space. Program 1 focuses on advancing implementation science in WA. Program 2 boosts visibility, connectivity and collaboration across WAHTN. Program 3 targets unmet research translation needs in rural primary care, and Program 4 enhances consumer and community involvement in health research. These initiatives align with WAHTN's updated strategic focus.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046160</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046160</identifier>
            <identifier type="nhmrc">2046160</identifier>
            <name type="primary">
                <namePart>Health Translation SA: Accelerating and amplifying the translation of research addressing priority health service issues in SA</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3832-541</identifier>
                <title>Prof Maria Makrides</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03e3kts03</identifier>
                <title>South Australian Health and Medical Research Institute Limited</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03e3kts03</identifier>
                <title>South Australian Health and Medical Research Institute Limited</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems</subject>
            <subject type="local">mental health services</subject>
            <subject type="local">lived experiences</subject>
            <subject type="local">implementation</subject>
            <subject type="local">collaboration</subject>
            <subject type="local">service delivery</subject>
            <description type="Chief Investigator Team">Prof Maria Makrides&lt;br/&gt;Ms Sinead O'Brien&lt;br/&gt;Prof Michelle McKay&lt;br/&gt;Ms Liz Prowse&lt;br/&gt;Prof Gillian Harvey&lt;br/&gt;Dr Michael Cusack&lt;br/&gt;Prof Paul Worley&lt;br/&gt;Assoc Prof Scott Clark&lt;br/&gt;Dr Gerry O'Callaghan&lt;br/&gt;Mrs Ellie Hodges&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Health Translation SA (HTSA) is SA’s statewide NHMRC accredited Research Translation Centre. HTSA will develop a statewide model to accelerate the adoption of evidence-based practices into routine care using the integration of lived experience peer workers in mental health services as a demonstration project. This work will enable HTSA to accelerate the translation of mental health research evidence, while creating a model to drive improvements in other health priority areas in the future.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046173</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046173</identifier>
            <identifier type="nhmrc">2046173</identifier>
            <name type="primary">
                <namePart>Accelerating Sydney Health Partners' strategic priorities</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6497-2827</identifier>
                <title>Prof Donald Nutbeam</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Multimorbidity</subject>
            <subject type="local">access to health care</subject>
            <subject type="local">evidence-based health care</subject>
            <subject type="local">health care delivery</subject>
            <subject type="local">health consumers</subject>
            <subject type="local">implementation</subject>
            <description type="Chief Investigator Team">Prof Donald Nutbeam&lt;br/&gt;Assoc Prof Angela Todd&lt;br/&gt;Prof Nancy Baxter&lt;br/&gt;Prof Anthony Schembri&lt;br/&gt;Assoc Prof Paula Bray&lt;br/&gt;Prof Clara Chow&lt;br/&gt;Prof Sarah Hilmer&lt;br/&gt;Prof Timothy Shaw&lt;br/&gt;Prof Philip O'Connell&lt;br/&gt;Mr Claude Gauchat&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Sydney Health Partners is a well-established partnership between five major health organisations, a university and 10 affiliated medical research institutes. Together the Partnership is working to focus more research on addressing the priorities of health services, clinicians and patients and on accelerating the use of that research to improve health care and health outcomes. This grant proposal aims to help the Partnership make faster progress on its agree strategic priorities.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046177</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046177</identifier>
            <identifier type="nhmrc">2046177</identifier>
            <name type="primary">
                <namePart>Strengthening Aboriginal Community-Controlled Health Organisations to lead health research in the Top End of the Northern Territory</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Leisa_McCarthy</identifier>
                <title>Dr Leisa McCarthy</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/006mbby82</identifier>
                <title>Menzies School of Health Research</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/57024747460</identifier>
                <title>Danila Dilba Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/23351866925</identifier>
                <title>Katherine West Health Board Aboriginal Corporation</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/89357836457</identifier>
                <title>Mala'la Health Service Aboriginal Corporation</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/26778213582</identifier>
                <title>Sunrise Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">capacity building</subject>
            <subject type="local">health systems</subject>
            <subject type="local">social determinants of health</subject>
            <subject type="local">community health care</subject>
            <description type="Chief Investigator Team">Dr Leisa McCarthy&lt;br/&gt;Ms Tiana McCoy&lt;br/&gt;Mr Sinon Cooney&lt;br/&gt;Rebecca Bond&lt;br/&gt;Ray Matthews&lt;br/&gt;Dr Paul Burgess&lt;br/&gt;Prof Alan Cass&lt;br/&gt;Prof Dominic Upton&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Medical Research Institute</description>
            <description type="full">Aboriginal Community-Controlled Health Services (ACCHS) have a vital role in improving health outcomes for Aboriginal people across the Top End of the Northern Territory. Working in collaboration with other key government and health services, and the key research institutions of the Northern Territory, TEAHRA is resourcing and strengthening the institutional capacity of ACCHS to lead health research that makes a difference to improve the health and wellbeing of Aboriginal people in the Top End.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">NT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046193</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046193</identifier>
            <identifier type="nhmrc">2046193</identifier>
            <name type="primary">
                <namePart>TAAHC Accelerator: Connecting Research and Research Translation</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-2165-5917</identifier>
                <title>Assoc Prof Rae Thomas</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04gsp2c11</identifier>
                <title>James Cook University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/25285907786</identifier>
                <title>Cairns and Hinterland Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/60821496581</identifier>
                <title>Torres and Cape Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/22406683778</identifier>
                <title>North West Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04gsp2c11</identifier>
                <title>James Cook University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/35605757640</identifier>
                <title>Northern Queensland Primary Health Network</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/97111116762</identifier>
                <title>Queensland Aboriginal and Islander Health Council</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/86747187217</identifier>
                <title>Townsville Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01w2yhe61</identifier>
                <title>Mackay Hospital and Health Service</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/52633876936</identifier>
                <title>Tropical Australian Academic Health Centre Limited</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Rural and remote health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation</subject>
            <subject type="local">translational research</subject>
            <subject type="local">capacity building</subject>
            <subject type="local">rural workforce</subject>
            <subject type="local">health care worker education</subject>
            <subject type="local">rural and remote health services</subject>
            <description type="Chief Investigator Team">Assoc Prof Rae Thomas&lt;br/&gt;Scott Davis&lt;br/&gt;Emer Prof Rhondda Jones&lt;br/&gt;Prof Andrew Mallett&lt;br/&gt;Prof Edward Strivens&lt;br/&gt;Prof Jonathan Golledge&lt;br/&gt;Prof Sarah Larkins&lt;br/&gt;Lee-Ann Farley&lt;br/&gt;Ben Tooth&lt;br/&gt;Natasha Fretwell&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The Tropical Australian Academic Health Centre (TAAHC) is based in northern Queensland. TAAHC will build on a strong platform of research and research translation education services to deliver new activities that 1) expand our training to more researchers and target research translation projects; 2) fund research translation projects; and 3) embed community and cultural values into our training. This will to improve the research capacity within NQ health and clinical practice.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046215</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046215</identifier>
            <identifier type="nhmrc">2046215</identifier>
            <name type="primary">
                <namePart>New South Wales Regional Health Partners</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Lisa_McFayden</identifier>
                <title>Dr Lisa McFayden</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00wfvh315</identifier>
                <title>Charles Sturt University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/050b31k83</identifier>
                <title>Hunter New England Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04r659a56</identifier>
                <title>The University of New England</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/019y11h89</identifier>
                <title>Western NSW Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/52081388810</identifier>
                <title>NSW Rural Doctors Network</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/63598010203</identifier>
                <title>NSW Regional Health Partners</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/57946356658</identifier>
                <title>Mid North Coast Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00wfvh315</identifier>
                <title>Charles Sturt University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health and community services</subject>
            <subject type="local">pain management</subject>
            <subject type="local">health economics</subject>
            <subject type="local">health outcomes</subject>
            <subject type="local">health policy</subject>
            <subject type="local">health services research</subject>
            <description type="Chief Investigator Team">Dr Lisa McFayden&lt;br/&gt;Prof Julian Grant&lt;br/&gt;Prof Christopher Levi&lt;br/&gt;Andrew Bailey&lt;br/&gt;Dr Kerrie Noonan&lt;br/&gt;Prof Megan Smith&lt;br/&gt;Assoc Prof Clara Murray&lt;br/&gt;Mike Edwards&lt;br/&gt;Peter Smith&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Research Translation Coordinators embedded in regional LHDs will drive research translation activities to address health service priorities and directly support healthcare workers to undertake projects that address local problems. Seed funding will accelerate research activity and CCI grants will ensure end-user involvement. A project to develop a community-based approach to pain management will address the disproportionately high burden of chronic pain among Aboriginal people in regional areas.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046520</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046520</identifier>
            <identifier type="nhmrc">2046520</identifier>
            <name type="primary">
                <namePart>Transforming healthcare at the Melbourne Academic Centre for Health</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2079-1586</identifier>
                <title>Prof John Savill</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/054bs2v13</identifier>
                <title>Mercy Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03grnna41</identifier>
                <title>The Royal Women's Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02p4mwa83</identifier>
                <title>Western Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04z4kmw33</identifier>
                <title>Melbourne Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/001kjn539</identifier>
                <title>St Vincent's Hospital Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/009k7c907</identifier>
                <title>Northern Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/008q4kt04</identifier>
                <title>The Royal Victorian Eye &amp; Ear Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02a8bt934</identifier>
                <title>Peter MacCallum Cancer Centre</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/35655720546</identifier>
                <title>The Royal Children's Hospital Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/05dbj6g52</identifier>
                <title>Austin Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems</subject>
            <subject type="local">health services research</subject>
            <subject type="local">health consumers</subject>
            <subject type="local">health care evaluation</subject>
            <subject type="local">access to health care</subject>
            <subject type="local">health care delivery</subject>
            <description type="Chief Investigator Team">Prof John Savill&lt;br/&gt;Prof Harriet Hiscock&lt;br/&gt;Assoc Prof Nicole Rankin&lt;br/&gt;Prof Kim Dalziel&lt;br/&gt;Dr Sanjeevan Muruganandan&lt;br/&gt;Assoc Prof Anita Skandarajah&lt;br/&gt;Prof Rochelle Wynne&lt;br/&gt;Ms Elena Gerstman&lt;br/&gt;Prof David Berlowitz&lt;br/&gt;Timothy Chittleborough&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Consumers of healthcare want to spend less time in hospital, communicate their progress more easily to health professionals and benefit from care pathways made more efficient by data sharing and analysis. To deliver these objectives we will bring together consumers and clinician-researchers to design and test successfully piloted new systems to care for patients that after adoption by healthcare providers will transform routine practice.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046742</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046742</identifier>
            <identifier type="nhmrc">2046742</identifier>
            <name type="primary">
                <namePart>Western Alliance: Accelerating health research translation</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-5046-3992</identifier>
                <title>Prof Warren Payne</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/14615833951</identifier>
                <title>Western Alliance</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Rural and remote health services</subject>
            <subject type="local">rural and remote health services</subject>
            <subject type="local">rural workforce</subject>
            <subject type="local">consumer participation</subject>
            <subject type="local">capacity building</subject>
            <subject type="local">aboriginal health</subject>
            <description type="Chief Investigator Team">Prof Warren Payne&lt;br/&gt;Mr Drew Aras&lt;br/&gt;Prof Vincent Versace&lt;br/&gt;Assoc Prof Annkarin Wong Shee&lt;br/&gt;Assoc Prof Nicole Mercer&lt;br/&gt;Dr Olivia King&lt;br/&gt;Dr Michael Field&lt;br/&gt;Dr Ella Ottrey&lt;br/&gt;Dr Jessie Adams&lt;br/&gt;Ms Katherine Stanley&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The 'Western Alliance: Accelerating Health Research Translation' project comprises high-priority activities designed to enhance rural and regional research translation efforts across western Victoria. These activities align with the Western Alliance Strategic Plan 2023-26, directly reflecting Alliance Health Service partner priorities. The project focuses on advancing Aboriginal-led research translation and accelerating efforts to involve consumers and community members in research translation.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2046800</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2046800</identifier>
            <identifier type="nhmrc">2046800</identifier>
            <name type="primary">
                <namePart>Aboriginal-Led Research Translation for Central Australia and the Barkly.</namePart>
            </name>
            <name type="alternative">
                <namePart>Supporting Research Translation Centres</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7552</identifier>
                <title>2025 Supporting Research Translation Centres</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5076-8160</identifier>
                <title>Prof Heather D'Antoine</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/76210591710</identifier>
                <title>Central Australian Aboriginal Congress Aboriginal Corporation</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/76210591710</identifier>
                <title>Researcherenye Wappayalawangka-Central Australia Academic Health Science Network</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander social determinants of health HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Primary health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">primary care</subject>
            <subject type="local">translational research</subject>
            <subject type="local">health systems</subject>
            <subject type="local">culturally appropriate methodology</subject>
            <description type="Chief Investigator Team">Prof Heather D'Antoine&lt;br/&gt;Mr John Huigen&lt;br/&gt;Ms Dallas McKeown&lt;br/&gt;Prof Alan Cass&lt;br/&gt;Mr Stuart McGifford&lt;br/&gt;Dr Richard Johnson&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-06-20T00:00:00</description>
            <description type="Application Year">2025</description>
            <description type="Organisation_Type">Health</description>
            <description type="full">This project will enhance and strengthen an Aboriginal-led Research Translation Centre (CAAHSN) to improve health, wellbeing, and social outcomes for Aboriginal people in Central Australia and the Barkly regions. It will help to expand practical health research, increase Aboriginal involvement, improve communication and application of findings for real-world impact, and strengthen CAAHSN’s support, training, and research collaboration functions.</description>
            <description type="fundingAmount">$1,000,000.00</description>
            <coverage>
                <spatial type="text">NT</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2040178</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2040178</identifier>
            <identifier type="nhmrc">2040178</identifier>
            <name type="primary">
                <namePart>The Research Ethics Plus AI (REP-AI) Project</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-2617-8694</identifier>
                <title>Prof Stacy Carter</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00jtmb277</identifier>
                <title>University of Wollongong</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00jtmb277</identifier>
                <title>University of Wollongong</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01sf06y89</identifier>
                <title>Macquarie University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">PHILOSOPHY AND RELIGIOUS STUDIES</subject>
            <subject type="anzsrc-for">Applied ethics</subject>
            <subject type="anzsrc-for">Ethical use of new technology INFORMATION AND COMPUTING SCIENCES</subject>
            <subject type="anzsrc-for">Human-centred computing</subject>
            <subject type="anzsrc-for">Fairness, accountability, transparency, trust and ethics of computer systems HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health informatics and information systems</subject>
            <subject type="local">bioethics</subject>
            <subject type="local">health services research</subject>
            <subject type="local">qualitative research</subject>
            <subject type="local">artificial intelligence</subject>
            <subject type="local">ethics</subject>
            <description type="Chief Investigator Team">Prof Stacy Carter&lt;br/&gt;Dr Lisa Eckstein&lt;br/&gt;Prof Farah Magrabi&lt;br/&gt;Dr Yagiz Alp Aksoy&lt;br/&gt;Prof Annette Braunack-Mayer&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Internationally and in Australia, the rapid advancement of artificial intelligence (AI) research and development is creating significant uncertainty for research governance and ethics review processes in even the best-administered organisations. This project will refine, test and scale solutions to support Human Research Ethics Committees, research governance units, and data access committees to oversee and evaluate health research that uses or develops health AI.</description>
            <description type="fundingAmount">$1,052,356.80</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043916</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043916</identifier>
            <identifier type="nhmrc">2043916</identifier>
            <name type="primary">
                <namePart>Establishment of horizon scanning of new medical and health technologies in Australia</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-9749-4160</identifier>
                <title>Dr Orin Chisholm</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation</subject>
            <subject type="local">future therapy</subject>
            <subject type="local">health service decision making</subject>
            <subject type="local">health systems</subject>
            <subject type="local">public health policy</subject>
            <subject type="local">surveillance</subject>
            <description type="Chief Investigator Team">Dr Orin Chisholm&lt;br/&gt;Prof Christine Lu&lt;br/&gt;Assoc Prof Sarah Norris&lt;br/&gt;Dr Franz Pichler&lt;br/&gt;Prof Jean Yang&lt;br/&gt;Prof Leszek Lisowski&lt;br/&gt;Prof Robyn Jamieson&lt;br/&gt;Prof Andrew Wilson&lt;br/&gt;Dr Amanda Rush&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United Kingdom&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This application proposes to develop a horizon scanning function for Australia, the Health Innovation Observatory-Australia, focused on the key needs of Commonwealth and State government decision-makers. The goal is to support short-term service preparedness and longer-term health system adaptation to emerging disruptive technology, thus helping streamline the review and implementation of new technologies, acting to reduce patient delays in accessing new therapies.</description>
            <description type="fundingAmount">$1,490,658.90</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2028-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2043935</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2043935</identifier>
            <identifier type="nhmrc">2043935</identifier>
            <name type="primary">
                <namePart>Risk Assessment for moving Individuals SafEly (RAISE) - optimising staff and patient safety</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-8825-5109</identifier>
                <title>Assoc Prof Natasha Brusco</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/001kjn539</identifier>
                <title>St Vincent's Hospital Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00vyyx863</identifier>
                <title>Eastern Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02t1bej08</identifier>
                <title>Monash Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/33370684005</identifier>
                <title>Cabrini Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">COMMERCE, MANAGEMENT, TOURISM AND SERVICES</subject>
            <subject type="anzsrc-for">Human resources and industrial relations</subject>
            <subject type="anzsrc-for">Occupational and workplace health and safety HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Patient safety HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Nursing</subject>
            <subject type="anzsrc-for">Aged care nursing</subject>
            <subject type="local">occupational health and safety</subject>
            <subject type="local">patient safety</subject>
            <subject type="local">physical inactivity</subject>
            <subject type="local">injury prevention</subject>
            <subject type="local">training</subject>
            <description type="Chief Investigator Team">Assoc Prof Natasha Brusco&lt;br/&gt;Prof Nicholas Taylor&lt;br/&gt;Prof Helen Rawson&lt;br/&gt;Ms Helen Kugler&lt;br/&gt;Prof Alex Collie&lt;br/&gt;Assoc Prof Christina Ekegren&lt;br/&gt;Prof Keith Hill&lt;br/&gt;Prof Terrence Haines&lt;br/&gt;Prof Jessica Kasza&lt;br/&gt;Dr Amelia Crabtree&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The health and aged care workforce are at risk of workplace injuries during staff-assisted patient or resident movement, and manual handling training alone does not reduce the risk. The new Risk Assessment for moving Individuals SafEly (RAISE) program is different, as RAISE also upskills staff in Dynamic Risk Assessment (DRA), which integrates with organisational systems to reduce or eliminate risks. Our work has shown RAISE-trained staff can effectively embed DRA into clinical practice.</description>
            <description type="fundingAmount">$1,439,943.29</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044107</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044107</identifier>
            <identifier type="nhmrc">2044107</identifier>
            <name type="primary">
                <namePart>Spark: A community co-design model to fight loneliness</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7614-5041</identifier>
                <title>Dr Nadia Corsini</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01p93h210</identifier>
                <title>University of South Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01p93h210</identifier>
                <title>University of South Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care</subject>
            <subject type="local">social capital</subject>
            <subject type="local">social health issues</subject>
            <subject type="local">community intervention</subject>
            <subject type="local">community participation</subject>
            <subject type="local">prevention</subject>
            <description type="Chief Investigator Team">Dr Nadia Corsini&lt;br/&gt;Prof Deborah Turnbull&lt;br/&gt;Assoc Prof Carmel Williams&lt;br/&gt;Prof Marion Eckert&lt;br/&gt;Assoc Prof Fanke Peng&lt;br/&gt;Assoc Prof Ecushla Linedale&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Loneliness is an emerging health threat with one in three Australians lonely. Partnering with state government, councils and community organisations, Spark addresses loneliness at the community level by co-designing, supporting and evaluating evidence-based innovations to ignite human connection. Spark creates community capacity through a volunteer network, education and a toolkit to ensure sustainability. Partnering with state government policy-makers bridges the gap from evidence to practice.</description>
            <description type="fundingAmount">$496,243.35</description>
            <coverage>
                <spatial type="text">SA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044139</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044139</identifier>
            <identifier type="nhmrc">2044139</identifier>
            <name type="primary">
                <namePart>Implementing Cognitive Bias Modification during inpatient withdrawal treatment to prevent alcohol relapse</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3908-5980</identifier>
                <title>Prof Victoria Manning</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00eae9z71</identifier>
                <title>The University of Newcastle</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Mental health services</subject>
            <subject type="local">alcohol addiction</subject>
            <subject type="local">addiction treatment</subject>
            <subject type="local">cognition</subject>
            <subject type="local">implementation</subject>
            <subject type="local">health services research</subject>
            <description type="Chief Investigator Team">Prof Victoria Manning&lt;br/&gt;Prof Paul Haber&lt;br/&gt;Prof Daniel Lubman&lt;br/&gt;Prof Patrick Olivier&lt;br/&gt;Prof Adrian Dunlop&lt;br/&gt;Prof Kirsten Morley&lt;br/&gt;Prof Jessica Kasza&lt;br/&gt;Prof Cathrine Mihalopoulos&lt;br/&gt;Prof Malcolm Hopwood&lt;br/&gt;Dr Alex Waddell&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">“Cognitive bias modification” (CBM) is a form of computerised brain training that reduces urges to drink alcohol. Multiple clinical trials have found that CBM helps alcohol dependent patients avoid alcohol during the months after leaving inpatient treatment, yet it is still not used in clinical practice. This project will develop and test ways to make it easy for treatment services to routinely offer CBM, both during and after residential treatment to optimise patient outcomes.</description>
            <description type="fundingAmount">$1,499,118.61</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044201</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044201</identifier>
            <identifier type="nhmrc">2044201</identifier>
            <name type="primary">
                <namePart>RISE: Modelling RSV Immunisation Strategies for Evidence-based Policy</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-6434-8290</identifier>
                <title>Assoc Prof Hannah Moore</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n415q13</identifier>
                <title>Curtin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02n415q13</identifier>
                <title>Curtin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01dbmzx78</identifier>
                <title>The Kids Research Institute Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Epidemiology</subject>
            <subject type="anzsrc-for">Epidemiological modelling HUMAN SOCIETY</subject>
            <subject type="anzsrc-for">Policy and administration</subject>
            <subject type="anzsrc-for">Health policy BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Infectious diseases</subject>
            <subject type="local">respiratory syncytial virus</subject>
            <subject type="local">immunisation</subject>
            <subject type="local">epidemiology</subject>
            <subject type="local">health policy</subject>
            <subject type="local">child health</subject>
            <description type="Chief Investigator Team">Assoc Prof Hannah Moore&lt;br/&gt;Prof Christopher Blyth&lt;br/&gt;Prof Peter Richmond&lt;br/&gt;Prof Kathryn Glass&lt;br/&gt;Dr Alexandra Hogan&lt;br/&gt;Dr Jeffrey Cannon&lt;br/&gt;Dr Avram Levy&lt;br/&gt;Dr Paul Effler&lt;br/&gt;Prof Kristine Macartney&lt;br/&gt;Mrs Catherine Hughes&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Respiratory syncytial virus (RSV) causes significant burden. Immunisation strategies are now available but decisions need to be made for effective policy. The RISE project will guide equitable and efficient RSV immunisation policy by using real-world data and mathematical models. We will assess the health and economic impact of different immunisation strategies, develop communication tools for effective policy advice, and refine these with two-way communication between Partner Organisations.</description>
            <description type="fundingAmount">$1,499,072.60</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044290</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044290</identifier>
            <identifier type="nhmrc">2044290</identifier>
            <name type="primary">
                <namePart>Optimising maternal and neonatal outcomes through data driven, co-designed initiatives in maternal immunisation programs</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-3007-1822</identifier>
                <title>Prof Michelle Giles</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03grnna41</identifier>
                <title>The Royal Women's Hospital</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04d87y574</identifier>
                <title>Sydney Children's Hospitals Network</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01e2ynf23</identifier>
                <title>Women's and Children's Health Network</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/048fyec77</identifier>
                <title>Murdoch Children's Research Institute</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Monash_Partners</identifier>
                <title>Monash Partners</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02t1bej08</identifier>
                <title>Monash Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation HUMAN SOCIETY</subject>
            <subject type="anzsrc-for">Policy and administration</subject>
            <subject type="anzsrc-for">Health policy</subject>
            <subject type="local">pregnancy</subject>
            <subject type="local">vaccination</subject>
            <subject type="local">public health policy</subject>
            <subject type="local">implementation</subject>
            <subject type="local">public health impact</subject>
            <description type="Chief Investigator Team">Prof Michelle Giles&lt;br/&gt;Prof Caroline Homer&lt;br/&gt;Prof Helen Marshall&lt;br/&gt;Assoc Prof Bette Liu&lt;br/&gt;Assoc Prof Ryan Hodges&lt;br/&gt;Dr Sandra Reeder&lt;br/&gt;Dr Allison Cairns&lt;br/&gt;Mrs Catherine Hughes&lt;br/&gt;Prof Nigel Crawford&lt;br/&gt;Assoc Prof Zoe Bradfield&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">In Australia there are up to 4 vaccines recommended in pregnancy- influenza, pertussis, COVID-19 and RSV. The aim of this research is to tackle the suboptimal coverage in pregnancy by linking datasets to understand the factors contributing to low uptake, to work with these populations to co-design a maternal vaccine schedule, and to evaluate the implementation, effectiveness, and sustainability of the RSV combination program starting in 2025 to inform future RSV prevention strategies.</description>
            <description type="fundingAmount">$1,491,392.80</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044337</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044337</identifier>
            <identifier type="nhmrc">2044337</identifier>
            <name type="primary">
                <namePart>Enhancing primary care workforce capacity and cultural competency to optimise early childhood growth: a co-design approach</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-1381-4022</identifier>
                <title>Prof Li Ming Wen</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04w6y2z35</identifier>
                <title>Sydney Local Health District</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Implementation science and evaluation HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion</subject>
            <subject type="local">work capacity evaluation</subject>
            <subject type="local">infant development</subject>
            <subject type="local">participatory action research</subject>
            <subject type="local">community child health</subject>
            <subject type="local">evidence-based health care</subject>
            <description type="Chief Investigator Team">Prof Li Ming Wen&lt;br/&gt;Prof Louise Baur&lt;br/&gt;Dr Sarah Marshall&lt;br/&gt;Prof Elizabeth Denney-Wilson&lt;br/&gt;Prof Susan Woolfenden&lt;br/&gt;Assoc Prof Jane Kohlhoff&lt;br/&gt;Prof Philayrath Phongsavan&lt;br/&gt;Ms Eve House&lt;br/&gt;Prof Valsamma Eapen&lt;br/&gt;Dr Sarah Taki&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Promoting health behaviours in early childhood is important for child health growth and long-term health benefits, in particular, of children from non-English-speaking backgrounds. This proposal aims to develop an appropriate training program for improving skills and knowledge of primary healthcare professionals in promoting nutrition and physical activity of young children. This national project will develop policy and practice recommendations for children’s optimal nutrition and growth.</description>
            <description type="fundingAmount">$897,402.20</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2028-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044530</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044530</identifier>
            <identifier type="nhmrc">2044530</identifier>
            <name type="primary">
                <namePart>Innovative digital solution to optimise STI/HIV management in general practice</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-5580-360X</identifier>
                <title>Dr Jane Goller</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">General practice HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Preventative health care HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Primary health care</subject>
            <subject type="local">sexually-transmitted infections (sti)</subject>
            <subject type="local">sexual health</subject>
            <subject type="local">primary care</subject>
            <subject type="local">health services research</subject>
            <subject type="local">clinical decision making</subject>
            <description type="Chief Investigator Team">Dr Jane Goller&lt;br/&gt;Dr Jacqueline Coombe&lt;br/&gt;Prof Jane Hocking&lt;br/&gt;Prof Lena Sanci&lt;br/&gt;Prof Douglas Boyle&lt;br/&gt;Dr Barbara Hunter&lt;br/&gt;Dr Amalia Karahalios&lt;br/&gt;Prof Jason Ong&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Sexually transmissible infections (STIs) are rising in Australia and cause serious complications like infertility and infant death. Most people visit a general practice doctor each year. But doctors may not talk about sexual health care if a patient visits for a different reason. This research will develop a digital tool to remind doctors to talk to patients about STI or HIV and link them to the best information. It will find out if doctors like the tool and if it improves STI or HIV care.</description>
            <description type="fundingAmount">$1,499,991.80</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044568</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044568</identifier>
            <identifier type="nhmrc">2044568</identifier>
            <name type="primary">
                <namePart>Helping Those Who Help: A co-created lifestyle intervention for health professionals to maximise retention and performance.</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5394-0931</identifier>
                <title>Prof Lauren Ball</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04sjbnx57</identifier>
                <title>University of Southern Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04cxm4j25</identifier>
                <title>Australian Catholic University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion COMMERCE, MANAGEMENT, TOURISM AND SERVICES</subject>
            <subject type="anzsrc-for">Human resources and industrial relations</subject>
            <subject type="anzsrc-for">Workplace wellbeing and quality of working life HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health services and systems not elsewhere classified</subject>
            <subject type="local">health professionals</subject>
            <subject type="local">health behaviours</subject>
            <subject type="local">wellbeing</subject>
            <subject type="local">nutrition</subject>
            <subject type="local">physical activity</subject>
            <description type="Chief Investigator Team">Prof Lauren Ball&lt;br/&gt;Prof Joy Parkinson&lt;br/&gt;Prof Genevieve Healy&lt;br/&gt;Prof Sarah McNaughton&lt;br/&gt;Prof Tracy Kolbe-Alexander&lt;br/&gt;Dr Jaimon Kelly&lt;br/&gt;Dr Amy Kirkegaard&lt;br/&gt;Dr Isaac Koomson&lt;br/&gt;Mrs Emma Rebolledo -Atherton&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This project aims to improve the health and wellbeing of health professionals in Springfield, Queensland. We will design and test an interventions that helps health professionals optimise their diet and physical activity, as well as other lifestyle behaviours deemed important to local health professionals. The results will inform future strategies for creating healthier workplaces and communities, benefiting healthcare professionals and the wider population.</description>
            <description type="fundingAmount">$263,444.60</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2028-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044573</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044573</identifier>
            <identifier type="nhmrc">2044573</identifier>
            <name type="primary">
                <namePart>Developing evidence for the implementation of effective Food Voucher InitiaTives in AustraLia (FOOD VITAL)</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-7343-2424</identifier>
                <title>Dr Christina Zorbas</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0130frc33</identifier>
                <title>University of North Carolina at Chapel Hill</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Nutrition and dietetics</subject>
            <subject type="anzsrc-for">Public health nutrition HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health equity HUMAN SOCIETY</subject>
            <subject type="anzsrc-for">Policy and administration</subject>
            <subject type="anzsrc-for">Health policy</subject>
            <subject type="local">public health policy</subject>
            <subject type="local">socioeconomic status</subject>
            <subject type="local">dietary intake</subject>
            <subject type="local">community health</subject>
            <subject type="local">health inequalities</subject>
            <description type="Chief Investigator Team">Dr Christina Zorbas&lt;br/&gt;Assoc Prof Jaithri Ananthapavan&lt;br/&gt;Shu Wen Ng&lt;br/&gt;Dr Rebecca Lindberg&lt;br/&gt;Prof Kathryn Backholer&lt;br/&gt;Prof Liliana Orellana&lt;br/&gt;Dr Suzanne Kleve&lt;br/&gt;Dr Anna Chapman&lt;br/&gt;Prof Anna Peeters&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United States of America&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Australia has a growing food insecurity problem with major implications for access to healthy diets. Our proposal brings together community partners to evaluate novel food voucher programs implemented to support people experiencing food insecurity. This research will bridge key knowledge and practice gaps to establish the impacts, benefits and challenges of these food voucher programs, and inform a universal understanding of program acceptability and scalability in Australia.</description>
            <description type="fundingAmount">$689,397.60</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2028-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044582</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044582</identifier>
            <identifier type="nhmrc">2044582</identifier>
            <name type="primary">
                <namePart>PRESTIGE: Preoperative Rehabilitation Evaluation and Surgical Treatment Intervention for Enhanced Recovery</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3479-0683</identifier>
                <title>Prof Manuela Ferreira</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/023331s46</identifier>
                <title>The George Institute for Global Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science</subject>
            <subject type="anzsrc-for">Allied health and rehabilitation science not elsewhere classified BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Surgery PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Clinical and health psychology</subject>
            <subject type="anzsrc-for">Counselling psychology</subject>
            <subject type="local">low back pain</subject>
            <subject type="local">rehabilitation</subject>
            <subject type="local">clinical effectiveness</subject>
            <subject type="local">health service utilisation</subject>
            <subject type="local">physical disability</subject>
            <description type="Chief Investigator Team">Prof Manuela Ferreira&lt;br/&gt;Prof Paulo Ferreira&lt;br/&gt;Emer Prof Adrian Bauman&lt;br/&gt;Dr Jillian Eyles&lt;br/&gt;Prof Blake Dear&lt;br/&gt;Prof Emily Callander&lt;br/&gt;Mr Qiang Li&lt;br/&gt;Dr David Anderson&lt;br/&gt;Prof David Beard&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Spinal surgery costs Australians almost $1.8 billion/year and does not always result in the benefits people hoped for. We will test new ways to enhance and optimise the surgical pathway to improve function after surgery and reduce hospital stay. We will conduct a large study to test which modernised way to deliver healthcare is more cost-effective.</description>
            <description type="fundingAmount">$1,497,027.90</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044640</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044640</identifier>
            <identifier type="nhmrc">2044640</identifier>
            <name type="primary">
                <namePart>Transforming the delivery of acute cardiac care: Getting the right patient, the right care, at the right time and place</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0001-8686-2709</identifier>
                <title>Prof Dion Stub</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/009k7c907</identifier>
                <title>Northern Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00z7r8y22</identifier>
                <title>Ambulance Victoria</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04scfb908</identifier>
                <title>Alfred Health</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Paramedicine BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases)</subject>
            <subject type="local">health services research</subject>
            <subject type="local">emergency medical service</subject>
            <subject type="local">health systems</subject>
            <subject type="local">continuity of care</subject>
            <subject type="local">cardiac</subject>
            <description type="Chief Investigator Team">Prof Dion Stub&lt;br/&gt;Dr Jocasta Ball&lt;br/&gt;Dr Ziad Nehme&lt;br/&gt;Prof David Kaye&lt;br/&gt;Dr Loren Sher&lt;br/&gt;Prof Jessica Kasza&lt;br/&gt;Dr Ella Zomer&lt;br/&gt;Mark Horrigan&lt;br/&gt;Prof Derek Chew&lt;br/&gt;Dr Susan Cartledge&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">Managing cardiac patients is increasingly complex. We have shown that a delay in ambulance offloading at hospital raises the risk of death and reattendance. With &gt;1 million ambulance calls in Victoria each year, all cardiac patients are taken to hospital regardless of risk which is costly. We're partnering with health services, government and consumers to introduce risk stratification and virtual care, allowing low-risk cardiac patients to stay at home, reducing transports to hospital and costs.</description>
            <description type="fundingAmount">$1,499,792.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044727</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044727</identifier>
            <identifier type="nhmrc">2044727</identifier>
            <name type="primary">
                <namePart>A community based participatory research approach to strengthening social and emotional development from early childhood to young adulthood.</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5927-2014</identifier>
                <title>Prof Craig Olsson</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/42498937037</identifier>
                <title>Mildura Rural City Council</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02czsnj07</identifier>
                <title>Deakin University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02fcqpe40</identifier>
                <title>Municipal Association of Victoria</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02xvc5r05</identifier>
                <title>Victorian State Government</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/93103445051</identifier>
                <title>North Central Local Learning and Employment Network</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/21973226012</identifier>
                <title>YARRA RANGES SHIRE COUNCIL</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">PSYCHOLOGY</subject>
            <subject type="anzsrc-for">Applied and developmental psychology</subject>
            <subject type="anzsrc-for">Child and adolescent development</subject>
            <subject type="local">monitoring</subject>
            <subject type="local">young children</subject>
            <subject type="local">adolescence</subject>
            <subject type="local">young adults</subject>
            <subject type="local">mental health promotion</subject>
            <description type="Chief Investigator Team">Prof Craig Olsson&lt;br/&gt;Prof Matthew Fuller-Tyszkiewicz&lt;br/&gt;Emer Prof Stephen Zubrick&lt;br/&gt;Prof Melissa Green&lt;br/&gt;Dr Christopher Greenwood&lt;br/&gt;Prof Suzanne Robinson&lt;br/&gt;Prof Peter Butterworth&lt;br/&gt;Dr Kate Lycett&lt;br/&gt;Assoc Prof Rebecca Glauert&lt;br/&gt;Martin Guhn&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The Comprehensive Monitoring System (CMS) was co-designed with communities to support place-based data collection from early childhood to young adulthood. The CMS has been shown to help communities make place-based decisions about where and with whom to place often limited mental health promotion resources. This partnership project extends CMS testing to larger and more complex areas, empowering communities with their own data to drive social change.</description>
            <description type="fundingAmount">$1,392,119.40</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044771</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044771</identifier>
            <identifier type="nhmrc">2044771</identifier>
            <name type="primary">
                <namePart>Evaluating health economic and equity consequences of government regulations of e-cigarette use (E4 study)</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-3159-4249</identifier>
                <title>Prof Louisa Collins</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03g5d6c96</identifier>
                <title>Cancer Council Queensland</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03g5d6c96</identifier>
                <title>Cancer Council Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Public Health Research</subject>
            <subject type="anzsrc-for">ECONOMICS</subject>
            <subject type="anzsrc-for">Applied economics</subject>
            <subject type="anzsrc-for">Health economics HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Public health</subject>
            <subject type="anzsrc-for">Health promotion HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Health systems</subject>
            <subject type="local">tobacco control</subject>
            <subject type="local">health policy</subject>
            <subject type="local">health economics</subject>
            <subject type="local">equity</subject>
            <subject type="local">population studies</subject>
            <description type="Chief Investigator Team">Prof Louisa Collins&lt;br/&gt;Assoc Prof Michelle Jongenelis&lt;br/&gt;Prof Kerrianne Watt&lt;br/&gt;Assoc Prof Alexander Larcombe&lt;br/&gt;Dr Daniel Lindsay&lt;br/&gt;Dr Anita Lal&lt;br/&gt;Assoc Prof Henry Marshall&lt;br/&gt;Prof Francis Mitrou&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">Other</description>
            <description type="full">In 2024, laws in Australia were passed so that the manufacture, supply and sales of e-cigarettes for recreational use is now prohibited. Vapes can only be purchased from pharmacies for smoking cessation. This study will evaluate the health, economic and equity impacts of the new e-cigarette reforms. We will work with our partners to construct and implement a detailed mathematical e-cigarette policy model for Australia and assess both the short term (5 year) and long term (30 year) outcomes.</description>
            <description type="fundingAmount">$232,886.80</description>
            <coverage>
                <spatial type="text">QLD</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2027-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044775</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044775</identifier>
            <identifier type="nhmrc">2044775</identifier>
            <name type="primary">
                <namePart>Developing an evidence-based clinical pathway for reducing coronary artery disease risks related to per- and polyfluoroalkyl substances (PFAS) in firefighters and communities with high exposure levels</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-5080-6083</identifier>
                <title>Prof Gemma Figtree</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00rqy9422</identifier>
                <title>The University of Queensland</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/0384j8v12</identifier>
                <title>University of Sydney</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases)</subject>
            <subject type="local">cardiovascular disease</subject>
            <subject type="local">environmental health</subject>
            <subject type="local">biomarkers</subject>
            <subject type="local">systems biology</subject>
            <subject type="local">health outcomes</subject>
            <description type="Chief Investigator Team">Prof Gemma Figtree&lt;br/&gt;Prof Clara Chow&lt;br/&gt;Prof Stuart Grieve&lt;br/&gt;Prof Peter Psaltis&lt;br/&gt;Assoc Prof Leisa-Maree Toms&lt;br/&gt;Prof Jochen Mueller&lt;br/&gt;Dr Sandra Nilsson&lt;br/&gt;Prof Jean Yang&lt;br/&gt;Dr Margaret Kay&lt;br/&gt;Prof Kazuaki Negishi&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;United Kingdom&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">This research aims to reduce heart disease risk linked to "forever chemicals" called PFAS, found in the environment and in people, especially firefighters and communities with high exposure. By studying heart scans and blood data from 4,000 Australians, we will develop screening and treatment options, including testing the effect of blood reduction strategies on heart health. The project will help set guidelines for testing, managing, and treating PFAS exposure.</description>
            <description type="fundingAmount">$1,496,961.40</description>
            <coverage>
                <spatial type="text">NSW</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2028-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044807</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044807</identifier>
            <identifier type="nhmrc">2044807</identifier>
            <name type="primary">
                <namePart>Revolutionising Prehospital Stroke Care: Imaging, Connectivity and World’s First Air Stroke Ambulance</namePart>
            </name>
            <name type="alternative">
                <namePart>Partnership Projects</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO6697</identifier>
                <title>2024 Partnership Projects - Peer Review Cycle 3</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="local">Dr_Anna_Balabanski</identifier>
                <title>Dr Anna Balabanski</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://abr.business.gov.au/ABN/View/74438059643</identifier>
                <title>Royal Flying Doctor Service of Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/00892tw58</identifier>
                <title>The University of Adelaide</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02bfwt286</identifier>
                <title>Monash University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Health Services Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Rural and remote health services BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Cardiovascular medicine and haematology</subject>
            <subject type="anzsrc-for">Cardiology (incl. cardiovascular diseases) BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Medical biotechnology</subject>
            <subject type="anzsrc-for">Medical biotechnology not elsewhere classified</subject>
            <subject type="local">acute stroke</subject>
            <subject type="local">brain imaging</subject>
            <subject type="local">rural and remote health services</subject>
            <subject type="local">access to health care</subject>
            <subject type="local">indigenous health</subject>
            <description type="Chief Investigator Team">Dr Anna Balabanski&lt;br/&gt;Dr Angela Dos Santos&lt;br/&gt;Prof Stephen Davis&lt;br/&gt;Prof Geoffrey Donnan&lt;br/&gt;Prof Timothy Kleinig&lt;br/&gt;Prof Dominique Cadilhac&lt;br/&gt;Prof Leonid Churilov&lt;br/&gt;Dr Joosup Kim&lt;br/&gt;Mr Brian Gonzales&lt;br/&gt;Dr Zoe Schofield&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-10T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The Australian Stroke Alliance (ASA) is addressing the unmet need of urgent stroke treatment in regional and remote Australia by reshaping prehospital care. In partnership with technology company Micro-X Ltd, the ASA have developed a lightweight brain scanner to detect stroke. We will undertake a world-first study using these brain scanners in air ambulances in remote Australia. This innovation has the potential to transform prehospital stroke care delivery on a national and global scale.</description>
            <description type="fundingAmount">$1,412,970.30</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-10-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2030-09-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044684</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044684</identifier>
            <identifier type="nhmrc">2044684</identifier>
            <name type="primary">
                <namePart>Co-design of Indigenous dementia Resources in Canada and AustraLia (CIRCLE): Enhancing health communication for Indigenous peoples along the dementia journey</namePart>
            </name>
            <name type="alternative">
                <namePart>International Collaborations</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7114</identifier>
                <title>2024 NHMRC-CIHR Canadian Consortium on Neurodegeneration in Aging (CCNA): Indigenous Health Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0003-4077-1996</identifier>
                <title>Assoc Prof Kate Smith</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04gsp2c11</identifier>
                <title>James Cook University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03yjb2x39</identifier>
                <title>University of Calgary</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/047272k79</identifier>
                <title>University of Western Australia</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health services HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Aged health care INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing</subject>
            <subject type="anzsrc-for">Aboriginal and Torres Strait Islander health and wellbeing not elsewhere classified</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">aged health</subject>
            <subject type="local">dementia</subject>
            <subject type="local">cognitive assessment</subject>
            <subject type="local">community preferences</subject>
            <description type="Chief Investigator Team">Assoc Prof Kate Smith&lt;br/&gt;Dr Pamela Roach&lt;br/&gt;Prof Dawn Bessarab&lt;br/&gt;Ms Roslyn Malay&lt;br/&gt;Dr Daniel Hunt&lt;br/&gt;Prof Dina LoGiudice&lt;br/&gt;Assoc Prof Sarah Russell&lt;br/&gt;Prof Leon Flicker&lt;br/&gt;Assoc Prof Carmela Pestell&lt;br/&gt;Ms Lianne Gilchrist&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;Canada&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-27T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">CIRCLE aims to improve the quality of dementia care for Indigenous peoples in Australia and Canada. This project will collaboratively develop community-informed resources for culturally responsive and respectful health communication along the dementia journey, enhancing the accessibility and quality of health care. CIRCLE directly addresses a crucial dementia care priority identified by Indigenous Elders, enabling better health and quality of life outcomes for Indigenous peoples internationally.</description>
            <description type="fundingAmount">$1,500,000.00</description>
            <coverage>
                <spatial type="text">WA</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
    <registryObject group="National Health and Medical Research Council">
        <key>http://purl.org/au-research/grants/nhmrc/2044716</key>
        <originatingSource>www.nhmrc.gov.au/grants/research-funding-statistics-and-data</originatingSource>
        <activity type="grant">
            <identifier type="purl">http://purl.org/au-research/grants/nhmrc/2044716</identifier>
            <identifier type="nhmrc">2044716</identifier>
            <name type="primary">
                <namePart>Strengths-based approaches to cognitive impairment, dementia and frailty in older First Nations people in Canada and Australia</namePart>
            </name>
            <name type="alternative">
                <namePart>International Collaborations</namePart>
            </name>
            <relatedInfo type="activity">
                <identifier type="local">GO7114</identifier>
                <title>2024 NHMRC-CIHR Canadian Consortium on Neurodegeneration in Aging (CCNA): Indigenous Health Research</title>
                <relation type="isPartOf"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="orcid">0000-0002-0391-3898</identifier>
                <title>Prof Dina LoGiudice</title>
                <relation type="hasPrincipalInvestigator"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="doi">10.13039/501100000925</identifier>
                <title>National Health and Medical Research Council</title>
                <relation type="isFundedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="isManagedBy"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/04gsp2c11</identifier>
                <title>James Cook University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/01ej9dk98</identifier>
                <title>University of Melbourne</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/02fa3aq29</identifier>
                <title>McMaster University</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <relatedInfo type="party">
                <identifier type="uri">https://ror.org/03r8z3t63</identifier>
                <title>University of New South Wales</title>
                <relation type="hasParticipant"/>
            </relatedInfo>
            <subject type="local">Clinical Medicine and Science Research</subject>
            <subject type="anzsrc-for">HEALTH SCIENCES</subject>
            <subject type="anzsrc-for">Health services and systems</subject>
            <subject type="anzsrc-for">Multimorbidity INDIGENOUS STUDIES</subject>
            <subject type="anzsrc-for">Other Indigenous studies</subject>
            <subject type="anzsrc-for">Other Indigenous studies not elsewhere classified BIOMEDICAL AND CLINICAL SCIENCES</subject>
            <subject type="anzsrc-for">Clinical sciences</subject>
            <subject type="anzsrc-for">Geriatrics and gerontology</subject>
            <subject type="local">aboriginal health</subject>
            <subject type="local">dementia</subject>
            <subject type="local">frailty</subject>
            <subject type="local">community preferences</subject>
            <subject type="local">geriatric assessment</subject>
            <description type="Chief Investigator Team">Prof Dina LoGiudice&lt;br/&gt;Jennifer Walker&lt;br/&gt;Prof Sean Taylor&lt;br/&gt;Dr Jesse Zanker&lt;br/&gt;Dr Ebony Lewis&lt;br/&gt;Assoc Prof Kate Smith&lt;br/&gt;Mr Harold Douglas&lt;br/&gt;Ms Joanne Luke&lt;br/&gt;Prof Leon Flicker&lt;br/&gt;Dr Huong Nguyen&lt;br/&gt;</description>
            <description type="Collaborating Countries">Australia&lt;br/&gt;Canada&lt;br/&gt;</description>
            <description type="Date Announced">2025-07-27T00:00:00</description>
            <description type="Application Year">2024</description>
            <description type="Organisation_Type">University</description>
            <description type="full">The overall goal of this collaborative project between First Nations in Canada and Australia is to develop strength-based approaches to assessing and measuringcognitive impairment, dementia, and frailtythat are rooted in First Nations understandings of aging, health, and frailty and informed by clinical understandings of frailty, cognition, and dementia. In addition, this proposal will lead to increased collaboration between First Nations researchers and communities in Australia and Canada.</description>
            <description type="fundingAmount">$1,500,000.00</description>
            <coverage>
                <spatial type="text">VIC</spatial>
            </coverage>
            <existenceDates>
                <startDate dateFormat="W3CDTF">2025-07-01T00:00:00</startDate>
                <endDate dateFormat="W3CDTF">2029-06-30T00:00:00</endDate>
            </existenceDates>
        </activity>
    </registryObject>
</registryObjects>